The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk

Abstract

Life expectancy is increasing throughout the world and coincides with a rise in non-communicable diseases (NCDs), especially for metabolic disease that includes diabetes mellitus (DM) and neurodegenerative disorders. The debilitating effects of metabolic disorders influence the entire body and significantly affect the nervous system impacting greater than one billion people with disability in the peripheral nervous system as well as with cognitive loss, now the seventh leading cause of death worldwide. Metabolic disorders, such as DM, and neurologic disease remain a significant challenge for the treatment and care of individuals since present therapies may limit symptoms but do not halt overall disease progression. These clinical challenges to address the interplay between metabolic and neurodegenerative disorders warrant innovative strategies that can focus upon the underlying mechanisms of aging-related disorders, oxidative stress, cell senescence, and cell death. Programmed cell death pathways that involve autophagy, apoptosis, ferroptosis, and pyroptosis can play a critical role in metabolic and neurodegenerative disorders and oversee processes that include insulin resistance, β-cell function, mitochondrial integrity, reactive oxygen species release, and inflammatory cell activation. The silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1), AMP activated protein kinase (AMPK), and Wnt1 inducible signaling pathway protein 1 (WISP1) are novel targets that can oversee programmed cell death pathways tied to β-nicotinamide adenine dinucleotide (NAD⁺), nicotinamide, apolipoprotein E (APOE), severe acute respiratory syndrome (SARS-CoV-2) exposure with coronavirus disease 2019 (COVID-19), and trophic factors, such as erythropoietin (EPO). The pathways of programmed cell death, SIRT1, AMPK, and WISP1 offer exciting prospects for maintaining metabolic homeostasis and nervous system function that can be compromised during aging-related disorders and lead to cognitive impairment, but these pathways have dual roles in determining the ultimate fate of cells and organ systems that warrant thoughtful insight into complex autofeedback mechanisms.

1 Introduction

Disorders such as diabetes mellitus (DM) and cellular metabolic disease are increasing in prevalence throughout the world. Over a thirty-five year course from the year 1980, the number of individuals with DM increased from one hundred eight million to over four hundred twenty-two million individuals (1, 2). By the year 2045, seven hundred million individuals may have DM (3, 4). From the years 2013 to 2016, the prevalence of DM has risen from over nine percent (5). DM is a chronic disorder that affects all organs of the body leading to cardiac disease, retinal disease, hepatic injury, cerebral ischemia, limb amputation, and renal failure (5–18). Almost one half billion individuals have DM and at least half of the four million deaths that occur per year with DM impact individuals less than seventy years of age (1, 7, 19–22). Ten percent of the population in the United States (US) are currently reported to suffer from DM (23, 24). However, it is believed that many additional individuals have disorders of metabolism or have elevated risk to develop DM, but remain undiagnosed at present (3, 16, 21, 25–37). It is estimated that in individuals greater than eighteen years old, seven million may not be correctly diagnosed as having DM and more than thirty-five percent of US adults may have prediabetes due to elevations in their fasting glucose and hemoglobin A1c (HbA_1c) parameters (7, 38). Globally, four hundred million individuals are estimated to have metabolic disease or be at risk for developing DM (3, 39–41).

Metabolic disease affects low and middle income countries more than high income developed countries with approximately eighty percent of people residing in low-income nations (3, 42). This may be a result of the prevalence of DM being affected by a number of parameters that include socioeconomic status, comorbidities such as infection with the severe acute respiratory syndrome coronavirus (SARS-CoV-2), and level of education (43–54). In regard to education level, those individuals with less than a high school education represent thirteen percent of DM patients, individuals with a high school education equal ten percent of DM patients, and those individuals with more than a high school education represent approximately seven percent of DM patients (2). Other factors that can contribute to the development and progression of DM include limited exercise, tobacco consumption, high serum cholesterol, hypertension, and obesity (8, 13, 48, 55–57). Obesity alters a number of pathways in the body and can impact oxidative stress cell injury, stem cell survival, inflammation, aging processes, and the maintenance of mitochondrial function (21, 33, 40, 51, 56, 58–73). As a result, the additional body weight fosters insulin insensitivity and glucose intolerance that progresses to DM (19, 24, 28, 36, 74–80) (Table 1).

Additional challenges for the care of individuals with DM involve financial expenditures. At least twenty thousand United States Dollars (USD) on an annual basis is necessary for the basic care of people with DM that can involve the maintenance of glucose homeostasis, wound care, and nutritional education (6, 9, 19, 20, 28, 41, 74, 81–87). Yet, the required resources for DM care is growing and is greater than seven hundred sixty billion USD with an additional seventy billion USD necessary for those with severe disability and loss of function (3). Greater than seventeen percent of the Gross Domestic Product in the US is consumed for the care of people with DM (88).

The debilitating nature of DM affects the entire body and leads to the degeneration of all organ systems (6, 7, 12, 16, 19, 21, 24, 27, 31, 34, 36, 46, 60, 85, 89–94). In particular, the metabolic disorders affect the nervous system and can lead to cognitive impairment, peripheral neuropathies, demyelinating disorders, and risk for developing infection as well as memory loss (Figure 1). An additional risk that includes metabolic disease for the development of neurodegenerative disorders is the observed rise in lifespan (95–100). Life expectancy is increasing especially in developed nations (101) and over the past fifty years the number of people greater than the age of sixty-five has increased greater than one hundred percent (4, 68, 96, 97, 102–113). Neurodegenerative disorders comprise a portion of non-communicable diseases (NCDs) and over seventy to seventy-five percent of the deaths that occur each year are due to NCDs (8, 22, 56, 60, 114–116). The increase in lifespan coincides with the rise of NCDs (91, 111, 117–129). As a result, the increase in lifespan for the world’s population has resulted in an increased prevalence for diseases of the nervous system (117, 130–133). Nervous system disorders comprise greater than six hundred disease entities, lead to the death of over seven million people annually, and can impact greater than one billion people (111, 117, 134–146). In relation to financial exposure, more than eight hundred billion USD in the US is required annually to care for multiple neurological disorders that include stroke, trauma, epilepsy, back pain, Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), and dementia (116). Cognitive loss can be the most significant burden to the financial system and these cost considerations do not include the expenses required for companion care, social health programs, and senior daily care with the additional greater than seventy million clinicians and social workers needed to fill these unmet needs (22, 116, 147). These additional services will reach 2 trillion USD annually in the US and more than four million people will need over four billion USD for treatment each year. The market for dementia could exceed eleven billion USD (34, 141, 148). Furthermore, additional significant costs involve other neurological disorders, such as PD with greater than fifty-five billion USD necessary for care in the US annually. In the year 2030, the number of those affected with PD is predicted to double. Present expenses are currently at a large annual cost per individual of approximately twenty-five thousand USD per year (5, 97, 137, 144, 146, 149–165).

Figure 1

2 The intimate relationship among metabolic disease, oxidative stress, aging, and neurodegenerative disorders

Metabolic disorders, such as DM, increase the risk for the onset and progression of neurodegenerative disorders through multiple pathways. DM is a primary mechanism for the onset of cardiovascular disease that can ultimately lead to disorders of the nervous system (8, 53, 166–170). When compared to people that do not have DM, individuals with DM can have two times the risk of developing cardiac disability or cerebral ischemia (40, 43, 91, 108, 111). DM results in insulin resistance (9, 19, 24, 60, 80, 90, 171–174), vascular injury (16, 19, 26, 27, 29, 30, 32, 33, 61, 74, 86, 87, 170, 175–182), alterations in cerebral blood flow (2, 7, 9, 53, 91, 176, 183), endothelial dysfunction (19, 27, 40, 83, 94, 184), mitochondrial injury (13, 28, 53, 60, 115, 172, 178, 185, 186), retinal disease (30, 66, 94, 187–189), stem cell loss (35, 38, 54, 66, 72, 77, 84, 111, 190), susceptibility to infections (34, 46, 48–51, 54, 92, 191, 192), and immune system dysfunction (30, 54, 64, 68, 84, 173, 178, 193–199).

DM and cellular metabolism also play a significant role in the processes of oxidative stress and aging (7, 16, 47, 64, 75, 89–91, 108, 178, 196, 200). DM can lead to changes in transcriptional networks, loss of mitochondrial homeostasis, inflammation, production of reactive oxygen species (ROS), and cell senescence (7, 16, 20, 21, 30, 32, 66, 78, 79, 90, 91, 108, 174, 178, 193, 194, 201–203). ROS that are generated during oxidative stress include hydrogen peroxide, superoxide free radicals, nitric oxide, singlet oxygen, and peroxynitrite (36, 37, 65, 90, 96, 113, 120, 137, 154, 180, 186, 204–218). During conditions that oversee the detrimental effects of ROS, antioxidant systems are in play that involve glutathione peroxidase, catalase, superoxide dismutase, and the nutrient vitamins B, K, E, D, and C (20, 34, 42, 47, 53, 100, 132, 186, 202, 217, 219–225). If these systems are overwhelmed or unable to limit excessive ROS production, mitochondrial injury, loss of DNA integrity, and shortened lifespan can occur (8, 34, 69, 78, 96, 104, 120, 122, 162, 207, 209, 218, 226–229). Oxidative stress can result in vascular endothelial cell injury (9, 40, 83, 230–234), neuronal cell compromise (24, 66, 122, 123, 152, 156, 162, 233, 235–245), alterations in neurotransmitters (69, 246, 247), myelin degradation (79, 224, 248–252), cell senescence (8, 33, 55, 112, 253–255), loss of stem cell proliferation (34, 66, 168, 228, 241, 251, 256–259), and cognitive impairment (7, 10, 120, 121, 200, 223, 243, 245, 260–266).

In regard to aging and cellular metabolism, the shortening of telomeres (TLs), complexes of deoxyribonucleic acid (DNA), can lead to the increased risk for the development of DM (8, 267) and greater cell senescence with the loss metabolic homeostasis (16, 33, 178, 190, 268). Changes in TL length can promote aging processes, cellular senescence, and neurodegeneration as well (70, 112, 113, 118, 154, 255, 269–275). TLs are positioned on chromosome ends and oversee replication of cells, preservation of the genomic DNA, and cell survival (8, 16, 274, 276–279). More than two thousand repetitions of double-stranded non-coding DNA with the ‘TTAGGG” sequence that is finalized with guanine rich single-stranded DNA compose TLs (8, 70, 139, 265, 279). Complexes of proteins that include CTC1-STN1-TEN1 (CST), shelterin, and telosome are part of the TL family (7, 139, 252). To oversee the division of cells, these proteins control function and stability of TLs that can lose twenty-five to over two hundred base pairs during the process of dividing cells. Telomerase protein can prevent the loss of base pairs in TLs by providing tandem repeat ribonucleic acid (RNA) templates (274, 276, 280). However, cell senescence ultimately ensues when TLs become very short with less than five hundred base pairs and telomerase function is impaired (33, 95, 102, 118, 134, 154, 221, 253, 255, 269, 272, 275, 281). At this point, tissues and organs cannot undergo repair, the immune system is less viable, and age-related disorders can progress (7, 73, 139, 164, 282–286). These events with the shortening of TLs and cellular senescence also promote oxidative stress and the release of ROS that impairs cell organelles, such as mitochondria and cellular energy homeostasis (7, 32, 104, 121, 122, 196, 282, 287, 288).

3 The clinical onset of metabolic mediated neurodegenerative disease

Given the ability of DM to lead to aging processes tied to oxidative stress, neuronal and vascular injury, mitochondrial dysfunction, stem cell loss, and immune system disorders, it becomes evident that loss of metabolic homeostasis with DM can result in multiple neurodegenerative disorders. Metabolic disorders can affect both the peripheral and central nervous systems (Figure 1). In the peripheral nervous system in the presence of DM, autonomic dysfunction (289–291) and neuropathies can be common and affect more than seventy-five percent of individuals (5, 38, 78, 79, 83, 290, 292).

In the central nervous system, cognitive loss with DM is a significant co-morbidity. DM results in memory impairment (7, 10, 55, 115, 200, 263, 293–296) and can lead to the onset and progression of Alzheimer’s disease (AD) (2, 6, 28, 44, 89, 153, 201, 266, 297–302) (Figure 1). Dementia is present in all nations throughout the world and is now considered to be the seventh primary reason for death (109, 116, 131, 141, 144, 161, 164, 223, 252, 266, 303–308). At least five percent of the world’s population has dementia and by the year 2050 it is believed that over one hundred fifty-five million people will have cognitive loss (2, 73, 97, 115, 126, 205, 226, 275, 309, 310). Of those individuals with dementia, approximately sixty percent of people have the sporadic form of AD and greater than ten percent are over the age of sixty-five (5, 110, 139, 148, 277, 311–313). Diagnosis for dementia can fall significantly behind the onset of the disorder and may not be recognized until twelve to twenty-four months after the initial clinical presentation (38, 252, 314). Currently, more than six million people in the US have the sporadic form of AD (5, 309, 315–318), but this is expected to increase to thirty million people during the next two decades (6, 7, 110, 205, 226, 245, 282, 319, 320). In contrast, familial AD (FAD) is present in about two hundred families in the world (6, 73, 110, 121, 134, 282, 311). FAD represents an autosomal dominant version of amyloid precursor protein (APP) gene that is mutated, occurs in variable single-gene mutations on chromosomes 1, 14, and 21, and is usually clinical present prior to fifty-five years of age (115, 321, 322).

Risk factors also exist for dementia that can have a metabolic basis as well. In experimental models, insulin signaling can be associated with AD pathology (71). Late-onset AD can result in the presence of the ϵ4 allele of the apolipoprotein E (APOE-ε4) gene (5, 7, 148, 161, 252, 323–325) (Figure 1). The risk for developing AD is more than twenty times greater in those individuals with two APOE-ϵ4 alleles. APOE is produced in liver cells and is vital for metabolic cellular function to oversee the homeostasis of lipids through the transport of triglycerides, phospholipids, and cholesterol (7, 127, 161, 325–328). In the brain, astrocytes produce APOE to modulate the transfer of cholesterol to neurons through APOE receptors (7, 127, 252, 326, 328, 329). Interestingly, β-amyloid (Aβ) can be removed and destroyed by APOE through apoptosis and the exposure of phosphatidylserine (PS) membranes that are a part of the apoptotic cell death process (330, 331). Other forms of APOE that do not involve APOE-ε4 may inhibit Aβ aggregation during PS membrane exposure (332). However, Aβ aggregation is not believed to be blocked by APOE-ϵ4 which can therefore allow amyloid deposition to proceed and potentially foster the development of AD (44, 161, 323, 332–334). APOE-ϵ4 also may assist with the infection of viral antigens and lead to cerebral microhemorrhages during severe acute respiratory syndrome (SARS-CoV-2) exposure with coronavirus disease 2019 (COVID-19) (326) (Figure 1). SARS-CoV-2, a β-coronavirus family virion, has resulted in a global pandemic (34, 46, 49, 50, 335, 336) and can attach to nasal epithelial cells (337) and neurovascular cells in the brain (54). These processes subsequently result in hyperactivation of the immune system (335, 336, 338–340). Following SARS-CoV-2 infection, memory loss and cognitive failure can develop and lead to long-COVID, also termed long-haul COVID, chronic COVID-19, or post-acute COVID (34, 49, 50, 325, 336, 341–345). The combination of APOE-ϵ4 and SARS-CoV-2 infection can lead to cognitive loss and cortical vascular disease (57, 97, 181, 226, 326, 346–350).

Multiple sclerosis (MS), an additional significant neurodegenerative disorder, also may develop as a result of metabolic disease, pathways of APOE-ϵ4, and Aβ deposition (125, 252, 350–359) (Figure 1). MS impacts large portions of the global population, affects greater than two and one-half million people, and is a primary disease of myelin and myelin producing cells that is immune system mediated (159, 351, 358, 360–364). MS appears to lead to disease in more women than men (357) and can markedly impair cognitive function (252, 365, 366). The memory loss can be progressive in nature and affect both women and men (367). At least sixty-five percent of patients with MS have difficulty with memory recall and executive ability (252). Cognitive loss in MS patients may be tied to metabolic pathways and APOE-ϵ4 since individuals with MS can demonstrate lower cognitive function and delayed responses to stimuli (368). APOE serum levels are elevated in individuals with demyelinating optic neuritis and the genotype of APOE ϵ3/ϵ3 may lead to the male onset of optic neuritis (327). In the setting of APOE risk factors and metabolic dysfunction similar to AD that can increase susceptibility to viral infections, MS patients may experience higher rates of death during SARS-CoV-2 with COVID-19 (369). Treatment with metformin, commonly used during DM, can reduce the degree of functional impairment in obese individuals or those with DM during COVID-19 (52, 370). MS also may have common pathways with AD and Aβ (140, 252, 371). Tau seeding, also present in AD (7, 123, 311, 372–376), has been reported in the brains of MS patients (140) and this tau deposition may produce demyelination through injury to oligodendrocytes (128). Alterations in Aβ deposition similar to those observed in AD may also indicate early memory impairment in people with MS (371).

4 Addressing unmet clinical avenues for metabolic and neurodegenerative disorders

Multiple factors can impact the role of metabolic disorders that can lead to the onset and progression of neurodegenerative disease. If one focuses upon metabolic disease and DM, therapies that improve nutritional intake that can be complemented by pharmaceutical agents to assist with serum glucose homeostasis and insulin resistance may limit periods of hyperglycemia and the complications of hypoglycemia (6, 8, 16, 19–21, 25, 27–29, 49, 167, 175, 176, 370, 377–379). Yet, progression of DM even at a less marked pace will ensue and can be affected by off-target treatment effects that result in cellular injury, neuronal and vascular cell loss, and the atrophy of organs (33, 87, 172, 380). In the nervous system, a number of diverse pathways that involve inflammation, infection, circadian rhythm, excitotoxicity, metabotropic receptors, tau, Aβ, mitochondrial injury, acetylcholine loss, heavy metal toxicity, and oxidative stress can lead to cognitive loss (24, 33, 34, 42, 50, 63, 65, 66, 96, 106, 119, 121, 131, 165, 168, 175, 205, 223, 226, 261, 282, 286, 303, 330, 338, 346, 381–398). Current therapies for AD that employ cholinesterase inhibitors may limit memory loss but these treatments do not stop the progression of disease (115, 164, 299, 399, 400). Recent developments for AD to use immunotherapy to decrease Aβ load in the brain also may reduce memory loss, but these therapies are currently limited to a small group of patients that are not at risk for cerebral microhemorrhages and also such treatments do not prevent overall disease progression (119, 126, 401). In regard to MS, disease modifying therapies (DMTs) can reduce the frequency of relapses in relapsing–remitting MS, but disease progression can continue (252, 362, 371). For example, despite the reduction in brain volume loss with DMTs, cognitive impairment can continue unabated (402). These treatment considerations that rest on the side of metabolic disorders as well as neurodegenerative disease warrant new avenues of inquiry for the development of innovative therapeutic strategies that may address the onset and progression of these disorders. Novel pathways that may offer new insights into these disorders involve programmed cell death regulation, the silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1), AMP activated protein kinase (AMPK), and Wnt1 inducible signaling pathway protein 1 (WISP1) (Figure 2).

Figure 2

5 Programmed cell death in metabolic and nervous system diseases

Programmed cell death that involves autophagy, apoptosis, ferroptosis, and pyroptosis has a vital role in the determination of both metabolic and neurodegenerative disorders (Figure 2). Recent studies on exome sequence analysis indicate that metabolic cellular dysfunction directly affects neuronal cell death through DNA and apoptosis (403). In metabolic disorders, programmed cell death can affect neuronal survival (24, 122, 310, 404–411), vascular integrity (8, 40, 61, 87, 182, 188, 412–414), mitochondrial function (42, 61, 172, 186), and inflammation (36, 50, 87, 186, 415–418). In a similar manner, programmed cell death in the nervous system can lead to neuronal and non-neuronal cell injury (65, 121, 132–134, 143, 148, 155, 224, 240, 262, 376, 405, 419–428), cerebral ischemia (91, 122, 182, 405, 423, 427, 429–433), microglial cell loss (120, 125, 133, 152, 356, 421, 430, 434, 435), and dysfunction of pathways for cognitive function (100, 120, 121, 141, 143, 148, 260–262, 275, 301, 421, 436–440).

During autophagy, organelles in the cytoplasm as well as other subunits in the cell are recycled for future remodeling of tissues (5, 121, 376, 408, 409, 428, 441, 442). Of the different forms of autophagy, macroautophagy is the prominent type of autophagy that is usually described and consists of sequestering proteins and organelles in the cytoplasm of cells into autophagosomes that will be merged into lysosomes that can be degraded and recycled (117, 136, 141, 275, 443). During microautophagy, components of the cytoplasm are sequestered for eventual digestion through invagination of lysosomal membranes (97). In chaperone-mediated autophagy, protein “chaperones” are created in the cytoplasm to carry components of the cytoplasm over the membranes of lysosomes (134, 136, 444, 445).

Autophagy can foster beneficial outcomes during metabolic and neurodegenerative disorders. Activation of autophagy can be necessary for fatty acid metabolism during obesity (62) and for the oversight of muscle tissue generation (441). Autophagy can oversee the proliferation and size of pancreatic β-cells (446), may limit insulin resistance during inflammation with high serum lipids in obesity models of autophagy Atg7 gene deletion (447), may prevent diabetic nephropathy with maintenance of Atg7, Atg5, and LC3 autophagy proteins (448), and can prevent DM progression through promoting β-cell function and eliminating misfolded proteins and dysfunctional mitochondria (449). Increased physical activity in murine models helps control glucose serum regulation through autophagy pathways (450) that are tied to greater insulin efficacy (451) and improved function of microglial cells (416). In the brain, loss of autophagy activation can lead to memory impairment in AD with the progression of DM (44). The pathways that lead to the activation of autophagy may require inhibition of the mechanistic target of rapamycin (mTOR) with agents such as rapamycin or metformin (7, 49, 121, 284, 335, 359, 376, 393, 442, 452–457). In addition, activation of mTOR can inhibit autophagy induction through the phosphorylation of the autophagic related gene (Atg) protein Atg13 and UNC-51 like kinases (ULKs) such as UNC-51 like kinase 1 (ULK1) to prevent formation of the ULK-Atg13-FIP200 complex (97, 458). During mTOR inhibition and autophagy activation, reduction in ROS release occurs (459), dopamine cell survival is increased (460), neuronal demise is blocked through pathways of glutamine (461), and mitochondrial integrity is preserved (462). Autophagy activation can limit tau deposition (463) and reduce Aß accumulation with improved memory function and metabolic homeostasis (464). Control of blood mononuclear cells in MS during inflammation can be mediated by autophagy activation (465), induction of autophagy can improve the clinical outcome of relapsing-remitting and experimental autoimmune encephalomyelitis (466) and reduce retinal MS-induced degeneration (189), cytokine release and microglial activation is limited during autophagy activation in experimental autoimmune encephalomyelitis (358), and the risk for developing MS may be lessened during mTOR blockade and autophagy induction (359). Autophagy activity with metformin treatment also may lead to myelin repair with oligodendrocytes (356) and assist with the reduction of viral susceptibility during DM in over-weight individuals exposed to COVID-19 (52, 370).

However, there exists another side to autophagy that suggests careful modulation of activity is required for clinical disease. Cardiomyopathy (467), atherosclerosis (468), and endoplasmic reticulum stress (469) can ensue with advanced glycation end products (AGEs), elevated glucose exposure, and autophagy activation. Induction of autophagy can lead to the reduction in cardiac and liver tissue mass during treatments to improve glucose regulation (380), promote neuronal cell death under some conditions (470–472), prevent cerebral interneuron progenitor cell growth (473), result in mitochondrial injury (61, 145, 172, 216, 306, 379, 474–479), reduce numbers of progenitor endothelial cells (480), limit angiogenesis in the presence of elevated glucose (480), and lead to cognitive loss (141, 148, 275, 361, 393, 437). In addition, growth factor cell protection, such as with the trophic factor erythropoietin (EPO) (114, 304, 385, 481–484), requires decreases in autophagy activation in conjunction with modulation of mTOR, protein kinase B (Akt), the proline rich Akt substrate 40 kDa (PRAS40), and mammalian forkhead transcription factors to promote neuronal and vascular survival (145, 485–489).

Apoptotic cell injury can be initiated through pathways of oxidative stress (40, 68, 96, 120, 201, 216, 244, 245, 256, 260, 261, 303, 490–495) and inflammation (7, 36, 120, 143, 169, 212, 225, 256, 260, 275, 303, 310, 425, 430, 496–501) as part of metabolic and neurodegenerative disorders. Apoptotic cell death has early and late components that can occur in this process (97, 122, 408, 409, 426). The loss of PS membrane asymmetry is the early phase of apoptotic cell death (502–506). Once cells become injured, the PS residues become externalized on the cell membrane that attracts inflammatory microglia to recognize these injured cells and remove them from the central and peripheral nervous systems (502, 507–510). However, injured cells may recover if they are not engulfed by microglia. Treatments directed to restore PS membrane asymmetry for injured cells can then prevent microglial attraction and preserve the function of these necessary cells in the nervous system (66, 511–513). In contrast, the later phase of apoptotic cell death that consists of the destruction of nuclear deoxyribonucleic acid (DNA) (18, 96, 113, 229, 483, 514–518) and a cascade of caspase activation (65, 96, 130, 143, 347, 348, 405, 425, 483, 519) is not reversible.

Reductions in apoptosis activation can prevent cell injury during glial cell excessive activity and oxidative stress (120), limit dopaminergic cell demise during inflammatory cell activation (152), protect retinal cells during ischemia exposure (516), and increase neuronal cell survival during Aß toxicity (320, 520–522). Controlling apoptotic cell death also reduces inflammatory cell pathways (50, 186, 212, 225, 256, 260, 261, 418, 496, 497, 499, 500, 523–525) and can limit memory loss (7, 100, 143, 262, 421, 439). These pathways are significantly tied to microglial activity. Microglia account for about fifteen percent of the cells in the central nervous system and as noted can remove injured cells during apoptosis (97, 120, 133, 134, 152, 155, 425, 430, 502, 503). These inflammatory cells can release ROS to generate oxidative stress (7, 18, 62, 121, 282, 526–528) through pathways that involve Wnt signaling (2, 6, 97, 122, 181, 529–531), mammalian forkhead transcription factors (17, 67, 68, 117, 426, 519, 532), and growth factors with EPO (6, 145, 159, 482, 533–536). During cognitive dysfunction, microglial activity may lead to increased risk for the development of AD (141, 537) as well as endothelial dysfunction (119).

Ferroptosis is a process in the programmed cell death pathway that leads to the storage of iron in the cell that results in the inability to maintain glutathione homeostasis (225, 538, 539). Once oxidative defenses that require glutathione are lost, lipid peroxidation can ensue to result in the demise of cells (224, 229, 540). Ferroptosis can lead to cell death in multiple systems such as the musculoskeletal system (225), cardiovascular system (8, 540), and breast tissue (229). In the nervous system, ferroptosis may lead to cognitive impairment (7, 224, 274) and produce pathogenic T lymphocytes that lead to dysfunction in neuronal and glial cells (252, 538).

Given the associations of autophagy, apoptosis, and ferroptosis with inflammatory cell pathways, it is of interest to note that pyroptosis is part of the programmed cell death pathway that can specifically modulate inflammatory cell activity (5, 178, 410, 500, 541). The inflammasome, also known as the pyroptosome, is a supramolecular entity that initiates the pyroptotic cell death process. The inflammasome family of nucleotide-binding oligomerization domain and leucine-rich repeat-containing receptors (NLRs) has the members NLRP1, NLRP3, NLRP6, and NLRC4. Pattern recognition receptors responding to damage associated molecular pattern (DAMP) in host cells and pathogen-associated molecular pattern (PAMP) in families of microbes lead to the activation of inflammasomes and caspase 4, caspase 1, and caspase 5 (7, 303, 358, 515, 541–545). DAMP molecules with DNA and adenosine triphosphate (ATP) traverse through open cell membranes and lead to NLRP3 canonical inflammasome activation while caspase 5 and caspase 4 can result in noncanonical inflammasome activation with lipopolysaccharide proteins in infections with Gram-negative bacteria. For membranes to open, pores are formed through the degradation of N-terminal domain with the C-terminal domains as part of gasdermin proteins. Cytokines such as interleukin-1 family members are released to generate inflammatory reactions and require gasdermin since these cytokines cannot alone result in pore formation (2, 212, 515). Pyroptosis can result in cell injury as a result of cytokine release (410, 411) and lead to neuronal and vascular cell dysfunction that results in loss of memory and executive function (11, 60, 252, 263, 275, 298, 301, 344, 546). In addition, elevated cytokine release during pyroptosis can affect immune cell activity in the body (358) and lead to failed clinical outcomes, such as in MS patients, with elevated inflammasome levels (541).

6 SIRT1 regulation of cellular metabolism and neurodegeneration

The silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1) controls both cellular metabolism (11, 60, 111, 263, 275, 294, 298, 344, 400, 546–549) and neurodegeneration (98, 102, 117, 156, 210, 232, 240, 400, 438, 550–555). There exist mammalian homologues of Sir2 that are SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7 (6, 12, 13, 97, 134, 255, 333, 556). SIRT1 exists in the brain, liver, heart, skeletal muscle, pancreas, adipose tissue, and spleen (16, 179, 210, 223, 440, 550, 557). SIRT1 is a histone deacetylase that controls transcription of DNA that involves acetyl group transfer from ϵ-N-acetyl lysine amino acids to DNA histones (6, 17, 70, 78, 106, 117, 223, 259, 309, 335, 558, 559) (Figure 2). Histone deacetylases oversee multiple cellular processes such as aging, wound healing, neuronal function, oxidative stress, transcription factor activity, cardiovascular function, and cancer (8, 78, 98, 175, 550, 560–563). One substrate for SIRT1 is the coenzyme ß-nicotinamide adenine dinucleotide (NAD⁺) (24, 42, 65, 70, 78, 96, 98, 111, 196, 330, 475, 550, 564).

SIRT1 regulation of cellular metabolic homeostasis can be critical to the onset and progression of disorders in the nervous system (13, 16, 17, 38, 98, 223, 259, 333, 544, 549, 565, 566). SIRT1 is dependent upon NAD⁺ and nicotinamide (24, 98, 210, 255, 417, 475, 514, 550). As a precursor for NAD⁺, nicotinamide is the amide form of vitamin B₃ (niacin) (8, 34, 42, 330, 378, 567–570). Nicotinamide can be produced through SIRT1 transferring of the acetyl residue of the histone acetyllysine residue to the ADP-ribose moiety of NAD⁺. As part of a feedback pathway, nicotinamide can limit the activity of SIRT1 through the interception of an ADP-ribosyl-enzyme-acetyl peptide intermediate with the regeneration of NAD⁺ (571). As a result, nicotinamide can bind to sirtuins through NAD⁺ in the C pocket of sirtuins (572) and can noncompetitively inhibit SIRT1 (560) and prevent anti-inflammatory gene expression (573). In addition, SIRT1 activation through nicotinamide phosphoribosyltransferase (NAMPT) can occur with periods of glucose restriction. This leads to increases in NAD⁺ and reduction in nicotinamide levels that become ineffective to block SIRT1 (574). Replenishment of NAD⁺ can assist with cardiovascular health (53) with SIRT1 activation limiting inflammation, metabolic dysfunction, and cell injury (111, 113, 203). As an example during hyperglycemia, SIRT1 can increase vascular cell survival (575).

SIRT1 can oversee insulin sensitivity (8, 61, 78, 417, 576–578) and mitochondrial function (13, 34, 70, 240, 475, 558). SIRT1 expression is reduced in the liver and pancreas during high fat diets that can lead to insulin resistance (579). Elevated SIRT1 activity can modulate glucose and hepatic lipid processing to prevent metabolic syndrome dysfunction (580). SIRT1 controls insulin sensitivity via protein tyrosine phosphatase (PTP) (335, 581). SIRT1 also is a positive feedback system for insulin signaling through Akt and can lead to the activity of Akt through phosphotidylinositide 3-kinase (PI 3-K) (532, 581).

In the nervous system, SIRT1 activity can lead to neurite outgrowth and enhance neuronal survival in environments that limit nutrients (582). SIRT1 can foster survival for photoreceptor cells (583), prevent the senescence of endothelial cells (584), and enhance the function of mitochondria in embryonic stem cells during oxidative stress (585). The absence of SIRT1 activity may lead to dysregulation in the immune system such as during MS (406). SIRT1 activity may be required for limiting the toxicity of oxidative stress and preserving memory (262), fostering Aβ degradation (586), increase lifespan in higher level organisms (587), and protecting neuronal and vascular cells against oxidative stress (98, 134, 232, 240, 438, 502, 510, 550, 551, 554, 555, 588).

SIRT1 also functions through trophic factor regulation in metabolic and neurological disorders that is linked to NAD⁺ activity (34, 145, 203, 499, 533–535, 589). The trophic factor EPO employs SIRT1 to block depolarization of mitochondrial, release of cytochrome c, induction of BCL2 associated agonist of cell death (Bad) activation, and caspase cleavage (510). EPO through SIRT1 can protect neurons (590) that may be responsible for SIRT1 synaptic memory improvement (223). As a result of SIRT1 activity, EPO prevents mitochondrial injury (483, 521, 536, 591–593), increases microglial survival (594), blocks caspase activity (520), protects human cardiomyocytes (592), and oversees cellular metabolism (304, 482, 595, 596).

7 Oversight of metabolic and nervous system disorders through AMPK

AMP-activated protein kinase (AMPK) is an important component of the mTOR pathway, is intimately associated with SIRT1, and is a significant target for metabolic and neurodegenerative disorders (2, 30, 38, 112, 113, 118, 218, 229, 452, 558, 559, 597–600) (Figure 2). AMPK can lead to the generation of adenosine triphosphate (ATP), improve insulin sensitivity, oversee the oxidation of fatty acids, and reduce levels of oxidative stress (30, 34, 229, 230, 234, 288, 309). Increased AMPK activity is present in diets high in fish oil that can prevent endothelial cell injury (601) and improve insulin sensitivity (451). In the nervous system, AMPK can limit stroke damage in animal models of DM (602), reduce tau deposition (463), regulate neuroinflammation (134, 226, 603), reduce Aß brain accumulation (604), block Aß toxicity (605), oversee mitophagy with ULK1 (606, 607) and improve cognition in experimental models with DM and AD (608). Pain sensation that can become problematic with peripheral neuropathies in DM can be attenuated in experimental models with AMPK (292).

A number of agents that are involved in metabolic homeostasis also rely upon AMPK. Nicotinamide can protect mitochondria with the activation of AMPK (288). In addition, metformin and biguanides control autophagy through AMPK. DM cardiac cell injury through the activation of autophagy with AMPK is reduced during treatment with metformin (609). As previously noted, activation of autophagy under some circumstances can reduce toxicity from oxidative stress (33, 121, 145, 189, 216, 226, 306, 309, 540) and may shift to beneficial oxidative metabolism (610). In addition, other pathways such as Wnt family members may require AMPK activity to reduce neuronal brain injury (611). AMPK signaling is necessary with inhibition of mTOR pathways for the maintenance of electrical activity of the brain for control of behavior (597), for the acceleration of myelin brain recovery during treatment with metformin (356), and for mitochondrial preservation during ferroptotic cell death (229). Without AMPK activity, cell death, cell senescence, and mitochondrial loss can result (16, 113).

Bidirectional pathways of modulation of activity also exist for SIRT1 and AMPK. SIRT1 expression leads to deacetylation of serine-threonine liver kinase B1 (LKB1) that may be through indirect or direct means and can result in AMPK activation (612). Although AMPK does not directly activate SIRT1, SIRT1 activity can increase with AMPK either by elevating the cellular NAD⁺/NADH ratio that leads to deacetylation and downstream SIRT1 target activity changes to involve peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) and forkhead transcription factors (613) or through increasing NAMPT to raise NAD⁺ and lower SIRT1 inhibitors such as nicotinamide (574). Resveratrol, an activator of SIRT1, can elevate AMPK activity through SIRT1 dependent or independent pathways (613, 614). Through combined pathways, AMPK and SIRT1 block mitochondrial loss (61) and limit endothelial cell death during elevated glucose exposure (575).

8 WISP1 in metabolic homeostasis and nervous system function

Closely coordinated with the pathways AMPK in metabolic and neurodegenerative disease is the Wnt1 inducible signaling pathway protein 1 (WISP1) (6, 75, 529, 615–618). WISP1 is a downstream target of the wingless pathway of Wnt proteins. Wnt proteins are cysteine-rich glycosylated proteins that can control cellular metabolism, stem cell proliferation, new vascular cell growth, musculoskeletal disease, nervous system sensation, and neuronal cell development (57, 83, 122, 181, 203, 346, 349, 350, 530, 531, 619, 620). Wnt signaling that includes Wnt1 can control autophagy (621–624), prevent endothelial cell death in experimental models of DM (412), limit dopaminergic neuron cell loss in PD (625), oversee repair of wounds during DM (626), assist with human β-cell proliferation (627), foster growth in the musculoskeletal system (57, 497, 628), and inhibit cognitive loss with DM and aging (629).

WISP1 is a CCN family member that consists of six secreted extracellular matrix associated proteins that are termed by the first three members of the family that include Cysteine-rich protein 61, Connective tissue growth factor, and Nephroblastoma over-expressed gene (130, 630) (Figure 2). WISP1 can be influenced by increased weight in humans, becomes elevated with insulin resistance in children and adolescents (616, 631), and is elevated during gestational DM (632). WISP1 may be vital for glucose homeostasis since it is over-expressed during regeneration of the pancreas (633), controls β-cell proliferation (75), and can control cellular senescence (634). WISP1 can stabilize atherosclerotic plaques (347) that can ultimately lead to cerebrovascular disease, can limit lipopolysaccharide-induced cell injury through pathways of Akt (348), can attenuate blood-brain barrier disruption (635), and decrease toxicity of oxidative stress and Aß exposure (97, 520, 522). However, it should be noted that WISP1, a trophic agent, also can promote tumorigenesis (281, 529, 636–642).

WISP1 is dependent upon the pathways of AMPK for glucose homeostasis and the ability to affect neuronal survival. WISP1 can oversee AMPK post-translational phosphorylation during cellular metabolism (6, 33, 455, 643–645). WISP1 controls the activation of AMPK activation by differentially decreasing phosphorylation of tuberous sclerosis 2 (TSC2) at serine¹³⁸⁷, an AMPK target, and increasing phosphorylation of TSC2 at threonine¹⁴⁶², an Akt target (522). This process allows WISP1 to provide a minimal level of TSC2 and AMPK activity to offer a proper biological balance for optimum metabolic homeostasis and survival of cells. This balance in AMPK activation and levels is critical. Although AMPK activation can limit insulin resistance and oxidative stress (451) and assist with differentiation of adipocytes during lipid accumulation in obesity (646), under other conditions AMPK through autophagy may lead to cell injury. A fine balance of AMPK activity is necessary to increase basal autophagy activity and maintain neuronal and endothelial cell survival during periods of metabolic homeostasis loss (230, 234, 575, 584). AMPK can modulate apoptosis and autophagy during coronary artery disease (647) and ROS release (234, 648). This is also seen with the growth factor EPO. EPO controls AMPK during oxidative stress (522), inflammation (114, 385, 649), angiogenesis (650, 651), and modulation of endothelial nitric oxide synthase (652). The concentration of EPO and duration of treatment can influence a specific level of AMPK activity, as well as the activity of mTOR (114, 653–655). If this activity is not balanced, elevated EPO and AMK activity can lead to cell injury (656).

9 Discussion

With the increase in lifespan and NCDs, disorders of cellular metabolism that include DM and neurodegenerative disorders are increasing in prevalence throughout the world. These disorders may be significantly under diagnosed with estimates of at least thirty-five percent of individuals in developed countries not receiving appropriate care to slow the progression of metabolic and neurodegenerative disease. Metabolic and neurodegenerative disorders also impose a significant financial challenge for the treatment and care of individuals. It is expected that additional care costs for current unmet clinical and staffing needs will exceed over two trillion USD per year.

The clinical onset and progression of metabolic and neurodegenerative disorders is closely tied to aging, dysfunction in telomere processing, and the processes of cellular senescence and oxidative stress (Table 1). These underlying processes not only lead to neuronal and vascular death, mitochondrial loss, stem cell injury, and immune system dysfunction, but also result in significant co-morbidities in the nervous system leading autonomic dysfunction and peripheral neuropathies as well as cognitive loss. In fact, cognitive loss is now the seventh cause throughout the world for death and it is estimated that close to two hundred million individuals may have dementia by the year 2050. Although dementia may present in multiple neurological disorders, AD encompasses almost sixty percent of individuals with cognitive loss and it is estimated that more than sixty-five percent of people with MS have cognitive impairment. The cognitive loss in neurological disorders has an important metabolic basis and involves risk factors with APOE that can lead to the cognitive loss present in AD and MS as well as increase susceptibility to viral infections, such as during SARS-CoV-2 with COVID-19.

Metabolic disorders, such as DM, and neurologic disease remain a significant challenge for the treatment and care of individuals. Although strategies that address nutritional intake and the use of pharmaceutical agents to control glucose homeostasis can slow disease progression of DM, clinical off-target effects can lead to progressive neuronal and vascular cell loss and the atrophy of organs in the body. To a similar degree, present therapies for AD assist with symptoms of memory loss, but do not halt disease progression. In addition, recently approved therapies and DMTs for AD and MS that involve immunotherapies may be suited for a small subset of people, such as with AD, and can achieve some decrease in disease progression but the overall course of cognitive loss in these disorders will continue unabated. These clinical challenges to address the interplay between metabolic and neurodegenerative disorders require innovative strategies that can focus upon the underlying mechanisms of aging, oxidative stress, cell senescence, and cell death.

Programmed cell death pathways that involve autophagy, apoptosis, ferroptosis, and pyroptosis can play an important role in DM and neurodegenerative disorders. Autophagy can regulate the proliferation and size of pancreatic β-cells, reduce insulin resistance, prevent diabetic nephropathy, and limit progression of DM through promoting β-cell function and eliminating misfolded proteins and dysfunctional mitochondria. Autophagy activation in conjunction with mTOR inhibition can reduce ROS release, protect dopamine cells, preserve mitochondrial integrity, reduce inflammatory processes that may lead to clinical relapses, limit Aß and tau brain deposition, reduce cytokine release and microglial activity, and repair myelin in the nervous system. In regard to apoptotic cell death, strategies that can limit apoptosis activation can prevent cell injury during excessive glial activity during oxidative stress, limit ischemic toxicity to retinal cells, preserve dopaminergic cells during inflammation, and block cell demise during Aß exposure. Similar to apoptotic cell injury but involving iron accumulation in the cell with the loss of glutathione homeostasis, ferroptosis leads to cognitive impairment, immune dysfunction in T lymphocytes that can injure neuronal and glial cells, and cell death in the musculoskeletal system, cardiovascular system, and breast tissue. Pyroptosis cell death involves inflammasome activation that yields cytokine release, cell injury, inflammatory cell dysfunction, and neurovascular injury with cognitive loss.

Given that pathways of programmed cell death play a dual role in determining the fate of cellular survival and organ systems, it is important to recognize that a balance among these pathways is essential to optimize clinical outcome. For example, activation of autophagy can lead to cardiac disease, atherosclerosis, block interneuron progenitor cell growth, foster neuronal death, lead to memory impairment, and prevent neurovascular protection with growth factors. As a result, the basal activity of autophagy should be considered since changes in the autophagic flux have been shown to limit the induction of cell senescence. With apoptosis, it can be equally as crucial to control early apoptotic pathways that involve PS membrane asymmetry in an effort to block the later phase progression of the apoptotic cascade and prevent nuclear DNA degradation that leads to cell death. In addition, apoptotic pathways are tightly linked to inflammatory cell activity. Although increased glial cell activity may contribute to oxidative stress and apoptosis, microglial cells can be beneficial at times with autophagy induction to maintain cholesterol homeostasis (133), provide protection during amyotrophic lateral sclerosis (657), and for the clearance of amyloid in the brain (598). Triggering receptor expressed on myeloid cells 2 (TREM2) that can foster microglial survival can prevent inflammation during AD through forkhead transcription factors (FoxOs), Wnt signaling, and microglial activation (323, 658).

Pathways with SIRT1, AMPK, and WISP1 also provide us with clues for maintaining a proper environmental homeostasis for cells especially during aging processes that can lead to cognitive loss. SIRT1 is dependent upon NAD⁺ and nicotinamide and can control insulin sensitivity, prevent cell senescence, modulate immune system activity, promote Aβ degradation, and increase lifespan in higher organisms. In addition, mitochondrial oxidative stress can be dependent upon nicotinamide adenine dinucleotide phosphate (NADPH) depletion and increase of aldose reductase. These pathways are important in the pentose phosphate pathway that involves transaldolase, which is encoded by the TALDO1 gene (659) and has been linked to Parkinson’s disease (660). Such mitochondrial dysfunction can be mediated through mTOR pathways that lead to antiphospholipid antibodies (661). Yet, feedback pathways are required at times through nicotinamide and Akt for replenishment of NAD⁺ and effective modulation of cellular pathways, such as those involving insulin signaling and inflammation. AMPK activation can improve insulin sensitivity, reduce oxidative stress toxicity, limit tau and Aß cell injury, and lead to cognitive improvement in conjunction with autophagy activation. Yet, during periods when autophagy activation can be detrimental, AMPK may require modulation to limit its activity. This loss of AMPK activity to alter autophagy pathways may negatively impact other pathways such as with SIRT1. There exist conditions when SIRT1 in conjunction with AMPK is required to prevent mitochondrial loss and vascular cell death. WISP1 also requires AMPK pathways to offer glucose homeostasis and protection of neuronal and vascular cells. The ability for WISP1 to effectively promote metabolic stability and cell survival is dependent upon WISP1 providing a proper biological balance of AMPK activity to foster cell survival, control inflammatory pathways, assist with growth factor protection, and prevent cell injury that can occur through autophagic and apoptotic mechanisms. The pathways of programmed cell death, SIRT1, AMPK, and WISP1 offer vital insights and are extremely attractive for identifying processes that can contribute to the onset and progression of metabolic and neurodegenerative diseases that can be linked to multiple entities such as APOE, SARS-CoV-2, NAD⁺, nicotinamide, and trophic factors, such as EPO, but will require further insight into the elaborate relationship of these pathways for effective clinical translation.

References

• 1

  OrganizationWH. Global Report on Diabetes. Geneva: World Health Organization (2016) p. 1–83.

  • Google Scholar
  • View reference in article

• 2

  MaieseK. Dysregulation of Metabolic flexibility: the impact of mtor on autophagy in neurodegenerative disease. Int Rev Neurobiol (2020) 155:1–35. doi: 10.1016/bs.irn.2020.01.009

  • CrossRef
  • Google Scholar
  • View reference in article

• 3

  International Diabetes Federation. Diabetes. 9th Edition. Brussels, Belgium: IDF Diabetes Atlas (2019).

  • Google Scholar
  • View reference in article

• 4

  MaieseKChongZZShangYCHouJ. Novel avenues of drug discovery and biomarkers for diabetes mellitus. J Clin Pharmacol (2011) 51(2):128–52. doi: 10.1177/0091270010362904

  • CrossRef
  • Google Scholar
  • View reference in article

• 5

  MaieseK. The metabolic basis for nervous system dysfunction in alzheimer’s disease, parkinson’s disease, and huntington’s disease. Curr Neurovasc Res (2023) 20(3):314–33. doi: 10.2174/1567202620666230721122957

  • CrossRef
  • Google Scholar
  • View reference in article

• 6

  MaieseK. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways. Expert Rev Clin Pharmacol (2020) 13(1):23–34. doi: 10.1080/17512433.2020.1698288

  • CrossRef
  • Google Scholar
  • View reference in article

• 7

  MaieseK. Cellular metabolism: A fundamental component of degeneration in the nervous system. Biomolecules (2023) 13(5):816. doi: 10.3390/biom13050816

  • CrossRef
  • Google Scholar
  • View reference in article

• 8

  MaieseK. Innovative therapeutic strategies for cardiovascular disease. EXCLI J (2023) 22:690–715. doi: 10.17179/excli2023-6306

  • CrossRef
  • Google Scholar
  • View reference in article

• 9

  PapachristoforouELambadiariVMaratouEMakrilakisK. Association of glycemic indices (Hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res (2020) 2020:7489795. doi: 10.1155/2020/7489795

  • CrossRef
  • Google Scholar
  • View reference in article

• 10

  MinAYYooJMSokDEKimMR. Mulberry fruit prevents diabetes and diabetic dementia by regulation of blood glucose through upregulation of antioxidative activities and creb/bdnf pathway in alloxan-induced diabetic mice. Oxid Med Cell Longev (2020) 2020:1298691. doi: 10.1155/2020/1298691

  • CrossRef
  • Google Scholar
  • View reference in article

• 11

  XuTLiuJLiXRYuYLuoXZhengXet al. The mtor/nf-κb pathway mediates neuroinflammation and synaptic plasticity in diabetic encephalopathy. Mol Neurobiol (2021) 58(8):3848–62. doi: 10.1007/s12035-021-02390-1

  • CrossRef
  • Google Scholar
  • View reference in article

• 12

  WangZWuQWangHGaoYNieKTangYet al. Diosgenin Protects against Podocyte Injury in Early Phase of Diabetic Nephropathy through Regulating Sirt6. Phytomedicine: Int J phytotherapy phytopharmacology (2022) 104:154276. doi: 10.1016/j.phymed.2022.154276

  • CrossRef
  • Google Scholar
  • View reference in article

• 13

  WasserfurthPNeblJRühlingMRShammasHBednarczykJKoehlerKet al. Impact of dietary modifications on plasma sirtuins 1, 3 and 5 in older overweight individuals undergoing 12-weeks of circuit training. Nutrients (2021) 13(11). doi: 10.3390/nu13113824

  • CrossRef
  • Google Scholar
  • View reference in article

• 14

  MirandaLMOAgostiniLDCLimaWGCaminiFCCostaDC. Silymarin attenuates hepatic and pancreatic redox imbalance independent of glycemic regulation in the alloxan-induced diabetic rat model. BioMed Environ Sci (2020) 33(9):690–700. doi: 10.3967/bes2020.090

  • CrossRef
  • Google Scholar
  • View reference in article

• 15

  WangHZhangRWuXChenYJiWWangJet al. The wnt signaling pathway in diabetic nephropathy. Front Cell Dev Biol (2021) 9:701547. doi: 10.3389/fcell.2021.701547

  • CrossRef
  • Google Scholar
  • View reference in article

• 16

  BarcenaMLToniniGHaritonowNBreiterPMiltingHBaczkoIet al. Sex and age differences in ampk phosphorylation, mitochondrial homeostasis, and inflammation in hearts from inflammatory cardiomyopathy patients. Aging Cell (2023) 22(8):e13894. doi: 10.1111/acel.13894

  • CrossRef
  • Google Scholar
  • View reference in article

• 17

  KostićMKorićanacGTepavčevićSStanišićJRomićSĆulafićTet al. Low-intensity exercise affects cardiac fatty acid oxidation by increasing the nuclear content of pparα, foxo1, and lipin1 in fructose-fed rats. Metab Syndr Relat Disord (2023) 21(2):122–31. doi: 10.1089/met.2022.0078

  • CrossRef
  • Google Scholar
  • View reference in article

• 18

  StojanovicDStojanovicMMilenkovicJVelickovAIgnjatovicAMilojkovicM. The multi-faceted nature of renalase for mitochondrial dysfunction improvement in cardiac disease. Cells (2023) 12(12):1607. doi: 10.3390/cells12121607

  • CrossRef
  • Google Scholar
  • View reference in article

• 19

  JiangWDingKYueRLeiM. Therapeutic effects of icariin and icariside ii on diabetes mellitus and its complications. Crit Rev Food Sci Nutr (2023) 1–26. doi: 10.1080/10408398.2022.2159317

  • CrossRef
  • Google Scholar
  • View reference in article

• 20

  RaghuvanshiDSChakoleSKumarM. Relationship between vitamins and diabetes. Cureus (2023) 15(3):e36815. doi: 10.7759/cureus.36815

  • CrossRef
  • Google Scholar
  • View reference in article

• 21

  RautSKKhullarM. Oxidative stress in metabolic diseases: current scenario and therapeutic relevance. Mol Cell Biochem (2023) 478(1):185–96. doi: 10.1007/s11010-022-04496-z

  • CrossRef
  • Google Scholar
  • View reference in article

• 22

  World health organization. Description of the global burden of ncds, their risk factors and determinants. Global Status Rep noncommunicable Dis 2010 (2011), 1–176.

  • Google Scholar
  • View reference in article

• 23

  Centers for disease control and prevention Vol. 314227-A. Atlanta, GA, USA: National Diabetes Statistics Report (2020) p. 1–30.

  • Google Scholar
  • View reference in article

• 24

  MaieseK. Nicotinamide as a foundation for treating neurodegenerative disease and metabolic disorders. Curr Neurovasc Res (2021) 18(1):134–49. doi: 10.2174/1567202617999210104220334

  • CrossRef
  • Google Scholar
  • View reference in article

• 25

  AjiboyeBOShonibareMTOyinloyeBE. Antidiabetic activity of watermelon (Citrullus lanatus) juice in alloxan-induced diabetic rats. J Diabetes Metab Disord (2020) 19(1):343–52. doi: 10.1007/s40200-020-00515-2

  • CrossRef
  • Google Scholar
  • View reference in article

• 26

  ArildsenLAndersenJVWaagepetersenHSNissenJBDSheykhzadeM. Hypermetabolism and impaired endothelium-dependent vasodilation in mesenteric arteries of type 2 diabetes mellitus db/db mice. Diabetes Vasc Dis Res (2019) 16(6):1479164119865885. doi: 10.1177/1479164119865885

  • CrossRef
  • Google Scholar
  • View reference in article

• 27

  BayaraaOInmanCKThomasSAAl JallafFAlshaikhMIdaghdourYet al. Hyperglycemic conditions induce rapid cell dysfunction-promoting transcriptional alterations in human aortic endothelial cells. Sci Rep (2022) 12(1):20912. doi: 10.1038/s41598-022-24999-5

  • CrossRef
  • Google Scholar
  • View reference in article

• 28

  BurilloJMarquésPJiménezBGonzález-BlancoCBenitoMGuillénC. Insulin resistance and diabetes mellitus in alzheimer’s disease. Cells (2021) 10(5):1236. doi: 10.3390/cells10051236

  • CrossRef
  • Google Scholar
  • View reference in article

• 29

  ChenYHuangCZhuSYZouHCXuCYChenYX. Overexpression of hotair attenuates pi-induced vascular calcification by inhibiting wnt/β-catenin through regulating mir-126/klotho/sirt1 axis. Mol Cell Biochem (2021) 476(10):3551–61. doi: 10.1007/s11010-021-04164-8

  • CrossRef
  • Google Scholar
  • View reference in article

• 30

  GongQWangHYuPQianTXuX. Protective or harmful: the dual roles of autophagy in diabetic retinopathy. Front Med (Lausanne) (2021) 8:644121. doi: 10.3389/fmed.2021.644121

  • CrossRef
  • Google Scholar
  • View reference in article

• 31

  KaramzadNFarajiEAdeliSSullmanMJMPourghassem GargariB. The effect of menaquinone-7 supplementation on dp-ucmgp, pivkaii, inflammatory markers, and body composition in type 2 diabetes patients: A randomized clinical trial. Nutr Diabetes (2022) 12(1):15. doi: 10.1038/s41387-022-00192-5

  • CrossRef
  • Google Scholar
  • View reference in article

• 32

  MaieseK. New insights for oxidative stress and diabetes mellitus. Oxid Med Cell Longev (2015) 2015:875961. doi: 10.1155/2015/875961

  • CrossRef
  • Google Scholar
  • View reference in article

• 33

  MaieseK. Prospects and perspectives for wisp1 (Ccn4) in diabetes mellitus. Curr Neurovasc Res (2020) 17(3):327–31. doi: 10.2174/1567202617666200327125257

  • CrossRef
  • Google Scholar
  • View reference in article

• 34

  MaieseK. Nicotinamide: oversight of metabolic dysfunction through sirt1, mtor, and clock genes. Curr Neurovasc Res (2020) 17(5):765–83. doi: 10.2174/1567202617999201111195232

  • CrossRef
  • Google Scholar
  • View reference in article

• 35

  O’DonnellBTMonjureTAAl-GhadbanSIvesCJL’EcuyerMPRheeCet al. Aberrant expression of cox-2 and foxg1 in infrapatellar fat pad-derived ascs from pre-diabetic donors. Cells (2022) 11(15):2367. doi: 10.3390/cells11152367

  • CrossRef
  • Google Scholar
  • View reference in article

• 36

  RenL. Circular rna pip5k1a act as microrna-552-3p sponge to regulates inflammation, oxidative damage in glucolipotoxicity-induced pancreatic ins-1 β-cells via janus kinase 1. Bioengineered (2022) 13(3):5724–36. doi: 10.1080/21655979.2021.2022076

  • CrossRef
  • Google Scholar
  • View reference in article

• 37

  ZuoJZhangZLuoMZhouLNiceECZhangWet al. Redox Signaling at the Crossroads of Human Health And disease. MedComm (2020) (2022) 3(2):e127. doi: 10.1002/mco2.127

  • CrossRef
  • Google Scholar
  • View reference in article

• 38

  MaieseK. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mtor. Neural regeneration Res (2016) 11(3):372–85. doi: 10.4103/1673-5374.179032

  • CrossRef
  • Google Scholar
  • View reference in article

• 39

  HarrisMIEastmanRC. Early detection of undiagnosed diabetes mellitus: A us perspective. Diabetes Metab Res Rev (2000) 16(4):230–6. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr122>3.0.co;2-w

  • CrossRef
  • Google Scholar
  • View reference in article

• 40

  MaieseK. Mtor: driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus. World J Diabetes (2015) 6(2):217–24. doi: 10.4239/wjd.v6.i2.217

  • CrossRef
  • Google Scholar
  • View reference in article

• 41

  MaieseKChongZZShangYC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem (2007) 14(16):1729–38. doi: 10.2174/092986707781058968

  • CrossRef
  • Google Scholar
  • View reference in article

• 42

  MaieseK. New insights for nicotinamide: metabolic disease, autophagy, and mtor. Front bioscience (Landmark edition) (2020) 25:1925–73. doi: 10.2741/4886

  • CrossRef
  • Google Scholar

• 43

  BahorikABobrowKHoangTYaffeK. Increased risk of dementia in older female us veterans with alcohol use disorder. Addiction (2021) 116(8):2049–55. doi: 10.1111/add.15416

  • CrossRef
  • Google Scholar

• 44

  CaberlottoLNguyenTPLauriaMPriamiCRimondiniRMaioliSet al. Cross-disease analysis of alzheimer’s disease and type-2 diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases. Sci Rep (2019) 9(1):3965. doi: 10.1038/s41598-019-39828-5

  • CrossRef
  • Google Scholar

• 45

  KaramzadNMalekiVCarson-ChahhoudKAziziSSahebkarAGargariBP. A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre-diabetes. BioFactors (Oxford England) (2019) 46(1):21–37. doi: 10.1002/biof.1569

  • CrossRef
  • Google Scholar

• 46

  PincheraBScottoRBuonomoARZappuloEStagnaroFGallicchioAet al. Diabetes and covid-19: the potential role of mtor. Diabetes Res Clin Pract (2022) 186:109813. doi: 10.1016/j.diabres.2022.109813

  • CrossRef
  • Google Scholar

• 47

  OrkabyARDushkesRWardRDjousseLBuringJELeeIMet al. Effect of vitamin D3 and omega-3 fatty acid supplementation on risk of frailty: an ancillary study of a randomized clinical trial. JAMA Network Open (2022) 5(9):e2231206. doi: 10.1001/jamanetworkopen.2022.31206

  • CrossRef
  • Google Scholar

• 48

  AlvesHRLombaGSBGonçalves-de-AlbuquerqueCFBurthP. Irisin, exercise, and covid-19. Front Endocrinol (2022) 13:879066. doi: 10.3389/fendo.2022.879066

  • CrossRef
  • Google Scholar

• 49

  BramanteCTBeckmanKBMehtaTKargerABOddeDJTignanelliCJet al. Metformin reduces sars-cov-2 in a phase 3 randomized placebo controlled clinical trial. medRxiv (2023). doi: 10.1101/2023.06.06.23290989

  • CrossRef
  • Google Scholar

• 50

  MaieseK. The mechanistic target of rapamycin (Mtor): novel considerations as an antiviral treatment. Curr Neurovasc Res (2020) 17(3):332–7. doi: 10.2174/1567202617666200425205122

  • CrossRef
  • Google Scholar

• 51

  MillerRWentzelARRichardsGA. Covid-19: nad(+) deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on sirt1 activity. Med Hypotheses (2020) 144:110044. doi: 10.1016/j.mehy.2020.110044

  • CrossRef
  • Google Scholar

• 52

  OngANTanCCCañeteMTLimBARoblesJ. Association between metformin use and mortality among patients with type 2 diabetes mellitus hospitalized for covid-19 infection. J ASEAN Fed Endocr Soc (2021) 36(2):133–41. doi: 10.15605/jafes.036.02.20

  • CrossRef
  • Google Scholar

• 53

  RotllanNCamachoMTondoMDiarte-AñazcoEMGCanyellesMMéndez-LaraKAet al. Therapeutic potential of emerging nad+-increasing strategies for cardiovascular diseases. Antioxidants (Basel Switzerland) (2021) 10(12):1939. doi: 10.3390/antiox10121939

  • CrossRef
  • Google Scholar

• 54

  SwainORomanoSKMiryalaRTsaiJParikhVUmanahGKE. Sars-cov-2 neuronal invasion and complications: potential mechanisms and therapeutic approaches. J Neurosci (2021) 41(25):5338–49. doi: 10.1523/jneurosci.3188-20.2021

  • CrossRef
  • Google Scholar

• 55

  PrattichizzoFDe NigrisVSpigaRMancusoELa SalaLAntonicelliRet al. Inflammageing and metaflammation: the yin and yang of type 2 diabetes. Ageing Res Rev (2018) 41:1–17. doi: 10.1016/j.arr.2017.10.003

  • CrossRef
  • Google Scholar

• 56

  SpeerHD’CunhaNMAlexopoulosNIMcKuneAJNaumovskiN. Anthocyanins and human health-a focus on oxidative stress, inflammation and disease. Antioxidants (Basel Switzerland) (2020) 9(5):366. doi: 10.3390/antiox9050366

  • CrossRef
  • Google Scholar

• 57

  MaieseK. Picking a bone with wisp1 (Ccn4): new strategies against degenerative joint disease. J Transl Sci (2016) 1(3):83–5. doi: 10.15761/JTS.1000120

  • CrossRef
  • Google Scholar

• 58

  LiuZGanLZhangTRenQSunC. Melatonin alleviates adipose inflammation through elevating alpha-ketoglutarate and diverting adipose-derived exosomes to macrophages in mice. J Pineal Res (2018) 64(1):12455. doi: 10.1111/jpi.12455

  • CrossRef
  • Google Scholar

• 59

  QuesadaIde PaolaMTorres-PalazzoloCCamargoAFerderLManuchaWet al. Effect of garlic’s active constituents in inflammation, obesity and cardiovascular disease. Curr Hypertens Rep (2020) 22(1):6. doi: 10.1007/s11906-019-1009-9

  • CrossRef
  • Google Scholar

• 60

  SchellMWardelmannKKleinriddersA. Untangling the effect of insulin action on brain mitochondria and metabolism. J Neuroendocrinol (2021) 33(4):e12932. doi: 10.1111/jne.12932

  • CrossRef
  • Google Scholar

• 61

  YangJSuoHSongJ. Protective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome. Crit Rev Food Sci Nutr (2021) 61(22):3857–387. doi: 10.1080/10408398.2020.1809344

  • CrossRef
  • Google Scholar

• 62

  CiesielskaKGajewskaM. Fatty acids as potent modulators of autophagy activity in white adipose tissue. Biomolecules (2023) 13(2):255. doi: 10.3390/biom13020255

  • CrossRef
  • Google Scholar

• 63

  du ToitWLKrugerRGafane-MatemaneLFSchutteAELouwRMelsCMC. Markers of arterial stiffness and urinary metabolomics in young adults with early cardiovascular risk: the african-predict study. Metabolomics (2023) 19(4):28. doi: 10.1007/s11306-023-01987-y

  • CrossRef
  • Google Scholar

• 64

  KahminiFRGhalehHDShahgaldiS. Sirtuins: subtle regulators involved in convoluted mechanisms of pregnancy. Cell Physiol Biochem (2022) 56(6):644–62. doi: 10.33594/000000588

  • CrossRef
  • Google Scholar

• 65

  ChongZZLiFMaieseK. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol (2005) 75(3):207–46. doi: 10.1016/j.pneurobio.2005.02.004

  • CrossRef
  • Google Scholar

• 66

  MaieseK. Novel applications of trophic factors, wnt and wisp for neuronal repair and regeneration in metabolic disease. Neural regeneration Res (2015) 10(4):518–28. doi: 10.4103/1673-5374.155427

  • CrossRef
  • Google Scholar

• 67

  MaieseKChongZZHouJShangYC. Oxidative stress: biomarkers and novel therapeutic pathways. Exp Gerontol (2010) 45(3):217–34. doi: 10.1016/j.exger.2010.01.004

  • CrossRef
  • Google Scholar

• 68

  MaieseKChongZZShangYC. Outfoxoing disease and disability: the therapeutic potential of targeting foxo proteins. Trends Mol Med (2008) 14(5):219–27. doi: 10.1016/j.molmed.2008.03.002

  • CrossRef
  • Google Scholar

• 69

  FernandesJUppalKLiuKHHuXOrrMTranVet al. Antagonistic interactions in mitochondria ros signaling responses to manganese. Antioxidants (Basel Switzerland) (2023) 12(4):804. doi: 10.3390/antiox12040804

  • CrossRef
  • Google Scholar

• 70

  SunCBaiSLiangYLiuDLiaoJChenYet al. The role of sirtuin 1 and its activators in age-related lung disease. BioMed Pharmacother (2023) 162:114573. doi: 10.1016/j.biopha.2023.114573

  • CrossRef
  • Google Scholar

• 71

  TramutolaALanzillottaSAcetoGPagnottaSRuffoloGCifelliPet al. Intranasal administration of kyccsrk peptide rescues brain insulin signaling activation and reduces alzheimer’s disease-like neuropathology in a mouse model for down syndrome. Antioxidants (Basel Switzerland) (2023) 12(1):111. doi: 10.3390/antiox12010111

  • CrossRef
  • Google Scholar

• 72

  MuthuSJeyaramanMJeyaramanNRajendranRLGangadaranP. Where do we stand in stem cell therapy for the management of diabetes mellitus?-a scientometric research trend analysis from 1990 to 2020. Bioengineering (Basel) (2021) 8(11):159. doi: 10.3390/bioengineering8110159

  • CrossRef
  • Google Scholar

• 73

  WangRZhuYQinLFXuZGGaoXRLiuCBet al. Comprehensive bibliometric analysis of stem cell research in alzheimer’s disease from 2004 to 2022. Dement Geriatr Cognit Disord (2023) 52(2):41–73. doi: 10.1159/000528886

  • CrossRef
  • Google Scholar

• 74

  FengJWangHJingZWangYChengYWangWet al. Role of magnesium in type 2 diabetes mellitus. Biol Trace element Res (2019) 196(1):74–85. doi: 10.1007/s12011-019-01922-0

  • CrossRef
  • Google Scholar

• 75

  Fernandez-RuizRGarcía-AlamánAEstebanYMir-CollJSerra-NavarroBFontcuberta-PiSunyerMet al. Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells. Nat Commun (2020) 11(1):5982. doi: 10.1038/s41467-020-19657-1

  • CrossRef
  • Google Scholar

• 76

  GuoTLiuTSunYLiuXXiongRLiHet al. Sonodynamic therapy inhibits palmitate-induced beta cell dysfunction via pink1/parkin-dependent mitophagy. Cell Death Dis (2019) 10(6):457. doi: 10.1038/s41419-019-1695-x

  • CrossRef
  • Google Scholar

• 77

  HuRZhuXYuanMHoKHKaverinaIGuG. Microtubules and Gαo-signaling modulate the preferential secretion of young insulin secretory granules in islet β Cells via independent pathways. PloS One (2021) 16(7):e0241939. doi: 10.1371/journal.pone.0241939

  • CrossRef
  • Google Scholar

• 78

  JalgaonkarMPParmarUMKulkarniYAOzaMJ. Sirt1-foxos activity regulates diabetic complications. Pharmacol Res (2022) 175:106014. doi: 10.1016/j.phrs.2021.106014

  • CrossRef
  • Google Scholar

• 79

  LiRWangBWuCLiDWuYYeLet al. Acidic fibroblast growth factor attenuates type 2 diabetes-induced demyelination via suppressing oxidative stress damage. Cell Death Dis (2021) 12(1):107. doi: 10.1038/s41419-021-03407-2

  • CrossRef
  • Google Scholar

• 80

  Quintana-PérezJCGarcía-DoloresFValdez-GuerreroASAlemán-González-DuhartDArellano-MendozaMGRojas HernándezSet al. Modeling type 2 diabetes in rats by administering tacrolimus. Islets (2022) 14(1):114–27. doi: 10.1080/19382014.2022.2051991

  • CrossRef
  • Google Scholar

• 81

  HillJHSoltCFosterMT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Hormone Mol Biol Clin Invest (2018) 33(2):20180012. doi: 10.1515/hmbci-2018-0012

  • CrossRef
  • Google Scholar

• 82

  NieXWeiXMaHFanLChenWD. The complex role of wnt ligands in type 2 diabetes mellitus and related complications. J Cell Mol Med (2021) 25(14):6479–95. doi: 10.1111/jcmm.16663

  • CrossRef
  • Google Scholar

• 83

  Sanabria-de la TorreRGarcía-FontanaCGonzález-SalvatierraSAndújar-VeraFMartínez-HerediaLGarcía-FontanaBet al. The contribution of wnt signaling to vascular complications in type 2 diabetes mellitus. Int J Mol Sci (2022) 23(13):6995. doi: 10.3390/ijms23136995

  • CrossRef
  • Google Scholar

• 84

  SunZYYuTYJiangFXWangW. Functional maturation of immature β Cells: A roadblock for stem cell therapy for type 1 diabetes. World J Stem Cells (2021) 13(3):193–207. doi: 10.4252/wjsc.v13.i3.193

  • CrossRef
  • Google Scholar

• 85

  TanSZangGWangYSunZLiYLuCet al. Differences of angiogenesis factors in tumor and diabetes mellitus. Diabetes Metab Syndr Obes (2021) 14:3375–88. doi: 10.2147/dmso.S315362

  • CrossRef
  • Google Scholar

• 86

  ZaiouM. Circrnas signature as potential diagnostic and prognostic biomarker for diabetes mellitus and related cardiovascular complications. Cells (2020) 9(3):659. doi: 10.3390/cells9030659

  • CrossRef
  • Google Scholar

• 87

  ZarneshanSNFakhriSFarzaeiMHKhanHSasoL. Astaxanthin targets pi3k/akt signaling pathway toward potential therapeutic applications. Food Chem Toxicol (2020) 145:111714. doi: 10.1016/j.fct.2020.111714

  • CrossRef
  • Google Scholar

• 88

  Centers for Medicare and Medicaid Services. National health expenditure projections 2018-2027 (Baltimore, Maryland, USA). (2019).

  • Google Scholar

• 89

  SonsallaMMLammingDW. Geroprotective interventions in the 3xtg mouse model of alzheimer’s disease. Geroscience (2023) 45(3):1343–81. doi: 10.1007/s11357-023-00782-w

  • CrossRef
  • Google Scholar

• 90

  SinghAKukretiRSasoLKukretiS. Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules (2022) 27(3):950. doi: 10.3390/molecules27030950

  • CrossRef
  • Google Scholar

• 91

  LiuLCaoQGaoWLiBYZengCXiaZet al. Melatonin ameliorates cerebral ischemia-reperfusion injury in diabetic mice by enhancing autophagy via the sirt1-bmal1 pathway. FASEB J (2021) 35(12):e22040. doi: 10.1096/fj.202002718RR

  • CrossRef
  • Google Scholar

• 92

  HeerCDSandersonDJVothLSAlhammadYMOSchmidtMSTrammellSAJet al. Coronavirus infection and parp expression dysregulate the nad metabolome: an actionable component of innate immunity. J Biol Chem (2020) 295(52):17986–96. doi: 10.1074/jbc.RA120.015138

  • CrossRef
  • Google Scholar

• 93

  LiJLinFHZhuXMLvZM. Impact of diabetic hyperglycaemia and insulin therapy on autophagy and impairment in rat epididymis. Andrologia (2020) 52(11):e13889. doi: 10.1111/and.13889

  • CrossRef
  • Google Scholar

• 94

  TomitaYLeeDTsubotaKKuriharaT. Pparα Agonist oral therapy in diabetic retinopathy. Biomedicines (2020) 8(10):433. doi: 10.3390/biomedicines8100433

  • CrossRef
  • Google Scholar

• 95

  MaieseK. Driving neural regeneration through the mammalian target of rapamycin. Neural regeneration Res (2014) 9(15):1413–7. doi: 10.4103/1673-5374.139453

  • CrossRef
  • Google Scholar

• 96

  MaieseK. The bright side of reactive oxygen species: lifespan extension without cellular demise. J Transl Sci (2016) 2(3):185–7. doi: 10.15761/jts.1000138

  • CrossRef
  • Google Scholar

• 97

  MaieseK. The mechanistic target of rapamycin (Mtor) and the silent mating-type information regulation 2 homolog 1 (Sirt1): oversight for neurodegenerative disorders. Biochem Soc Trans (2018) 46(2):351–60. doi: 10.1042/bst20170121

  • CrossRef
  • Google Scholar

• 98

  MinistriniSPuspitasariYMBeerGLiberaleLMontecuccoFCamiciGG. Sirtuin 1 in endothelial dysfunction and cardiovascular aging. Front Physiol (2021) 12:733696. doi: 10.3389/fphys.2021.733696

  • CrossRef
  • Google Scholar

• 99

  OlejniczakIPilorzVOsterH. Circle(S) of life: the circadian clock from birth to death. Biol (Basel) (2023) 12(3):383. doi: 10.3390/biology12030383

  • CrossRef
  • Google Scholar

• 100

  YamamotoHShimomuraNOuraKHasegawaY. Nacre extract from pearl oyster shell prevents D-galactose-induced brain and skin aging. Mar Biotechnol (NY) (2023) 25(4):503–18. doi: 10.1007/s10126-022-10192-2

  • CrossRef
  • Google Scholar

• 101

  National Center for Health Statistics. National vital statisitcs system. Hyattsville, Maryland, USA: National Center for Health Statistics Fact Sheet (2019) p. 1–2.

  • Google Scholar

• 102

  BegumMKKonjaDSinghSChlopickiSWangY. Endothelial sirt1 as a target for the prevention of arterial aging: promises and challenges. J Cardiovasc Pharmacol (2021) 78(Suppl 6):S63–s77. doi: 10.1097/fjc.0000000000001154

  • CrossRef
  • Google Scholar

• 103

  BraidyNLiuY. Nad+ Therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol (2020) 132:110831. doi: 10.1016/j.exger.2020.110831

  • CrossRef
  • Google Scholar

• 104

  Castro-PortuguezRSutphinGL. Kynurenine pathway, nad(+) synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan. Exp Gerontol (2020) 132:110841. doi: 10.1016/j.exger.2020.110841

  • CrossRef
  • Google Scholar

• 105

  ChongZZMaieseK. Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol (2012) 11(1):45. doi: 10.1186/1475-2840-11-45

  • CrossRef
  • Google Scholar

• 106

  ChongZZShangYCWangSMaieseK. Sirt1: new avenues of discovery for disorders of oxidative stress. Expert Opin Ther Targets (2012) 16(2):167–78. doi: 10.1517/14728222.2012.648926

  • CrossRef
  • Google Scholar

• 107

  De NobregaAKLuzKVLyonsLC. Resetting the aging clock: implications for managing age-related diseases. Adv Exp Med Biol (2020) 1260:193–265. doi: 10.1007/978-3-030-42667-5_9

  • CrossRef
  • Google Scholar

• 108

  FischerFGrigolonGBennerCRistowM. Evolutionarily conserved transcription factors as regulators of longevity and targets for geroprotection. Physiol Rev (2022) 102(3):1449–94. doi: 10.1152/physrev.00017.2021

  • CrossRef
  • Google Scholar

• 109

  JiJSLiuLZengYYanLL. Effect of foxo3 and air pollution on cognitive function: A longitudinal cohort study of older adults in China from 2000 to 2014. J Gerontol A Biol Sci Med Sci (2022) 77(8):1534–41. doi: 10.1093/gerona/glac016

  • CrossRef
  • Google Scholar

• 110

  LatheRSt ClairD. Programmed ageing: decline of stem cell renewal, immunosenescence, and alzheimer’s disease. Biol Rev Cambridge Philos Soc (2023) 98(4):1424–58. doi: 10.1111/brv.12959

  • CrossRef
  • Google Scholar

• 111

  MaieseK. Sirt1 and stem cells: in the forefront with cardiovascular disease, neurodegeneration and cancer. World J Stem Cells (2015) 7(2):235–42. doi: 10.4252/wjsc.v7.i2.235

  • CrossRef
  • Google Scholar

• 112

  TabibzadehS. Signaling pathways and effectors of aging. Front bioscience (Landmark edition) (2021) 26:50–96. doi: 10.2741/4889

  • CrossRef
  • Google Scholar

• 113

  WatrobaMSzukiewiczD. Sirtuins at the service of healthy longevity. Front Physiol (2021) 12:724506. doi: 10.3389/fphys.2021.724506

  • CrossRef
  • Google Scholar

• 114

  MaieseK. Erythropoietin and mtor: A “One-two punch” for aging-related disorders accompanied by enhanced life expectancy. Curr Neurovasc Res (2016) 13(4):329–40. doi: 10.2174/1567202613666160729164900

  • CrossRef
  • Google Scholar

• 115

  MaieseK. Sirtuins: developing innovative treatments for aged-related memory loss and alzheimer’s disease. Curr Neurovasc Res (2018) 15(4):367–71. doi: 10.2174/1567202616666181128120003

  • CrossRef
  • Google Scholar

• 116

  World Health Organization. Global action plan on the Public Health Response to Dementia 2017-2025 (Geneva, Switzerland). (2017). pp. 1–44.

  • Google Scholar

• 117

  MaieseK. Targeting the core of neurodegeneration: foxo, mtor, and sirt1. Neural regeneration Res (2021) 16(3):448–55. doi: 10.4103/1673-5374.291382

  • CrossRef
  • Google Scholar

• 118

  YuMZhangHWangBZhangYZhengXShaoBet al. Key signaling pathways in aging and potential interventions for healthy aging. Cells (2021) 10(3):660. doi: 10.3390/cells10030660

  • CrossRef
  • Google Scholar

• 119

  AdhikariUKKhanRMikhaelMBalezRDavidMAMahnsDet al. Therapeutic Anti-Amyloid β Antibodies Cause Neuronal Disturbances. Alzheimer’s & dementia: the journal of the Alzheimer’s Association (2022). doi: 10.1002/alz.12833

  • CrossRef
  • Google Scholar

• 120

  AhmadRKhanARehmanIULeeHJKhanIKimMO. Lupeol Treatment Attenuates activation of glial cells and oxidative-stress-mediated neuropathology in mouse model of traumatic brain injury. Int J Mol Sci (2022) 23(11):6086. doi: 10.3390/ijms23116086

  • CrossRef
  • Google Scholar

• 121

  AminiJSanchooliNMilajerdiMHBaeeriMHaddadiMSanadgolN. The interplay between tauopathy and aging through interruption of upr/nrf2/autophagy crosstalk in the alzheimer’s disease transgenic experimental models. Int J Neurosci (2023), 1–27. doi: 10.1080/00207454.2023.2210409

  • CrossRef
  • Google Scholar

• 122

  GuoTChenMLiuJWeiZYuanJWuWet al. Neuropilin-1 promotes mitochondrial structural repair and functional recovery in rats with cerebral ischemia. J Trans Med (2023) 21(1):297. doi: 10.1186/s12967-023-04125-3

  • CrossRef
  • Google Scholar

• 123

  Jarero-BasultoJRivera-CervantesMGasca-MartínezDGarcía-SierraFGasca-MartínezYBeas-ZárateC. Current evidence on the protective effects of recombinant human erythropoietin and its molecular variants against pathological hallmarks of alzheimer’s disease. Pharm (Basel Switzerland) (2020) 13(424):1–22. doi: 10.3390/ph13120424

  • CrossRef
  • Google Scholar

• 124

  LiuBZhaoGJinLShiJ. Nicotinamide improves cognitive function in mice with chronic cerebral hypoperfusion. Front Neurol (2021) 12:596641. doi: 10.3389/fneur.2021.596641

  • CrossRef
  • Google Scholar

• 125

  MaieseK. The many facets of cell injury: angiogenesis to autophagy. Curr Neurovasc Res (2012) 9(2):1–2. doi: 10.2174/156720212800410911

  • CrossRef
  • Google Scholar

• 126

  MavroidiBKaminariAMatiadisDHadjipavlou-LitinaDPelecanouMTziniaAet al. The prophylactic and multimodal activity of two isatin thiosemicarbazones against alzheimer’s disease in vitro. Brain Sci (2022) 12(6):806. doi: 10.3390/brainsci12060806

  • CrossRef
  • Google Scholar

• 127

  PontifexMGMartinsenASalehRNMHardenGTejeraNMüllerMet al. Apoe4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in apoe-tr mice. FASEB J (2021) 35(5):e21583. doi: 10.1096/fj.202002621RR

  • CrossRef
  • Google Scholar

• 128

  ToriiTMiyamotoYNakataRHigashiYShinmyoYKawasakiHet al. Identification of tau protein as a novel marker for maturation and pathological changes of oligodendrocytes. Glia (2023) 71(4):1002–17. doi: 10.1002/glia.24322

  • CrossRef
  • Google Scholar

• 129

  YalçinMMundorfAThielFAmatriain-FernándezSKalthoffISBeuckeJCet al. It’s about time: the circadian network as time-keeper for cognitive functioning, locomotor activity and mental health. Front Physiol (2022) 13:873237. doi: 10.3389/fphys.2022.873237

  • CrossRef
  • Google Scholar

• 130

  MaieseK. Wisp1: clinical insights for a proliferative and restorative member of the ccn family. Curr Neurovasc Res (2014) 11(4):378–89. doi: 10.2174/1567202611666140912115107

  • CrossRef
  • Google Scholar

• 131

  LevineKSLeonardHLBlauwendraatCIwakiHJohnsonNBandres-CigaSet al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron (2023) 111(7):1086–93. doi: 10.1016/j.neuron.2022.12.029

  • CrossRef
  • Google Scholar

• 132

  PradhanSSRaoKRManjunathMSaiswaroopRPatnanaDPPhalgunaKSet al. Vitamin B(6), B(12) and folate modulate deregulated pathways and protein aggregation in yeast model of huntington disease. 3 Biotech (2023) 13(3):96. doi: 10.1007/s13205-023-03525-y

  • CrossRef
  • Google Scholar

• 133

  ZhangWBHuangYGuoXRZhangMQYuanXSZuHB. Dhcr24 reverses alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xfad mice. Acta neuropathologica Commun (2023) 11(1):102. doi: 10.1186/s40478-023-01593-y

  • CrossRef
  • Google Scholar

• 134

  MaieseK. Targeting molecules to medicine with mtor, autophagy and neurodegenerative disorders. Br J Clin Pharmacol (2016) 82(5):1245–66. doi: 10.1111/bcp.12804

  • CrossRef
  • Google Scholar

• 135

  Borowicz-ReuttKKCzuczwarSJ. Role of oxidative stress in epileptogenesis and potential implications for therapy. Pharmacol Rep (2020) 72(5):1218–26. doi: 10.1007/s43440-020-00143-w

  • CrossRef
  • Google Scholar

• 136

  CortiOBlomgrenKPolettiABeartPM. Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases. J Neurochem (2020) 154(4):e15002. doi: 10.1111/jnc.15002

  • CrossRef
  • Google Scholar

• 137

  DuitamaMVargas-LópezVCasasZAlbarracinSLSutachanJJTorresYP. Trp channels role in pain associated with neurodegenerative diseases. Front Neurosci (2020) 14:782. doi: 10.3389/fnins.2020.00782

  • CrossRef
  • Google Scholar

• 138

  KaurDBehlTSehgalASinghSSharmaNBadavathVNet al. Unravelling the potential neuroprotective facets of erythropoietin for the treatment of alzheimer’s disease. Metab Brain Dis (2021) 37(1):1–16. doi: 10.1007/s11011-021-00820-6

  • CrossRef
  • Google Scholar

• 139

  KuanXYFauziNSANgKYBakhtiarA. Exploring the causal relationship between telomere biology and alzheimer’s disease. Mol Neurobiol (2023) 60(8):4169–83. doi: 10.1007/s12035-023-03337-4

  • CrossRef
  • Google Scholar

• 140

  LaCroixMSMirbahaHShangPZandeeSFoongCPratAet al. Tau seeding in cases of multiple sclerosis. Acta neuropathologica Commun (2022) 10(1):146. doi: 10.1186/s40478-022-01444-2

  • CrossRef
  • Google Scholar

• 141

  MaieseK. Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm. Front bioscience (Landmark edition) (2021) 26(9):614–27. doi: 10.52586/4971

  • CrossRef
  • Google Scholar

• 142

  MishraPDaviesDAAlbensiBC. The interaction between nf-κb and estrogen in alzheimer’s disease. Mol Neurobiol (2022) 60(3):1515–26. doi: 10.1007/s12035-022-03152-3

  • CrossRef
  • Google Scholar

• 143

  SabzaliMEidiAKhaksariMKhastarH. Anti-inflammatory, antioxidant, and antiapoptotic action of metformin attenuates ethanol neurotoxicity in the animal model of fetal alcohol spectrum disorders. Neurotox Res (2022) 40(2):605–13. doi: 10.1007/s12640-022-00499-2

  • CrossRef
  • Google Scholar

• 144

  SalemiMMogaveroMPLanzaGMongioìLMCalogeroAEFerriR. Examples of inverse comorbidity between cancer and neurodegenerative diseases: A possible role for noncoding rna. Cells (2022) 11(12):1930. doi: 10.3390/cells11121930

  • CrossRef
  • Google Scholar

• 145

  SenousyMAHanafyMEShehataNRizkSM. Erythropoietin and bacillus calmette-guérin vaccination mitigate 3-nitropropionic acid-induced huntington-like disease in rats by modulating the pi3k/akt/mtor/P70s6k pathway and enhancing the autophagy. ACS Chem Neurosci (2022) 13(6):721–32. doi: 10.1021/acschemneuro.1c00523

  • CrossRef
  • Google Scholar

• 146

  SuLDWangNHanJShenY. Group 1 metabotropic glutamate receptors in neurological and psychiatric diseases: mechanisms and prospective. Neuroscientist (2021) 28(5):10738584211021018. doi: 10.1177/10738584211021018

  • CrossRef
  • Google Scholar

• 147

  World Health Organization. Dementia: A public health priority. Geneva: World Health Organization (2012) p. 1–4.

  • Google Scholar

• 148

  MaieseK. Taking Aim at Alzheimer’s Disease through the Mammalian Target of Rapamycin. Ann Med (2014) 46(8):587–96. doi: 10.3109/07853890.2014.941921

  • CrossRef
  • Google Scholar

• 149

  FarmerKAbd-ElrahmanKSDerksenARoweEMThompsonAMRudykCAet al. Mglur5 allosteric modulation promotes neurorecovery in a 6-ohda-toxicant model of parkinson’s disease. Mol Neurobiol (2020) 57(3):1418–31. doi: 10.1007/s12035-019-01818-z

  • CrossRef
  • Google Scholar

• 150

  GalzignaLDe IuliisAZanattaL. Enzymatic dopamine peroxidation in substantia nigra of human brain. Clin Chim Acta (2000) 300(1-2):131–8. doi: 10.1016/s0009-8981(00)00313-2

  • CrossRef
  • Google Scholar

• 151

  Gonzalo-GobernadoRPeruchoJVallejo-MuñozMCasarejosMJReimersDJiménez-EscrigAet al. Liver growth factor “Lgf” as a therapeutic agent for alzheimer’s disease. Int J Mol Sci (2020) 21(3):9201. doi: 10.3390/ijms21239201

  • CrossRef
  • Google Scholar

• 152

  JayarajRLBeiramRAzimullahSMfNMOjhaSKAdemAet al. Valeric acid protects dopaminergic neurons by suppressing oxidative stress, neuroinflammation and modulating autophagy pathways. Int J Mol Sci (2020) 21(20):7670. doi: 10.3390/ijms21207670

  • CrossRef
  • Google Scholar

• 153

  KhanHTundisRUllahHAschnerMBelwalTMirzaeiHet al. Flavonoids targeting nrf2 in neurodegenerative disorders. Food Chem Toxicol (2020) 146:111817. doi: 10.1016/j.fct.2020.111817

  • CrossRef
  • Google Scholar

• 154

  KowalskaMPiekutTPrendeckiMSodelAKozubskiWDorszewskaJ. Mitochondrial and nuclear DNA oxidative damage in physiological and pathological aging. DNA Cell Biol (2020) 39(8):1410–20. doi: 10.1089/dna.2019.5347

  • CrossRef
  • Google Scholar

• 155

  LeiQWuTWuJHuXGuanYWangYet al. Roles of α−Synuclein in gastrointestinal microbiome dysbiosis−Related parkinson’s disease progression (Review). Mol Med Rep (2021) 24(4):734. doi: 10.3892/mmr.2021.12374

  • CrossRef
  • Google Scholar

• 156

  LiXFengYWangXXTruongDWuYC. The critical role of sirt1 in parkinson’s disease: mechanism and therapeutic considerations. Aging Dis (2020) 11(6):1608–22. doi: 10.14336/ad.2020.0216

  • CrossRef
  • Google Scholar

• 157

  LiuJLiuHZhaoZWangJGuoDLiuY. Regulation of actg1 and gsta2 is possible mechanism by which capsaicin alleviates apoptosis in cell model of 6-ohda-induced parkinson’s disease. Bioscience Rep (2020) 40(6):BSR20191796. doi: 10.1042/bsr20191796

  • CrossRef
  • Google Scholar

• 158

  MaieseK. Biomarkers for parkinson’s disease and neurodegenerative disorders: A role for non-coding rnas. Curr Neurovasc Res (2022) 19(2):127–30. doi: 10.2174/1567202619666220602125806

  • CrossRef
  • Google Scholar

• 159

  MaieseKChongZZShangYCWangS. Erythropoietin: new directions for the nervous system. Int J Mol Sci (2012) 13(9):11102–29. doi: 10.3390/ijms130911102

  • CrossRef
  • Google Scholar

• 160

  MarchettiB. Nrf2/wnt resilience orchestrates rejuvenation of glia-neuron dialogue in parkinson’s disease. Redox Biol (2020) 36:101664. doi: 10.1016/j.redox.2020.101664

  • CrossRef
  • Google Scholar

• 161

  MargrettJASchofieldTMartinPPoonLWMasakiKDonlonTAet al. Novel functional, health, and genetic determinants of cognitive terminal decline: kuakini honolulu heart program/honolulu-asia aging study. J Gerontol A Biol Sci Med Sci (2021) 77(8):1525–33. doi: 10.1093/gerona/glab327

  • CrossRef
  • Google Scholar

• 162

  OdnokozONakatsukaKWrightCCastellanosJKlichkoVIKretzschmarDet al. Mitochondrial redox signaling is critical to the normal functioning of the neuronal system. Front Cell Dev Biol (2021) 9:613036. doi: 10.3389/fcell.2021.613036

  • CrossRef
  • Google Scholar

• 163

  QuerfurthHLeeHK. Mammalian/mechanistic target of rapamycin (Mtor) complexes in neurodegeneration. Mol neurodegeneration (2021) 16(1):44. doi: 10.1186/s13024-021-00428-5

  • CrossRef
  • Google Scholar

• 164

  UllahHHussainAAsifMNawazFRasoolM. Natural products as bioactive agents in the prevention of dementia. CNS Neurol Disord Drug Targets (2023) 22(4):466–76. doi: 10.2174/1871527321666220422085835

  • CrossRef
  • Google Scholar

• 165

  WangQZhengJPetterssonSReynoldsRTanEK. The link between neuroinflammation and the neurovascular unit in synucleinopathies. Sci Adv (2023) 9(7):eabq1141. doi: 10.1126/sciadv.abq1141

  • CrossRef
  • Google Scholar

• 166

  LiuJJShentuLMMaNWangLYZhangGMSunYet al. Inhibition of nf-kappab and wnt/beta-catenin/gsk3beta signaling pathways ameliorates cardiomyocyte hypertrophy and fibrosis in streptozotocin (Stz)-induced type 1 diabetic rats. Curr Med Sci (2020) 40(1):35–47. doi: 10.1007/s11596-020-2144-x

  • CrossRef
  • Google Scholar

• 167

  MaieseK. Erythropoietin and diabetes mellitus. World J Diabetes (2015) 6(14):1259–73. doi: 10.4239/wjd.v6.i14.1259

  • CrossRef
  • Google Scholar

• 168

  MaieseKChongZZShangYCHouJ. Foxo proteins: cunning concepts and considerations for the cardiovascular system. Clin Sci (Lond) (2009) 116(3):191–203. doi: 10.1042/CS20080113

  • CrossRef
  • Google Scholar

• 169

  MaieseKHouJChongZZShangYC. A fork in the path: developing therapeutic inroads with foxo proteins. Oxid Med Cell Longev (2009) 2(3):119–29. doi: 10.4161/oxim.2.3.8916

  • CrossRef
  • Google Scholar

• 170

  PabelSHamdaniNLueddeMSossallaS. Sglt2 inhibitors and their mode of action in heart failure-has the mystery been unravelled? Curr Heart Fail Rep (2021) 18(5):315–28. doi: 10.1007/s11897-021-00529-8

  • CrossRef
  • Google Scholar

• 171

  CiardulloSMuracaEBianconiECannistraciRPerraSZerbiniFet al. Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general us population. J Clin Endocrinol Metab (2023) 108(2):361–7. doi: 10.1210/clinem/dgac580

  • CrossRef
  • Google Scholar

• 172

  MaieseK. Programming apoptosis and autophagy with novel approaches for diabetes mellitus. Curr Neurovasc Res (2015) 12(2):173–88. doi: 10.2174/1567202612666150305110929

  • CrossRef
  • Google Scholar

• 173

  MaieseK. Foxo transcription factors and regenerative pathways in diabetes mellitus. Curr Neurovasc Res (2015) 12(4):404–13. doi: 10.2174/1567202612666150807112524

  • CrossRef
  • Google Scholar

• 174

  PouresmaeilVAl AbudiAHMahimidAHSarafraz YazdiMEs-HaghiA. Evaluation of serum selenium and copper levels with inflammatory cytokines and indices of oxidative stress in type 2 diabetes. Biol Trace element Res (2022) 201(2):617–26. doi: 10.1007/s12011-022-03191-w

  • CrossRef
  • Google Scholar

• 175

  BeegumFAnunrajanaPVGeorgeKTDivyaKPBegumFKrishnadasNet al. Sirtuins as therapeutic targets for improving delayed wound healing in diabetes. J Drug Target (2022) 30(9):911–926. doi: 10.1080/1061186x.2022.2085729

  • CrossRef
  • Google Scholar

• 176

  ChiareliRACarvalhoGAMarquesBLMotaLSOliveira-LimaOCGomesRMet al. The role of astrocytes in the neurorepair process. Front Cell Dev Biol (2021) 9:665795. doi: 10.3389/fcell.2021.665795

  • CrossRef
  • Google Scholar

• 177

  DingSZhuYLiangYHuangHXuYZhongC. Circular rnas in vascular functions and diseases. Adv Exp Med Biol (2018) 1087:287–97. doi: 10.1007/978-981-13-1426-1_23

  • CrossRef
  • Google Scholar

• 178

  GengKMaXJiangZHuangWGaoCPuYet al. Innate immunity in diabetic wound healing: focus on the mastermind hidden in chronic inflammatory. Front Pharmacol (2021) 12:653940. doi: 10.3389/fphar.2021.653940

  • CrossRef
  • Google Scholar

• 179

  HajibabaieFAbedpoorNSafaviKTaghianF. Natural remedies medicine derived from flaxseed (Secoisolariciresinol diglucoside, lignans, and α-linolenic acid) improve network targeting efficiency of diabetic heart conditions based on computational chemistry techniques and pharmacophore modeling. J Food Biochem (2022) 46(12):e14480. doi: 10.1111/jfbc.14480

  • CrossRef
  • Google Scholar

• 180

  LiuPLiuJWuYXiWWeiYYuanZet al. Zinc supplementation protects against diabetic endothelial dysfunction via gtp cyclohydrolase 1 restoration. Biochem Biophys Res Commun (2020) 521(4):1049–54. doi: 10.1016/j.bbrc.2019.11.046

  • CrossRef
  • Google Scholar

• 181

  MaieseKLiFChongZZShangYC. The wnt signaling pathway: aging gracefully as a protectionist? Pharmacol Ther (2008) 118(1):58–81. doi: 10.1016/j.pharmthera.2008.01.004

  • CrossRef
  • Google Scholar

• 182

  ZhouQTangSZhangXChenL. Targeting pras40: A novel therapeutic strategy for human diseases. J Drug Target (2021) 29(7):703–715. doi: 10.1080/1061186x.2021.1882470

  • CrossRef
  • Google Scholar

• 183

  El-MarasySAAbdel-RahmanRFAbd-ElsalamRM. Neuroprotective effect of vildagliptin against cerebral ischemia in rats. Naunyn Schmiedebergs Arch Pharmacol (2018) 391(10):1133–45. doi: 10.1007/s00210-018-1537-x

  • CrossRef
  • Google Scholar

• 184

  JanuszewskiASWatsonCJO’NeillVMcDonaldKLedwidgeMRobsonTet al. Fkbpl is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Sci Rep (2020) 10(1):21655. doi: 10.1038/s41598-020-78676-6

  • CrossRef
  • Google Scholar

• 185

  EsterlineRLVaagAOscarssonJVoraJ. Mechanisms in endocrinology: sglt2 inhibitors; clinical benefits by restoration of normal diurnal metabolism? Eur J Endocrinol (2018) 178(4):R113–25. doi: 10.1530/eje-17-0832

  • CrossRef
  • Google Scholar

• 186

  Mocayar MarónFJFerderLReiterRJManuchaW. Daily and seasonal mitochondrial protection: unraveling common possible mechanisms involving vitamin D and melatonin. J Steroid Biochem Mol Biol (2020) 199:105595. doi: 10.1016/j.jsbmb.2020.105595

  • CrossRef
  • Google Scholar

• 187

  MishraMDuraisamyAJKowluruRA. Sirt1- a guardian of the development of diabetic retinopathy. Diabetes (2018) 67(4):745–54. doi: 10.2337/db17-0996

  • CrossRef
  • Google Scholar

• 188

  QiXMitterSKYanYBusikJVGrantMBBoultonME. Diurnal rhythmicity of autophagy is impaired in the diabetic retina. Cells (2020) 9(4):905. doi: 10.3390/cells9040905

  • CrossRef
  • Google Scholar

• 189

  CascianoFZauliERimondiEMuraMPreviatiMBusinMet al. The role of the mtor pathway in diabetic retinopathy. Front Med (Lausanne) (2022) 9:973856. doi: 10.3389/fmed.2022.973856

  • CrossRef
  • Google Scholar

• 190

  KitaASaitoYMiuraNMiyajimaMYamamotoSSatoTet al. Altered regulation of mesenchymal cell senescence in adipose tissue promotes pathological changes associated with diabetic wound healing. Commun Biol (2022) 5(1):310. doi: 10.1038/s42003-022-03266-3

  • CrossRef
  • Google Scholar

• 191

  FadiniGPMorieriMLLongatoEAvogaroA. Prevalence and impact of diabetes among people infected with sars-cov-2. J endocrinological Invest (2020) 43(6):867–9. doi: 10.1007/s40618-020-01236-2

  • CrossRef
  • Google Scholar

• 192

  LallyMATsoukasPHalladayCWO’NeillEGravensteinSRudolphJL. Metformin is associated with decreased 30-day mortality among nursing home residents infected with sars-cov2. J Am Med Dir Assoc (2021) 22(1):193–8. doi: 10.1016/j.jamda.2020.10.031

  • CrossRef
  • Google Scholar

• 193

  Gutiérrez-PliegoLEMartínez-CarrilloBEReséndiz-AlborAAValdés-RamosR. Effect on adipose tissue of diabetic mice supplemented with N-3 fatty acids extracted from microalgae. Endocr Metab Immune Disord Drug Targets (2020) 20(5):728–35. doi: 10.2174/1871530320666200213111452

  • CrossRef
  • Google Scholar

• 194

  LiSVaziriNDSwentekLTakasuCVoKStamosMJet al. Prevention of autoimmune diabetes in nod mice by dimethyl fumarate. Antioxidants (Basel Switzerland) (2021) 10(2):193. doi: 10.3390/antiox10020193

  • CrossRef
  • Google Scholar

• 195

  MaieseKChongZZHouJShangYC. The “O” Class: crafting clinical care with foxo transcription factors. Adv Exp Med Biol (2009) 665:242–60. doi: 10.1007/978-1-4419-1599-3_18

  • CrossRef
  • Google Scholar

• 196

  MaieseKChongZZHouJShangYC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules (2009) 14(9):3446–85. doi: 10.3390/molecules14093446

  • CrossRef
  • Google Scholar

• 197

  RashidiSMansouriRAli-HassanzadehMMojtahediZShafieiRSavardashtakiAet al. The host mtor pathway and parasitic diseases pathogenesis. Parasitol Res (2021) 120(4):1151–66. doi: 10.1007/s00436-021-07070-6

  • CrossRef
  • Google Scholar

• 198

  WenSJiangWZhouL. Islet autoantibodies in the patients with sjogren’s syndrome and thyroid disease and risk of progression to latent autoimmune diabetes in adults: A case series. Diabetes Metab Syndr Obes (2021) 14:1025–33. doi: 10.2147/dmso.S295847

  • CrossRef
  • Google Scholar

• 199

  ZhuangXMagriAHillMLaiAGKumarARambhatlaSBet al. The circadian clock components bmal1 and rev-erbα Regulate flavivirus replication. Nat Commun (2019) 10(1):377. doi: 10.1038/s41467-019-08299-7

  • CrossRef
  • Google Scholar

• 200

  ZhangYYuanYZhangJZhaoYZhangYFuJ. Astragaloside iv supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice. Front Aging Neurosci (2022) 14:1004557. doi: 10.3389/fnagi.2022.1004557

  • CrossRef
  • Google Scholar

• 201

  MaieseKChongZZWangSShangYC. Oxidant stress and signal transduction in the nervous system with the pi 3-K, akt, and mtor cascade. Int J Mol Sci (2013) 13(11):13830–66. doi: 10.3390/ijms131113830

  • CrossRef
  • Google Scholar

• 202

  LiuCZhongCChenRZhouXWuJHanJet al. Higher dietary vitamin C intake is associated with a lower risk of gestational diabetes mellitus: A longitudinal cohort study. Clin Nutr (2020) 39(1):198–203. doi: 10.1016/j.clnu.2019.01.015

  • CrossRef
  • Google Scholar

• 203

  MaieseK. Triple play: promoting neurovascular longevity with nicotinamide, wnt, and erythropoietin in diabetes mellitus. BioMed Pharmacother (2008) 62(4):218–32. doi: 10.1016/j.biopha.2008.01.009

  • CrossRef
  • Google Scholar

• 204

  Akila Parvathy DharshiniSTaguchiYHMichael GromihaM. Exploring the selective vulnerability in alzheimer disease using tissue specific variant analysis. Genomics (2019) 111(4):936–49. doi: 10.1016/j.ygeno.2018.05.024

  • CrossRef
  • Google Scholar

• 205

  AmanollahiMJameieMHeidariARezaeiN. The dialogue between neuroinflammation and adult neurogenesis: mechanisms involved and alterations in neurological diseases. Mol Neurobiol (2022) 60(2):923–59. doi: 10.1007/s12035-022-03102-z

  • CrossRef
  • Google Scholar

• 206

  BarnettJABandyMLGibsonDL. Is the use of glyphosate in modern agriculture resulting in increased neuropsychiatric conditions through modulation of the gut-brain-microbiome axis? Front Nutr (2022) 9:827384. doi: 10.3389/fnut.2022.827384

  • CrossRef
  • Google Scholar

• 207

  ChenZHeYHuFLiMYaoY. Genkwanin alleviates mitochondrial dysfunction and oxidative stress in a murine model of experimental colitis: the participation of sirt1. Ann Clin Lab Sci (2022) 52(2):301–13.

  • Google Scholar

• 208

  LeeSHLeeJJKimGHKimJAChoHS. Role of reactive oxygen species at reperfusion stage in isoflurane preconditioning-induced neuroprotection. Brain Res (2019) 1723:146405. doi: 10.1016/j.brainres.2019.146405

  • CrossRef
  • Google Scholar

• 209

  PonzettiMRucciNFaloneS. Rna methylation and cellular response to oxidative stress-promoting anticancer agents. Cell Cycle (2023) 22(8):870–905. doi: 10.1080/15384101.2023.2165632

  • CrossRef
  • Google Scholar

• 210

  TeertamSKPrakash BabuP. Differential role of sirt1/mapk pathway during cerebral ischemia in rats and humans. Sci Rep (2021) 11(1):6339. doi: 10.1038/s41598-021-85577-9

  • CrossRef
  • Google Scholar

• 211

  WawiMJMahlerCInguimbertNMarderTBRibouAC. A new mitochondrial probe combining pyrene and a triphenylphosphonium salt for cellular oxygen and free radical detection via fluorescence lifetime measurements. Free Radic Res (2022) 56(3-4):258–272. doi: 10.1080/10715762.2022.2077202

  • CrossRef
  • Google Scholar

• 212

  WuLXiongXWuXYeYJianZZhiZet al. Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci (2020) 13:28. doi: 10.3389/fnmol.2020.00028

  • CrossRef
  • Google Scholar

• 213

  XiongJBonneySGonçalvesRVEspositoD. Brassinosteroids control the inflammation, oxidative stress and cell migration through the control of mitochondrial function on skin regeneration. Life Sci (2022) 307:120887. doi: 10.1016/j.lfs.2022.120887

  • CrossRef
  • Google Scholar

• 214

  Zadeh-HaghighiHSimonC. Magnetic field effects in biology from the perspective of the radical pair mechanism. J R Soc Interface (2022) 19(193):20220325. doi: 10.1098/rsif.2022.0325

  • CrossRef
  • Google Scholar

• 215

  ZhangYZhuXWangGChenLYangHHeFet al. Melatonin rescues the ti particle-impaired osteogenic potential of bone marrow mesenchymal stem cells via the sirt1/sod2 signaling pathway. Calcif Tissue Int (2020) 107(5):474–88. doi: 10.1007/s00223-020-00741-z

  • CrossRef
  • Google Scholar

• 216

  ZhaoHYLiHYJinJJinJZZhangLYXuanMYet al. L-carnitine treatment attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Korean J Intern Med (2020) 36(Suppl 1):S180–95. doi: 10.3904/kjim.2019.413

  • CrossRef
  • Google Scholar

• 217

  ZhengZXieJMaLHaoZZhangWLiL. Vitamin D receptor activation targets ros-mediated crosstalk between autophagy and apoptosis in hepatocytes in cholestasis mice. Cell Mol Gastroenterol Hepatol (2022) 15(4):887–901. doi: 10.1016/j.jcmgh.2022.10.011

  • CrossRef
  • Google Scholar

• 218

  ZhuangXMaJXuGSunZ. Shp-1 knockdown suppresses mitochondrial biogenesis and aggravates mitochondria-dependent apoptosis induced by all trans retinal through the sting/ampk pathways. Mol Med (2022) 28(1):125. doi: 10.1186/s10020-022-00554-w

  • CrossRef
  • Google Scholar

• 219

  NikooyehBZahediradMKalayiAShariatzadehNHollisBWNeyestaniTR. Improvement of vitamin D status through consumption of either fortified food products or supplement pills increased hemoglobin concentration in adult subjects: analysis of pooled data from two randomized clinical trials. Nutr Health (2023) 29(3):567–74. doi: 10.1177/02601060221085351

  • CrossRef
  • Google Scholar

• 220

  ZhengYChenZYMaWJWangQZLiangHMaAG. B vitamins supplementation can improve cognitive functions and may relate to the enhancement of transketolase activity in a rat model of cognitive impairment associated with high-fat diets. Curr Med Sci (2021) 41(5):847–56. doi: 10.1007/s11596-021-2456-5

  • CrossRef
  • Google Scholar

• 221

  ZhouJChenHWangQChenSWangRWangZet al. Sirt1 overexpression improves senescence-associated pulmonary fibrosis induced by vitamin D deficiency through downregulating il-11 transcription. Aging Cell (2022) 21(8):e13680. doi: 10.1111/acel.13680

  • CrossRef
  • Google Scholar

• 222

  DorofteiBIlieODCojocariuROCiobicaAMafteiRGrabDet al. Minireview exploring the biological cycle of vitamin B3 and its influence on oxidative stress: further molecular and clinical aspects. Molecules (2020) 25(15):3323. doi: 10.3390/molecules25153323

  • CrossRef
  • Google Scholar

• 223

  JahanRYousafMKhanHShahSAKhanAABibiNet al. Zinc ortho methyl carbonodithioate improved pre and post-synapse memory impairment via sirt1/P-jnk pathway against scopolamine in adult mice. J neuroimmune Pharmacol (2023) 18(1-2):183–94. doi: 10.1007/s11481-023-10067-w

  • CrossRef
  • Google Scholar

• 224

  QinDLiDWangCGuoS. Ferroptosis and central nervous system demyelinating diseases. J Neurochem (2023) 165(6):759–71. doi: 10.1111/jnc.15831

  • CrossRef
  • Google Scholar

• 225

  ZhaoCSunGLiYKongKLiXKanTet al. Forkhead box O3 attenuates osteoarthritis by suppressing ferroptosis through inactivation of nf-κb/mapk signaling. J Orthop Translat (2023) 39:147–62. doi: 10.1016/j.jot.2023.02.005

  • CrossRef
  • Google Scholar

• 226

  MaieseK. Moving to the rhythm with clock (Circadian) genes, autophagy, mtor, and sirt1 in degenerative disease and cancer. Curr Neurovasc Res (2017) 14(3):299–304. doi: 10.2174/1567202614666170718092010

  • CrossRef
  • Google Scholar

• 227

  Mladenovic DjordjevicALoncarevic-VasiljkovicNGonosES. Dietary restriction and oxidative stress: friends or enemies? Antioxid Redox Signal (2020) 34(5):421–38. doi: 10.1089/ars.2019.7959

  • CrossRef
  • Google Scholar

• 228

  OyefesoFAMuotriARWilsonCGPecautMJ. Brain organoids: A promising model to assess oxidative stress-induced central nervous system damage. Dev Neurobiol (2021) 81(5):653–70. doi: 10.1002/dneu.22828

  • CrossRef
  • Google Scholar

• 229

  ZhongSChenWWangBGaoCLiuXSongYet al. Energy stress modulation of ampk/foxo3 signaling inhibits mitochondria-associated ferroptosis. Redox Biol (2023) 63:102760. doi: 10.1016/j.redox.2023.102760

  • CrossRef
  • Google Scholar

• 230

  MaieseK. Warming up to new possibilities with the capsaicin receptor trpv1: mtor, ampk, and erythropoietin. Curr Neurovasc Res (2017) 14(2):184–9. doi: 10.2174/1567202614666170313105337

  • CrossRef
  • Google Scholar

• 231

  MengJChenYWangJQiuJChangCBiFet al. Egcg protects vascular endothelial cells from oxidative stress-induced damage by targeting the autophagy-dependent pi3k-akt-mtor pathway. Ann Transl Med (2020) 8(5):200. doi: 10.21037/atm.2020.01.92

  • CrossRef
  • Google Scholar

• 232

  PiaoSLeeIJinSAKimSNagarHChoiSJet al. Sirt1 activation attenuates the cardiac dysfunction induced by endothelial cell-specific deletion of crif1. Biomedicines (2021) 9(1):52. doi: 10.3390/biomedicines9010052

  • CrossRef
  • Google Scholar

• 233

  WangFCaoYMaLPeiHRauschWDLiH. Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia. Front Aging Neurosci (2018) 10:376. doi: 10.3389/fnagi.2018.00376

  • CrossRef
  • Google Scholar

• 234

  ZhaoDSunXLvSSunMGuoHZhaiYet al. Salidroside attenuates oxidized lowdensity lipoproteininduced endothelial cell injury via promotion of the ampk/sirt1 pathway. Int J Mol Med (2019) 43(6):2279–90. doi: 10.3892/ijmm.2019.4153

  • CrossRef
  • Google Scholar

• 235

  AksenovMYAksenovaMVButterfieldDAGeddesJWMarkesberyWR. Protein oxidation in the brain in alzheimer’s disease. Neuroscience (2001) 103(2):373–83. doi: 10.1016/s0306-4522(00)00580-7

  • CrossRef
  • Google Scholar

• 236

  ChenGJXuJLahousseSACaggianoNLde la MonteSM. Transient hypoxia causes alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J Alzheimers Dis (2003) 5(3):209–28. doi: 10.3233/jad-2003-5305

  • CrossRef
  • Google Scholar

• 237

  DaiCXiaoXLiJCiccotostoGDCappaiRTangSet al. Molecular mechanisms of neurotoxicity induced by polymyxins and chemo-prevention. ACS Chem Neurosci (2018) 10(1):120–31. doi: 10.1021/acschemneuro.8b00300

  • CrossRef
  • Google Scholar

• 238

  FanoudiSHosseiniMAlaviMSBoroushakiMTHosseiniASadeghniaHR. Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. Excli J (2018) 17:999–1017. doi: 10.17179/excli2018-1626

  • CrossRef
  • Google Scholar

• 239

  FengHXLiCPShuSJLiuHZhangHY. A11, a novel diaryl acylhydrazone derivative, exerts neuroprotection against ischemic injury in vitro and in vivo. Acta Pharmacol Sin (2018) 40(2):160–9. doi: 10.1038/s41401-018-0028-4

  • CrossRef
  • Google Scholar

• 240

  GroenCMPodratzJLPathoulasJStaffNWindebankAJ. Genetic reduction of mitochondria complex I subunits is protective against cisplatin-induced neurotoxicity in drosophila. J Neurosci (2021) 42(5):922–37. doi: 10.1523/jneurosci.1479-20.2021

  • CrossRef
  • Google Scholar

• 241

  JaganjacMMilkovicLZarkovicNZarkovicK. Oxidative stress and regeneration. Free Radic Biol Med (2022) 181:154–65. doi: 10.1016/j.freeradbiomed.2022.02.004

  • CrossRef
  • Google Scholar

• 242

  LiPLiuHShiXProkoschV. Hydrogen sulfide: novel endogenous and exogenous modulator of oxidative stress in retinal degeneration diseases. Molecules (2021) 26(9):2411. doi: 10.3390/molecules26092411

  • CrossRef
  • Google Scholar

• 243

  MaieseKChongZZ. Insights into oxidative stress and potential novel therapeutic targets for alzheimer disease. Restor Neurol Neurosci (2004) 22(2):87–104.

  • Google Scholar

• 244

  SamaiyaPKKrishnamurthySKumarA. Mitochondrial dysfunction in perinatal asphyxia: role in pathogenesis and potential therapeutic interventions. Mol Cell Biochem (2021) 476(12):4421–34. doi: 10.1007/s11010-021-04253-8

  • CrossRef
  • Google Scholar

• 245

  SharmaVKSinghTGSinghSGargNDhimanS. Apoptotic pathways and alzheimer’s disease: probing therapeutic potential. Neurochem Res (2021) 46(12):3103–22. doi: 10.1007/s11064-021-03418-7

  • CrossRef
  • Google Scholar

• 246

  El-MissiryMAOthmanAIAmerMASedkiMAliSMEl-SherbinyIM. Nanoformulated ellagic acid ameliorates pentylenetetrazol-induced experimental epileptic seizures by modulating oxidative stress, inflammatory cytokines and apoptosis in the brains of male mice. Metab Brain Dis (2019) 35(2):385–99. doi: 10.1007/s11011-019-00502-4

  • CrossRef
  • Google Scholar

• 247

  MotawiTKDarwishHAHamedMAEl-RigalNSNaserAF. A therapeutic insight of niacin and coenzyme Q10 against diabetic encephalopathy in rats. Mol Neurobiol (2017) 54(5):3924. doi: 10.1007/s12035-016-9765-x

  • CrossRef
  • Google Scholar

• 248

  Dąbrowska-BoutaBStrużyńskaLSidoryk-WęgrzynowiczMSulkowskiG. Memantine modulates oxidative stress in the rat brain following experimental autoimmune encephalomyelitis. Int J Mol Sci (2021) 22(21):11330. doi: 10.3390/ijms222111330

  • CrossRef
  • Google Scholar

• 249

  DaiCTangSBiaoXXiaoXChenCLiJ. Colistin induced peripheral neurotoxicity involves mitochondrial dysfunction and oxidative stress in mice. Mol Biol Rep (2019) 46(2):1963–72. doi: 10.1007/s11033-019-04646-5

  • CrossRef
  • Google Scholar

• 250

  GovindappaPKTalukderMAHGurjarAAHegartyJPElfarJC. An effective erythropoietin dose regimen protects against severe nerve injury-induced pathophysiological changes with improved neural gene expression and enhances functional recovery. Int Immunopharmacol (2020) 82:106330. doi: 10.1016/j.intimp.2020.106330

  • CrossRef
  • Google Scholar

• 251

  OliveiraALLSantosGGLEspirito-SantoRFSilvaGSAEvangelistaAFSilvaDNet al. Reestablishment of redox homeostasis in the nociceptive primary afferent as a mechanism of antinociception promoted by mesenchymal stem/stromal cells in oxaliplatin-induced chronic peripheral neuropathy. Stem Cells Int (2021) 2021:8815206. doi: 10.1155/2021/8815206

  • CrossRef
  • Google Scholar

• 252

  MaieseK. Cognitive impairment in multiple sclerosis. Bioengineering (Basel) (2023) 10(7):871. doi: 10.3390/bioengineering10070871

  • CrossRef
  • Google Scholar

• 253

  LiuWLiYLuoB. Current perspective on the regulation of foxo4 and its role in disease progression. Cell Mol Life Sci (2020) 77(4):651–63. doi: 10.1007/s00018-019-03297-w

  • CrossRef
  • Google Scholar

• 254

  Puigoriol-IllamolaDGrinan-FerreCVasilopoulouFLeivaRVazquezSPallasM. 11beta-hsd1 inhibition by rl-118 promotes autophagy and correlates with reduced oxidative stress and inflammation, enhancing cognitive performance in samp8 mouse model. Mol Neurobiol (2018) 55(12):8904–15. doi: 10.1007/s12035-018-1026-8

  • CrossRef
  • Google Scholar

• 255

  ZhangGZDengYJXieQQRenEHMaZJHeXGet al. Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta (2020) 508:33–42. doi: 10.1016/j.cca.2020.04.016

  • CrossRef
  • Google Scholar

• 256

  Bahrampour JuybariKPourhanifehMHHosseinzadehAHematiKMehrzadiS. Melatonin potentials against viral infections including covid-19: current evidence and new findings. Virus Res (2020) 287:198108. doi: 10.1016/j.virusres.2020.198108

  • CrossRef
  • Google Scholar

• 257

  Jarosz-GriffithsHHCorbettNJRowlandHAFisherKJonesACBaronJet al. Proteolytic shedding of the prion protein via activation of metallopeptidase adam10 reduces cellular binding and toxicity of amyloid-beta oligomers. J Biol Chem (2019) 294(17):7085–97. doi: 10.1074/jbc.RA118.005364

  • CrossRef
  • Google Scholar

• 258

  KuscuNGungor-OrdueriNESozenBAdiguzelDCelik-OzenciC. Foxo transcription factors regulate mouse preimplantation embryo development. J Assist Reprod Genet (2019) 36(12):2605. doi: 10.1007/s10815-019-01555-1

  • CrossRef
  • Google Scholar

• 259

  MaieseK. Harnessing the power of sirt1 and non-coding rnas in vascular disease. Curr Neurovasc Res (2017) 14(1):82–8. doi: 10.2174/1567202613666161129112822

  • CrossRef
  • Google Scholar

• 260

  CheemaPSNandiDNagA. Exploring the therapeutic potential of forkhead box O for outfoxing covid-19. Open Biol (2021) 11(6):210069. doi: 10.1098/rsob.210069

  • CrossRef
  • Google Scholar

• 261

  FangYLuLLiangYPengDAschnerMJiangY. Signal transduction associated with lead-induced neurological disorders: A review. Food Chem Toxicol (2021) 150:112063. doi: 10.1016/j.fct.2021.112063

  • CrossRef
  • Google Scholar

• 262

  KhanMUllahRRehmanSUShahSASaeedKMuhammadTet al. 17beta-estradiol modulates sirt1 and halts oxidative stress-mediated cognitive impairment in a male aging mouse model. Cells (2019) 8(8):928. doi: 10.3390/cells8080928

  • CrossRef
  • Google Scholar

• 263

  MahmoudiNKiasalariZRahmaniTSanaieradAAfshin-MajdSNaderiGet al. Diosgenin attenuates cognitive impairment in streptozotocin-induced diabetic rats: underlying mechanisms. Neuropsychobiology (2021) 11:25–35. doi: 10.1159/000507398

  • CrossRef
  • Google Scholar

• 264

  RuhalPDhingraD. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats. Inflammopharmacology (2018) 26(5):1317–29. doi: 10.1007/s10787-018-0476-y

  • CrossRef
  • Google Scholar

• 265

  DhakalSKushairiNPhanCWAdhikariBSabaratnamVMacreadieI. Dietary polyphenols: A multifactorial strategy to target alzheimer’s disease. Int J Mol Sci (2019) 20(20):5090. doi: 10.3390/ijms20205090

  • CrossRef
  • Google Scholar

• 266

  EnginABEnginA. Alzheimer’s disease and protein kinases. Adv Exp Med Biol (2021) 1275:285–321. doi: 10.1007/978-3-030-49844-3_11

  • CrossRef
  • Google Scholar

• 267

  ZhaoJMiaoKWangHDingHWangDW. Association between telomere length and type 2 diabetes mellitus: A meta-analysis. PloS One (2013) 8(11):e79993. doi: 10.1371/journal.pone.0079993

  • CrossRef
  • Google Scholar

• 268

  LamokeFShawSYuanJAnanthSDuncanMMartinPet al. Increased oxidative and nitrative stress accelerates aging of the retinal vasculature in the diabetic retina. PloS One (2015) 10(10):e0139664. doi: 10.1371/journal.pone.0139664

  • CrossRef
  • Google Scholar

• 269

  CaiJQiHYaoKYaoYJingDLiaoWet al. Non-coding rnas steering the senescence-related progress, properties, and application of mesenchymal stem cells. Front Cell Dev Biol (2021) 9:650431. doi: 10.3389/fcell.2021.650431

  • CrossRef
  • Google Scholar

• 270

  ChungCLLawrenceIHoffmanMElgindiDNadhanKPotnisMet al. Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial. Geroscience (2019) 41:6. doi: 10.1007/s11357-019-00113-y

  • CrossRef
  • Google Scholar

• 271

  CsicsarATarantiniSYabluchanskiyABalasubramanianPKissTFarkasEet al. Role of endothelial nad+ Deficiency in age-related vascular dysfunction. Am J Physiol Heart Circ Physiol (2019) 316(6):H1253–H66. doi: 10.1152/ajpheart.00039.2019

  • CrossRef
  • Google Scholar

• 272

  DorvashMFarahmandniaMTavassolyI. A systems biology roadmap to decode mtor control system in cancer. Interdiscip Sci (2020) 12(1):1–11. doi: 10.1007/s12539-019-00347-6

  • CrossRef
  • Google Scholar

• 273

  MaieseK. Disease onset and aging in the world of circular rnas. J Transl Sci (2016) 2(6):327–9. doi: 10.15761/jts.1000158

  • CrossRef
  • Google Scholar

• 274

  MaieseK. The implications of telomere length: advanced aging, cell senescence, mri phenotypes, stem cells and alzheimer’s disease. Curr Neurovasc Res (2023) 20(2):171–4. doi: 10.2174/1567202620666230510150337

  • CrossRef
  • Google Scholar

• 275

  RapakaDBitraVRChallaSRAdiukwuPC. Mtor signaling as a molecular target for the alleviation of alzheimer’s disease pathogenesis. Neurochem Int (2022) 155:105311. doi: 10.1016/j.neuint.2022.105311

  • CrossRef
  • Google Scholar

• 276

  Ferrara-RomeoIMartinezPSaraswatiSWhittemoreKGraña-CastroOThelma PoluhaLet al. The mtor pathway is necessary for survival of mice with short telomeres. Nat Commun (2020) 11(1):1168. doi: 10.1038/s41467-020-14962-1

  • CrossRef
  • Google Scholar

• 277

  LaiKYWebsterCKumariSGallacherJEJSarkarC. The associations of socioeconomic status with incident dementia and alzheimer’s disease are modified by leucocyte telomere length: A population-based cohort study. Sci Rep (2023) 13(1):6163. doi: 10.1038/s41598-023-32974-x

  • CrossRef
  • Google Scholar

• 278

  OkadaMKimHWMatsu-UraKWangYGXuMAshrafM. Abrogation of age-induced microrna-195 rejuvenates the senescent mesenchymal stem cells by reactivating telomerase. Stem Cells (2015) 34(1):148–59. doi: 10.1002/stem.2211

  • CrossRef
  • Google Scholar

• 279

  TopiwalaANicholsTEWilliamsLZJRobinsonECAlfaro-AlmagroFTaschlerBet al. Telomere length and brain imaging phenotypes in uk biobank. PloS One (2023) 18(3):e0282363. doi: 10.1371/journal.pone.0282363

  • CrossRef
  • Google Scholar

• 280

  CardosoSLópezIPPiñeiro-HermidaSPichelJGMoreiraPI. Igf1r deficiency modulates brain signaling pathways and disturbs mitochondria and redox homeostasis. Biomedicines (2021) 9(2):158. doi: 10.3390/biomedicines9020158

  • CrossRef
  • Google Scholar

• 281

  MaieseK. Stem cell guidance through the mechanistic target of rapamycin. World J Stem Cells (2015) 7(7):999–1009. doi: 10.4252/wjsc.v7.i7.999

  • CrossRef
  • Google Scholar

• 282

  AmidfarMGarcezMLKimYK. The shared molecular mechanisms underlying aging of the brain, major depressive disorder, and alzheimer’s disease: the role of circadian rhythm disturbances. Prog Neuropsychopharmacol Biol Psychiatry (2023) 123:110721. doi: 10.1016/j.pnpbp.2023.110721

  • CrossRef
  • Google Scholar

• 283

  ChenYLHsiehCCChuPMChenJYHuangYCChenCY. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review). Oncol Rep (2023) 49(3):48. doi: 10.3892/or.2023.8485

  • CrossRef
  • Google Scholar

• 284

  HafezNRefaatLElGebalyOKElhariryHMGhareebMFathallaLA. Prognostic value of rgs1 and mtor immunohistochemical expression in Egyptian multiple myeloma patients; a single center study. PloS One (2023) 18(7):e0288357. doi: 10.1371/journal.pone.0288357

  • CrossRef
  • Google Scholar

• 285

  MengJJShenJWLiGOuyangCJHuJXLiZSet al. Light modulates glucose metabolism by a retina-hypothalamus-brown adipose tissue axis. Cell (2023) 186(2):398–412.e17. doi: 10.1016/j.cell.2022.12.024

  • CrossRef
  • Google Scholar

• 286

  XuYWangYJiangYLiuMZhongWGeZet al. Relationship between cognitive dysfunction and the promoter methylation of per1 and cry1 in patients with cerebral small vessel disease. Front Aging Neurosci (2023) 15:1174541. doi: 10.3389/fnagi.2023.1174541

  • CrossRef
  • Google Scholar

• 287

  FakouriNBHouYDemarestTGChristiansenLSOkurMNMohantyJGet al. Towards understanding genomic instability, mitochondrial dysfunction and aging. FEBS J (2018) 286(6):1058–73. doi: 10.1111/febs.14663

  • CrossRef
  • Google Scholar

• 288

  LaiYFWangLLiuWY. Nicotinamide pretreatment alleviates mitochondrial stress and protects hypoxic myocardial cells via ampk pathway. Eur Rev Med Pharmacol Sci (2019) 23(4):1797–806. doi: 10.26355/eurrev_201902_17143

  • CrossRef
  • Google Scholar

• 289

  AlbieroMPoncinaNTjwaMCiciliotSMenegazzoLCeolottoGet al. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated P66shc and sirt1. Diabetes (2014) 63(4):1353–65. doi: 10.2337/db13-0894

  • CrossRef
  • Google Scholar

• 290

  GomesMBNegratoCA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab syndrome (2014) 6(1):80. doi: 10.1186/1758-5996-6-80

  • CrossRef
  • Google Scholar

• 291

  KhoshdelACarneySGilliesAMouradAJonesBNanraRet al. Potential roles of erythropoietin in the management of anaemia and other complications diabetes. Diabetes Obes Metab (2008) 10(1):1–9. doi: 10.1111/j.1463-1326.2007.00711.x

  • CrossRef
  • Google Scholar

• 292

  AtefMMEl-SayedNMAhmedAAMMostafaYM. Donepezil improves neuropathy through activation of ampk signalling pathway in streptozotocin-induced diabetic mice. Biochem Pharmacol (2019) 159:1–10. doi: 10.1016/j.bcp.2018.11.006

  • CrossRef
  • Google Scholar

• 293

  JenwitheesukANopparatCMukdaSWongchitratPGovitrapongP. Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci (2014) 15(9):16848–84. doi: 10.3390/ijms150916848

  • CrossRef
  • Google Scholar

• 294

  LeeHJYangSJ. Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice. Int J Mol Sci (2019) 20(17):4196. doi: 10.3390/ijms20174196

  • CrossRef
  • Google Scholar

• 295

  OngWYWuYJFarooquiTFarooquiAA. Qi fu yin-a ming dynasty prescription for the treatment of dementia. Mol Neurobiol (2018) 55(9):7389–400. doi: 10.1007/s12035-018-0908-0

  • CrossRef
  • Google Scholar

• 296

  OthmanMAMRajabEAlMubarakAAlNaisarMBahzadNKamalA. Erythropoietin protects against cognitive impairment and hippocampal neurodegeneration in diabetic mice. Behav Sci (Basel Switzerland) (2018) 9(1):4. doi: 10.3390/bs9010004

  • CrossRef
  • Google Scholar

• 297

  CrespoMCTome-CarneiroJPintadoCDavalosAVisioliFBurgos-RamosE. Hydroxytyrosol restores proper insulin signaling in an astrocytic model of alzheimer’s disease. BioFactors (Oxford England) (2017) 43(4):540–8. doi: 10.1002/biof.1356

  • CrossRef
  • Google Scholar

• 298

  FanXZhaoZWangDXiaoJ. Glycogen synthase kinase-3 as a key regulator of cognitive function. Acta Biochim Biophys Sin (2020) 52(3):219–30. doi: 10.1093/abbs/gmz156

  • CrossRef
  • Google Scholar

• 299

  HuZJiaoRWangPZhuYZhaoJDe JagerPet al. Shared causal paths underlying alzheimer’s dementia and type 2 diabetes. Sci Rep (2020) 10(1):4107. doi: 10.1038/s41598-020-60682-3

  • CrossRef
  • Google Scholar

• 300

  LiFChongZZMaieseK. Cell life versus cell longevity: the mysteries surrounding the nad(+) precursor nicotinamide. Curr Med Chem (2006) 13(8):883–95. doi: 10.2174/092986706776361058

  • CrossRef
  • Google Scholar

• 301

  SuMNaderiKSamsonNYoussefIFulopLBozsoZet al. Mechanisms associated with type 2 diabetes as a risk factor for alzheimer-related pathology. Mol Neurobiol (2019) 56(8):5815–34. doi: 10.1007/s12035-019-1475-8

  • CrossRef
  • Google Scholar

• 302

  YamashimaTOtaTMizukoshiENakamuraHYamamotoYKikuchiMet al. Intake of Ω-6 polyunsaturated fatty acid-rich vegetable oils and risk of lifestyle diseases. Adv Nutr (2020) 11(6):1489–509. doi: 10.1093/advances/nmaa072

  • CrossRef
  • Google Scholar

• 303

  FengHXueMDengHChengSHuYZhouC. Ginsenoside and its therapeutic potential for cognitive impairment. Biomolecules (2022) 12(9):1310. doi: 10.3390/biom12091310

  • CrossRef
  • Google Scholar

• 304

  FesselJ. Cure of alzheimer’s dementia requires addressing all of the affected brain cell types. J Clin Med (2023) 12(2049):1–14. doi: 10.3390/jcm12052049

  • CrossRef
  • Google Scholar

• 305

  MaieseK. Cognitive impairment and dementia: gaining insight through circadian clock gene pathways. Biomolecules (2021) 11(7):1–18. doi: 10.3390/biom11071002

  • CrossRef
  • Google Scholar

• 306

  PerluigiMDi DomenicoFBaroneEButterfieldDA. Mtor in alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med (2021) 169:382–96. doi: 10.1016/j.freeradbiomed.2021.04.025

  • CrossRef
  • Google Scholar

• 307

  RehmanIUKhanAAhmadRChoeKParkHYLeeHJet al. Neuroprotective effects of nicotinamide against mptp-induced parkinson’s disease in mice: impact on oxidative stress, neuroinflammation, nrf2/ho-1 and tlr4 signaling pathways. Biomedicines (2022) 10(11):2929. doi: 10.3390/biomedicines10112929

  • CrossRef
  • Google Scholar

• 308

  ZhuGTongQYeXLiJZhouLSunPet al. Phototherapy for cognitive function in patients with dementia: A systematic review and meta-analysis. Front Aging Neurosci (2022) 14:936489. doi: 10.3389/fnagi.2022.936489

  • CrossRef
  • Google Scholar

• 309

  DingMRQuYJHuBAnHM. Signal pathways in the treatment of alzheimer’s disease with traditional chinese medicine. BioMed Pharmacother (2022) 152:113208. doi: 10.1016/j.biopha.2022.113208

  • CrossRef
  • Google Scholar

• 310

  JayaramanAReynoldsR. Diverse pathways to neuronal necroptosis in alzheimer’s disease. Eur J Neurosci (2022) 56(9):5428–41. doi: 10.1111/ejn.15662

  • CrossRef
  • Google Scholar

• 311

  RaniSDharSBKhajuriaAGuptaDJaiswalPKSinglaNet al. Advanced overview of biomarkers and techniques for early diagnosis of alzheimer’s disease. Cell Mol Neurobiol (2023) 43(6):2491–523. doi: 10.1007/s10571-023-01330-y

  • CrossRef
  • Google Scholar

• 312

  TongZChuGWanCWangQYangJMengZet al. Multiple metabolites derived from mushrooms and their beneficial effect on alzheimer’s diseases. Nutrients (2023) 15(12):2758. doi: 10.3390/nu15122758

  • CrossRef
  • Google Scholar

• 313

  WangMDZhangSLiuXYWangPPZhuYFZhuJRet al. Salvianolic acid B ameliorates retinal deficits in an early-stage alzheimer’s disease mouse model through downregulating bace1 and Aβ Generation. Acta Pharmacol Sin (2023). doi: 10.1038/s41401-023-01125-3

  • CrossRef
  • Google Scholar

• 314

  MaieseK. Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and rho/rock. Neural regeneration Res (2019) 14(5):773–4. doi: 10.4103/1673-5374.249224

  • CrossRef
  • Google Scholar

• 315

  RantanenLMBitarMLampinenRStewartRQuekHOikariLEet al. An alzheimer’s disease patient-derived olfactory stem cell model identifies gene expression changes associated with cognition. Cells (2022) 11(20):3258. doi: 10.3390/cells11203258

  • CrossRef
  • Google Scholar

• 316

  SchubertCRPaulsenAJPintoAAMertenNCruickshanksKJ. Effect of long-term storage on the reliability of blood biomarkers for alzheimer’s disease and neurodegeneration. J Alzheimers Dis (2022) 85(3):1021–9. doi: 10.3233/jad-215096

  • CrossRef
  • Google Scholar

• 317

  ShiravandiAYariFTofighNKazemi AshtianiMShahpasandKGhanianMHet al. Earlier detection of alzheimer’s disease based on a novel biomarker cis P-tau by a label-free electrochemical immunosensor. Biosensors (Basel) (2022) 12(10):879. doi: 10.3390/bios12100879

  • CrossRef
  • Google Scholar

• 318

  TangBZengWSongLLWangHMQuLQLoHHet al. Extracellular vesicle delivery of neferine for the attenuation of neurodegenerative disease proteins and motor deficit in an alzheimer’s disease mouse model. Pharm (Basel Switzerland) (2022) 15(1):83. doi: 10.3390/ph15010083

  • CrossRef
  • Google Scholar

• 319

  AgarwalDKumariRIlyasATyagiSKumarRPoddarNK. Crosstalk between epigenetics and mtor as a gateway to new insights in pathophysiology and treatment of alzheimer’s disease. Int J Biol macromolecules (2021) 192:895–903. doi: 10.1016/j.ijbiomac.2021.10.026

  • CrossRef
  • Google Scholar

• 320

  XuPWuZPengYGaoJZhengFTanJet al. Neuroprotection of triptolide against amyloid-beta1-42-induced toxicity via the akt/mtor/P70s6k-mediated autophagy pathway. Acad Bras Cienc (2022) 94(2):e20210938. doi: 10.1590/0001-3765202220210938

  • CrossRef
  • Google Scholar

• 321

  FilleyCMRollinsYDAndersonCAArciniegasDBHowardKLMurrellJRet al. The genetics of very early onset alzheimer disease. Cogn Behav Neurol (2007) 20(3):149–56. doi: 10.1097/WNN.0b013e318145a8c8

  • CrossRef
  • Google Scholar

• 322

  Agis-TorresASolhuberMFernandezMSanchez-MonteroJM. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for alzheimer’s disease. Curr neuropharmacology (2014) 12(1):2–36. doi: 10.2174/1570159x113116660047

  • CrossRef
  • Google Scholar

• 323

  MorrisGBerkMMaesMPuriBK. Could alzheimer’s disease originate in the periphery and if so how so? Mol Neurobiol (2019) 56(1):406–34. doi: 10.1007/s12035-018-1092-y

  • CrossRef
  • Google Scholar

• 324

  Safdari LordJSoltani RezaiezadehJYekaninejadMSIzadiP. The association of apoe genotype with covid-19 disease severity. Sci Rep (2022) 12(1):13483. doi: 10.1038/s41598-022-17262-4

  • CrossRef
  • Google Scholar

• 325

  MaieseK. Apolipoprotein-E4 allele (Apoe-E4) as a mediator of cognitive loss and dementia in long covid-19. Curr Neurovasc Res (2022) 19(5):435–9. doi: 10.2174/156720261905221227114624

  • CrossRef
  • Google Scholar

• 326

  KurkiSNKantonenJKaivolaKHokkanenLMäyränpääMIPuttonenHet al. Apoe E4 associates with increased risk of severe covid-19, cerebral microhaemorrhages and post-covid mental fatigue: A finnish biobank, autopsy and clinical study. Acta neuropathologica Commun (2021) 9(1):199. doi: 10.1186/s40478-021-01302-7

  • CrossRef
  • Google Scholar

• 327

  MomkuteLVilkeviciuteAGedvilaiteGDubinskaiteGKriauciunieneLLiutkevicieneR. Association of apoe serum levels and apoe E2, E3, and E4 alleles with optic neuritis. Genes (Basel) (2022) 13(7):1188. doi: 10.3390/genes13071188

  • CrossRef
  • Google Scholar

• 328

  OjoJOReedJMCrynenGVallabhaneniPEvansJShackletonBet al. Apoe genotype dependent molecular abnormalities in the cerebrovasculature of alzheimer’s disease and age-matched non-demented brains. Mol Brain (2021) 14(1):110. doi: 10.1186/s13041-021-00803-9

  • CrossRef
  • Google Scholar

• 329

  Di PatrePLReadSLCummingsJLTomiyasuUVartavarianLMSecorDLet al. Progression of clinical deterioration and pathological changes in patients with alzheimer disease evaluated at biopsy and autopsy. Arch Neurol (1999) 56(10):1254–61. doi: 10.1001/archneur.56.10.1254

  • CrossRef
  • Google Scholar

• 330

  MaieseKChongZZ. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci (2003) 24(5):228–32. doi: 10.1016/S0165-6147(03)00078-6

  • CrossRef
  • Google Scholar

• 331

  MaieseKVincentAM. Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J Neurosci Res (2000) 59(4):568–80. doi: 10.1002/(SICI)1097-4547(20000215)59:4<568::AID-JNR13>3.0.CO;2-R

  • CrossRef
  • Google Scholar

• 332

  LeeGPollardHBArispeN. Annexin 5 and Apolipoprotein E2 Protect against Alzheimer’s Amyloid-Beta-Peptide Cytotoxicity by Competitive Inhibition at a Common Phosphatidylserine Interaction Site. Peptides (2002) 23(7):1249–63. doi: 10.1016/s0196-9781(02)00060-8

  • CrossRef
  • Google Scholar

• 333

  CacabelosRCarrilJCCacabelosNKazantsevAGVostrovAVCorzoLet al. Sirtuins in alzheimer’s disease: sirt2-related genophenotypes and implications for pharmacoepigenetics. Int J Mol Sci (2019) 20(5):1249. doi: 10.3390/ijms20051249

  • CrossRef
  • Google Scholar

• 334

  ZhengHJiaLLiuCCLi ZhongZRYangLChenXFet al. Trem2 promotes microglial survival by activating wnt/beta-catenin pathway. J Neurosci (2017) 37(7):1771–84. doi: 10.1523/jneurosci.2459-16.2017

  • CrossRef
  • Google Scholar

• 335

  LiuZHuangHYuYJiaYLiLShiXet al. Exploring the potential mechanism of action of ursolic acid against gastric cancer and covid-19 using network pharmacology and bioinformatics analysis. Curr Pharm Des (2023) 29(16):1274–92. doi: 10.2174/1381612829666230510124716

  • CrossRef
  • Google Scholar

• 336

  TheoharidesTC. Could sars-cov-2 spike protein be responsible for long-covid syndrome? Mol Neurobiol (2022) 59(3):1850–61. doi: 10.1007/s12035-021-02696-0

  • CrossRef
  • Google Scholar

• 337

  SungnakWHuangNBecavinCBergMQueenRLitvinukovaMet al. Sars-cov-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med (2020) 26(5):681–7. doi: 10.1038/s41591-020-0868-6

  • CrossRef
  • Google Scholar

• 338

  Al-QahtaniAAPantaziIAlhamlanFSAlothaidHMatou-NasriSSourvinosGet al. Sars-cov-2 modulates inflammatory responses of alveolar epithelial type ii cells via pi3k/akt pathway. Front Immunol (2022) 13:1020624. doi: 10.3389/fimmu.2022.1020624

  • CrossRef
  • Google Scholar

• 339

  GeierCPerlA. Therapeutic mtor blockade in systemic autoimmunity: implications for antiviral immunity and extension of lifespan. Autoimmun Rev (2021) 20(12):102984. doi: 10.1016/j.autrev.2021.102984

  • CrossRef
  • Google Scholar

• 340

  ShirzadMNourigorjiMSajediARanjbarMRastiFSouraniZet al. Targeted therapy in coronavirus disease 2019 (Covid-19): implication from cell and gene therapy to immunotherapy and vaccine. Int Immunopharmacol (2022) 111:109161. doi: 10.1016/j.intimp.2022.109161

  • CrossRef
  • Google Scholar

• 341

  Jansen van VurenESteynSFBrinkCBMöllerMViljoenFPHarveyBH. The neuropsychiatric manifestations of covid-19: interactions with psychiatric illness and pharmacological treatment. BioMed Pharmacother (2021) 135:111200. doi: 10.1016/j.biopha.2020.111200

  • CrossRef
  • Google Scholar

• 342

  BlagosklonnyMV. From causes of aging to death from covid-19. Aging (Albany NY) (2020) 12(11):10004–21. doi: 10.18632/aging.103493

  • CrossRef
  • Google Scholar

• 343

  Borges do NascimentoIJCacicNAbdulazeemHMvon GrooteTCJayarajahUWeerasekaraIet al. Novel coronavirus infection (Covid-19) in humans: A scoping review and meta-analysis. J Clin Med (2020) 9(4):941. doi: 10.3390/jcm9040941

  • CrossRef
  • Google Scholar

• 344

  GusevESarapultsevAHuDChereshnevV. Problems of pathogenesis and pathogenetic therapy of covid-19 from the perspective of the general theory of pathological systems (General pathological processes). Int J Mol Sci (2021) 22(14):7582. doi: 10.3390/ijms22147582

  • CrossRef
  • Google Scholar

• 345

  CavalliEBramantiACiurleoRTchorbanovAIGiordanoAFagonePet al. Entangling covid-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: diagnostic and therapeutic perspectives (Review). Int J Mol Med (2020) 46(3):903–12. doi: 10.3892/ijmm.2020.4659

  • CrossRef
  • Google Scholar

• 346

  González-FernándezCGonzálezPGonzález-PérezFRodríguezF. Characterization of ex vivo and in vitro wnt transcriptome induced by spinal cord injury in rat microglial cells. Brain Sci (2022) 12(708):708. doi: 10.3390/brainsci12060708

  • CrossRef
  • Google Scholar

• 347

  LiuDZhangMTianJGaoMLiuMFuXet al. Wnt1-inducible signalling pathway protein 1 stabilizes atherosclerotic plaques in apolipoprotein-E-deficient mice via the focal adhesion kinase/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase pathway. J hypertension (2022) 40(9):1666–81. doi: 10.1097/hjh.0000000000003195

  • CrossRef
  • Google Scholar

• 348

  LiuLXuSLiPLiL. A novel adipokine wisp1 attenuates lipopolysaccharide-induced cell injury in 3t3-L1 adipocytes by regulating the pi3k/akt pathway. Obes Res Clin Pract (2022) 16(2):122–9. doi: 10.1016/j.orcp.2022.03.001

  • CrossRef
  • Google Scholar

• 349

  RenLLZhouJYLiangSJWangXQ. Impaired intestinal stem cell activity in etec infection: enterotoxins, cyclic nucleotides, and wnt signaling. Arch Toxicol (2022) 96(5):1213–25. doi: 10.1007/s00204-021-03213-x

  • CrossRef
  • Google Scholar

• 350

  TangYChenYLiuRLiWHuaBBaoY. Wnt signaling pathways: A role in pain processing. Neuromolecular Med (2022) 24(3):233–49. doi: 10.1007/s12017-021-08700-z

  • CrossRef
  • Google Scholar

• 351

  MarinelliCBertalotTZussoMSkaperSDGiustiP. Systematic review of pharmacological properties of the oligodendrocyte lineage. Front Cell Neurosci (2016) 10:27. doi: 10.1007/s13311-020-00923-5

  • CrossRef
  • Google Scholar

• 352

  Gökdoğan EdgünlüTÜnalYKarakaş ÇelikSGençÖEmreUKutluG. The effect of foxo gene family variants and global DNA metylation on rrms disease. Gene (2020) 726:144172. doi: 10.1016/j.gene.2019.144172

  • CrossRef
  • Google Scholar

• 353

  KellDBPretoriusE. No effects without causes: the iron dysregulation and dormant microbes hypothesis for chronic, inflammatory diseases. Biol Rev Cambridge Philos Soc (2018) 93(3):1518–57. doi: 10.1111/brv.12407

  • CrossRef
  • Google Scholar

• 354

  MaieseK. Novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, foxo, and mtor. Curr Neurovasc Res (2021) 18(2):1–4. doi: 10.2174/1567202618999210505124235

  • CrossRef
  • Google Scholar

• 355

  OktelikFBYilmazVTurkogluRAkbayirETuzunEDenizGet al. Expression of akt1 and P-akt1 in peripheral T cell subsets of multiple sclerosis patients. Acta Neurol Belg (2020) 121(6):1777–82. doi: 10.1007/s13760-020-01518-9

  • CrossRef
  • Google Scholar

• 356

  SanadgolNBaratiMHoushmandFHassaniSClarnerTShahlaeiMet al. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of ampk/nrf2/mtor signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep (2020) 72(3):641–58. doi: 10.1007/s43440-019-00019-8

  • CrossRef
  • Google Scholar

• 357

  WallinMTCulpepperWJCampbellJDNelsonLMLanger-GouldAMarrieRAet al. The prevalence of ms in the United States: A population-based estimate using health claims data. Neurology (2019) 92(10):e1029–e40. doi: 10.1212/wnl.0000000000007035

  • CrossRef
  • Google Scholar

• 358

  XuLZhangCJiangNHeDBaiYXinY. Rapamycin combined with mcc950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis. J Cell Biochem (2019) 120(4):5160–8. doi: 10.1002/jcb.27792

  • CrossRef
  • Google Scholar

• 359

  ZhangYCFanKYWangQHuJXWangQZhangHYet al. Genetically determined levels of mtor-dependent circulating proteins and risk of multiple sclerosis. Neurol Ther (2023) 12(3):751–62. doi: 10.1007/s40120-023-00455-y

  • CrossRef
  • Google Scholar

• 360

  HemmerBCepokSZhouDSommerN. Multiple sclerosis - a coordinated immune attack across the blood brain barrier. Curr Neurovasc Res (2004) 1(2):141–50. doi: 10.2174/1567202043480152

  • CrossRef
  • Google Scholar

• 361

  MaieseK. The challenges for drug development: cytokines, genes, and stem cells. Curr Neurovasc Res (2012) 9(4):231–2. doi: 10.2174/156720212803530690

  • CrossRef
  • Google Scholar

• 362

  MartinATeglaCACudriciCDKruszewskiAMAzimzadehPBoodhooDet al. Role of sirt1 in autoimmune demyelination and neurodegeneration. Immunologic Res (2015) 61(3):187–97. doi: 10.1007/s12026-014-8557-5

  • CrossRef
  • Google Scholar

• 363

  MouzakiARodiMDimisianosNEmmanuilAKalavriziotiDLagoudakiRet al. Immune parameters that distinguish multiple sclerosis patients from patients with other neurological disorders at presentation. PloS One (2015) 10(8):e0135434. doi: 10.1371/journal.pone.0135434

  • CrossRef
  • Google Scholar

• 364

  RodiMDimisianosNde LasticALSakellarakiPDeraosGMatsoukasJet al. Regulatory cell populations in relapsing-remitting multiple sclerosis (Rrms) patients: effect of disease activity and treatment regimens. Int J Mol Sci (2016) 17(9):1398. doi: 10.3390/ijms17091398

  • CrossRef
  • Google Scholar

• 365

  SunJJRenQGXuLZhangZJ. Lingo-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Sci Rep (2015) 5:14235. doi: 10.1038/srep14235

  • CrossRef
  • Google Scholar

• 366

  YapSMDavenportLCogleyCCraddockFKennedyAGaughanMet al. Word finding, prosody and social cognition in multiple sclerosis. J Neuropsychol (2023) 17(1):32–62. doi: 10.1111/jnp.12285

  • CrossRef
  • Google Scholar

• 367

  StaffNPLucchinettiCFKeeganBM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol (2009) 66(9):1139–43. doi: 10.1001/archneurol.2009.190

  • CrossRef
  • Google Scholar

• 368

  NaseriABaghernezhadKSeyedi-SahebariSAlhoseiniSAGholipour-KhaliliEZafaraniFet al. (Apoe) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis. Mult Scler Relat Disord (2022) 65:104011. doi: 10.1016/j.msard.2022.104011

  • CrossRef
  • Google Scholar

• 369

  FedeliUAmideiCBAvossaFSchievanoEKingwellE. Association of multiple sclerosis-related mortality with covid-19 and other common infections: A multiple causes of death analysis. Eur J Neurol (2023) 30(9):2870–3. doi: 10.1111/ene.15912

  • CrossRef
  • Google Scholar

• 370

  BramanteCIngrahamNMurrayTMarmorSHoverstenSGronskiJet al. Observational study of metformin and risk of mortality in patients hospitalized with covid-19. medRxiv (2020). doi: 10.1101/2020.06.19.20135095

  • CrossRef
  • Google Scholar

• 371

  TiuVEPopescuBOEnacheIITiuCTerecoasaEPaneaCA. Serum and csf biomarkers predict active early cognitive decline rather than established cognitive impairment at the moment of rrms diagnosis. Diagnostics (Basel) (2022) 12(11):2571. doi: 10.3390/diagnostics12112571

  • CrossRef
  • Google Scholar

• 372

  DialloABGayLCoiffardBLeoneMMezouarSMegeJL. Daytime variation in sars-cov-2 infection and cytokine production. Microb Pathog (2021) 158:105067. doi: 10.1016/j.micpath.2021.105067

  • CrossRef
  • Google Scholar

• 373

  GuXZhuJ. Roles of exosomes and exosomal micrornas in postoperative sleep disturbance. Nat Sci Sleep (2021) 13:1363–75. doi: 10.2147/nss.S310351

  • CrossRef
  • Google Scholar

• 374

  LioCTKacprowskiTKlaedtkeMJensenLRBouterYBayerTAet al. Small rna sequencing in the tg4-42 mouse model suggests the involvement of snornas in the etiology of alzheimer’s disease. J Alzheimers Dis (2022) 87(4):1671–81. doi: 10.3233/jad-220110

  • CrossRef
  • Google Scholar

• 375

  ZhangWBaiSYangJZhangYLiuYNieJet al. Foxo1 overexpression reduces Aβ Production and tau phosphorylation in vitro. Neurosci Lett (2020) 738:135322. doi: 10.1016/j.neulet.2020.135322

  • CrossRef
  • Google Scholar

• 376

  ZhaoWXieCZhangXLiuJLiuJXiaZ. Advances in the mtor signaling pathway and its inhibitor rapamycin in epilepsy. Brain Behav (2023) 13(6):e2995. doi: 10.1002/brb3.2995

  • CrossRef
  • Google Scholar

• 377

  El-BeltagyASalehAMBAttaallahAGahnemRA. Therapeutic role of azadirachta indica leaves ethanolic extract against diabetic nephropathy in rats neonatally induced by streptozotocin. Ultrastruct Pathol (2021) 46(6):391–406. doi: 10.1080/01913123.2021.1988015

  • CrossRef
  • Google Scholar

• 378

  EspinozaSEKhoslaSBaurJAde CaboRMusiN. Drugs targeting mechanisms of aging to delay age-related disease and promote healthspan: proceedings of a national institute on aging workshop. J Gerontol A Biol Sci Med Sci (2023) 78(Supplement_1):53–60. doi: 10.1093/gerona/glad034

  • CrossRef
  • Google Scholar

• 379

  McCoinCSFranczakEDengFPeiDDingWXThyfaultJP. Acute exercise rapidly activates hepatic mitophagic flux. J Appl Physiol (2022) 132(3):862–73. doi: 10.1152/japplphysiol.00704.2021

  • CrossRef
  • Google Scholar

• 380

  LeeJHLeeJHJinMHanSDChonGRKimIHet al. Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats. Exp Mol Med (2014) 46:e111. doi: 10.1038/emm.2014.52

  • CrossRef
  • Google Scholar

• 381

  Al-KuraishyHMAl-BuhadilyAKAl-GareebAIAlorabiMHadi Al-HarcanNAEl-BousearyMMet al. Citicoline and covid-19: vis-À-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol (2022) 395(12):1463–75. doi: 10.1007/s00210-022-02284-6

  • CrossRef
  • Google Scholar

• 382

  Al-KuraishyHMAl-GareebAIAl-MaiahyTJAlexiouAMukerjeeNBatihaGE. Prostaglandins and non-steroidal anti-inflammatory drugs in covid-19. Biotechnol Genet Eng Rev (2022), 1–21. doi: 10.1080/02648725.2022.2122290

  • CrossRef
  • Google Scholar

• 383

  AssognaMDi LorenzoFMartoranaAKochG. Synaptic effects of palmitoylethanolamide in neurodegenerative disorders. Biomolecules (2022) 12(8):1161. doi: 10.3390/biom12081161

  • CrossRef
  • Google Scholar

• 384

  BraunSZauckeFBrenneisMRappAEPollingerPSohnRet al. The corpus adiposum infrapatellare (Hoffa’s fat pad)-the role of the infrapatellar fat pad in osteoarthritis pathogenesis. Biomedicines (2022) 10(5):1071. doi: 10.3390/biomedicines10051071

  • CrossRef
  • Google Scholar

• 385

  MaieseKLiFChongZZ. New avenues of exploration for erythropoietin. Jama (2005) 293(1):90–5. doi: 10.1001/jama.293.1.90

  • CrossRef
  • Google Scholar

• 386

  MartinsBVieiraMDelerue-MatosCGrossoCSoaresC. Biological potential, gastrointestinal digestion, absorption, and bioavailability of algae-derived compounds with neuroprotective activity: A comprehensive review. Mar Drugs (2022) 20(6):362. doi: 10.3390/md20060362

  • CrossRef
  • Google Scholar

• 387

  PanJZhouLZhangCXuQSunY. Targeting protein phosphatases for the treatment of inflammation-related diseases: from signaling to therapy. Signal Transduct Target Ther (2022) 7(1):177. doi: 10.1038/s41392-022-01038-3

  • CrossRef
  • Google Scholar

• 388

  PantaziPClementsTVenøMAbrahamsVMHolderB. Distinct non-coding rna cargo of extracellular vesicles from M1 and M2 human primary macrophages. J Extracell Vesicles (2022) 11(12):e12293. doi: 10.1002/jev2.12293

  • CrossRef
  • Google Scholar

• 389

  LiuMJiangLCaoWWuJChenX. Identification of inhibitors and drug targets for human adenovirus infections. Viruses (2022) 14(5):959. doi: 10.3390/v14050959

  • CrossRef
  • Google Scholar

• 390

  ZhouYXuJHouYLeverenzJBKallianpurAMehraRet al. Network medicine links sars-cov-2/covid-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res Ther (2021) 13(1):110. doi: 10.1186/s13195-021-00850-3

  • CrossRef
  • Google Scholar

• 391

  ZhuangXTsukudaSWrenschFWingPASchillingMHarrisJMet al. The circadian clock component bmal1 regulates sars-cov-2 entry and replication in lung epithelial cells. iScience (2021) 24(10):103144. doi: 10.1101/2021.03.20.436163

  • CrossRef
  • Google Scholar

• 392

  BirnieMTClaydonMDBTroyOFlynnBPYoshimuraMKershawYMet al. Circadian regulation of hippocampal function is disrupted with corticosteroid treatment. Proc Natl Acad Sci U.S.A. (2023) 120(15):e2211996120. doi: 10.1073/pnas.2211996120

  • CrossRef
  • Google Scholar

• 393

  LiJBHuXYChenMWXiongCHZhaoNGeYHet al. P85s6k sustains synaptic glua1 to ameliorate cognitive deficits in alzheimer’s disease. Trans neurodegeneration (2023) 12(1):1. doi: 10.1186/s40035-022-00334-w

  • CrossRef
  • Google Scholar

• 394

  FeltenMDameCLachmannGSpiesCRubarthKBalzerFet al. Circadian rhythm disruption in critically ill patients. Acta Physiol (Oxf) (2023) 238(1):e13962. doi: 10.1111/apha.13962

  • CrossRef
  • Google Scholar

• 395

  HuangCZhangCCaoYLiJBiF. Major roles of the circadian clock in cancer. Cancer Biol Med (2023) 20(1):1–24. doi: 10.20892/j.issn.2095-3941.2022.0474

  • CrossRef
  • Google Scholar

• 396

  KalamFJamesDLLiYRColemanMFKieselVACespedes FelicianoEMet al. Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes. J Natl Cancer Inst Monogr (2023) 2023(61):84–103. doi: 10.1093/jncimonographs/lgad008

  • CrossRef
  • Google Scholar

• 397

  ChongZZKangJQMaieseK. Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. Histol Histopathol (2003) 18(1):173–89. doi: 10.14670/HH-18.173

  • CrossRef
  • Google Scholar

• 398

  LinSHMaieseK. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J Cereb Blood Flow Metab (2001) 21(3):262–75. doi: 10.1097/00004647-200103000-00010

  • CrossRef
  • Google Scholar

• 399

  ChengXSongCDuYGaurUYangM. Pharmacological treatment of alzheimer’s disease: insights from drosophila melanogaster. Int J Mol Sci (2020) 21(13):4621. doi: 10.3390/ijms21134621

  • CrossRef
  • Google Scholar

• 400

  MaieseK. Foxo proteins in the nervous system. Anal Cell Pathol (Amst) (2015) 2015:569392. doi: 10.1155/2015/569392

  • CrossRef
  • Google Scholar

• 401

  van DyckCHSwansonCJAisenPBatemanRJChenCGeeMet al. Lecanemab in early alzheimer’s disease. N Engl J Med (2023) 388(1):9–21. doi: 10.1056/NEJMoa2212948

  • CrossRef
  • Google Scholar

• 402

  SlezákováDKadlicPJezberováMBolekováVValkovičPMinarM. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy. Neurol Neurochir Pol (2023) 57(3):282–8. doi: 10.5603/PJNNS.a2023.0031

  • CrossRef
  • Google Scholar

• 403

  KaisingerLRKentistouKAStankovicSGardnerEJDayFRZhaoYet al. Large-scale exome sequence analysis identifies sex- and age-specific determinants of obesity. Cell Genomics (2023) 3(8):100362. doi: 10.1016/j.xgen.2023.100362

  • CrossRef
  • Google Scholar

• 404

  DongJLiHBaiYWuC. Muscone ameliorates diabetic peripheral neuropathy through activating akt/mtor signalling pathway. J Pharm Pharmacol (2019) 71(11):1706–13. doi: 10.1111/jphp.13157

  • CrossRef
  • Google Scholar

• 405

  LanTXuYLiSLiNZhangSZhuH. Cornin protects against cerebral ischemia/reperfusion injury by preventing autophagy via the pi3k/akt/mtor pathway. BMC Pharmacol Toxicol (2022) 23(1):82. doi: 10.1186/s40360-022-00620-3

  • CrossRef
  • Google Scholar

• 406

  SharmaNShandilyaAKumarNMehanS. Dysregulation of sirt-1 signaling in multiple sclerosis and neuroimmune disorders: A systematic review of sirtuin activators as potential immunomodulators and their influences on other dysfunctions. Endocr Metab Immune Disord Drug Targets (2021) 21(10):1845–68. doi: 10.2174/1871530321666210309112234

  • CrossRef
  • Google Scholar

• 407

  YangXHuoFLiuBLiuJChenTLiJet al. Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of pi3k/akt signaling pathway. J Mol Neurosci (2017) 61(4):581–9. doi: 10.1007/s12031-017-0899-8

  • CrossRef
  • Google Scholar

• 408

  KlionskyDJAbdel-AzizAKAbdelfatahSAbdellatifMAbdoliAAbelSet al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy (2021) 17(1):1–382. doi: 10.1080/15548627.2020.1797280

  • CrossRef
  • Google Scholar

• 409

  MaieseKChongZZShangYCWangS. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets (2012) 16(12):1203–14. doi: 10.1517/14728222.2012.719499

  • CrossRef
  • Google Scholar

• 410

  FarahaniMNiknamZMohammadi AmirabadLAmiri-DashatanNKoushkiMNematiMet al. Molecular pathways involved in covid-19 and potential pathway-based therapeutic targets. BioMed Pharmacother (2021) 145:112420. doi: 10.1016/j.biopha.2021.112420

  • CrossRef
  • Google Scholar

• 411

  YanWTLuSYangYDNingWYCaiYHuXMet al. Research trends, hot spots and prospects for necroptosis in the field of neuroscience. Neural regeneration Res (2021) 16(8):1628–37. doi: 10.4103/1673-5374.303032

  • CrossRef
  • Google Scholar

• 412

  ChongZZShangYCMaieseK. Vascular injury during elevated glucose can be mitigated by erythropoietin and wnt signaling. Curr Neurovasc Res (2007) 4(3):194–204. doi: 10.2174/156720207781387150

  • CrossRef
  • Google Scholar

• 413

  KandulaVKosuruRLiHYanDZhuQLianQet al. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy. Cardiovasc Diabetol (2016) 15(1):44. doi: 10.1186/s12933-016-0361-1

  • CrossRef
  • Google Scholar

• 414

  WeikelKACacicedoJMRudermanNBIdoY. Knockdown of gsk3beta increases basal autophagy and ampk signaling in nutrient-laden human aortic endothelial cells. Bioscience Rep (2016) 36(5):e00382. doi: 10.1042/bsr20160174

  • CrossRef
  • Google Scholar

• 415

  BarchettaICiminiFACiccarelliGBaroniMGCavalloMG. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation. J endocrinological Invest (2019) 42(11):1257–72. doi: 10.1007/s40618-019-01052-3

  • CrossRef
  • Google Scholar

• 416

  HsiehCFLiuCKLeeCTYuLEWangJY. Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep (2019) 9(1):840. doi: 10.1038/s41598-018-37215-0

  • CrossRef
  • Google Scholar

• 417

  MaieseKChongZZShangYCWangS. Novel directions for diabetes mellitus drug discovery. Expert Opin Drug Discovery (2013) 8(1):35–48. doi: 10.1517/17460441.2013.736485

  • CrossRef
  • Google Scholar

• 418

  RanDHongWYanWMengdieW. Properties and molecular mechanisms underlying geniposide-mediated therapeutic effects in chronic inflammatory diseases. J Ethnopharmacol (2021) 273:113958. doi: 10.1016/j.jep.2021.113958

  • CrossRef
  • Google Scholar

• 419

  Adle-BiassetteHLevyYColombelMPoronFNatchevSKeohaneCet al. Neuronal apoptosis in hiv infection in adults. Neuropathol Appl Neurobiol (1995) 21(3):218–27. doi: 10.1111/j.1365-2990.1995.tb01053.x

  • CrossRef
  • Google Scholar

• 420

  ChongZZShangYCHouJMaieseK. Wnt1 Neuroprotection Translates into Improved Neurological Function During Oxidant Stress and Cerebral Ischemia through Akt1 and Mitochondrial Apoptotic Pathways. Oxid Med Cell Longev (2010) 3(2):153–65. doi: 10.4161/oxim.3.2.11758

  • CrossRef
  • Google Scholar

• 421

  FuLLiuCChenLLvYMengGHuMet al. Protective effects of 1-methylnicotinamide on abeta1-42-induced cognitive deficits, neuroinflammation and apoptosis in mice. J neuroimmune Pharmacol (2019) 14(3):401–2. doi: 10.1007/s11481-018-09830-1

  • CrossRef
  • Google Scholar

• 422

  GrocLBezinLFosterJAJiangHJacksonTSWeissmannDet al. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development. Neurochem Int (2001) 39(2):127–33. doi: 10.1016/s0197-0186(01)00013-4

  • CrossRef
  • Google Scholar

• 423

  HeZZhaoYZhuYWangWLiuXLuF. Interfering tug1 attenuates cerebrovascular endothelial apoptosis and inflammatory injury after cerebral ischemia/reperfusion via tug1/mir-410/foxo3 cerna axis. Neurotox Res (2021) 40(1):1–13. doi: 10.1007/s12640-021-00446-7

  • CrossRef
  • Google Scholar

• 424

  KoHWHanKSKimEYRyuBRYoonWJJungYKet al. Synergetic Activation of P38 Mitogen-Activated Protein Kinase and Caspase-3-Like Proteases for Execution of Calyculin a-Induced Apoptosis but Not N-Methyl-D-Aspartate-Induced Necrosis in Mouse Cortical Neurons. J Neurochem (2000) 74(6):2455–61. doi: 10.1046/j.1471-4159.2000.0742455.x

  • CrossRef
  • Google Scholar

• 425

  MansourRMEl SayedNSAhmedMAEEl-SaharAE. Addressing peroxisome proliferator-activated receptor-gamma in 3-nitropropionic acid-induced striatal neurotoxicity in rats. Mol Neurobiol (2022) 59(7):4368–83. doi: 10.1007/s12035-022-02856-w

  • CrossRef
  • Google Scholar

• 426

  ZhaoTMiaoHSongZLiYXiaNZhangZet al. Metformin alleviates the cognitive impairment induced by benzo[a]Pyrene via glucolipid metabolism regulated by fto/foxo6 pathway in mice. Environ Sci pollut Res Int (2023) 30(26):69192–204. doi: 10.1007/s11356-023-27303-8

  • CrossRef
  • Google Scholar

• 427

  ZhaoYLützenUGohlkePJiangPHerdegenTCulmanJ. Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by pi3k/akt and nrf2/are pathways. J Mol Med (Berlin Germany) (2021) 99(8):1073–83. doi: 10.1007/s00109-021-02065-3

  • CrossRef
  • Google Scholar

• 428

  MastrapasquaMRossiRDe CosmoLRestaAErredeMBizzocaAet al. Autophagy increase in merosin-deficient congenital muscular dystrophy type 1a. Eur J Transl Myol (2023) 33(3):11501. doi: 10.4081/ejtm.2023.11501

  • CrossRef
  • Google Scholar

• 429

  ChongZZLiFMaieseK. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by wnt1 and canonical signaling pathways. Cell Signal (2007) 19(6):1150–62. doi: 10.1016/j.cellsig.2006.12.009

  • CrossRef
  • Google Scholar

• 430

  DehghanianFSoltaniZKhaksariM. Can mesenchymal stem cells act multipotential in traumatic brain injury? J Mol Neurosci (2020) 70(5):677–88. doi: 10.1007/s12031-019-01475-w

  • CrossRef
  • Google Scholar

• 431

  LiuAWuJYangCWuYZhangYZhaoFet al. Trpm7 in chbp-induced renoprotection upon ischemia reperfusion-related injury. Sci Rep (2018) 8(1):5510. doi: 10.1038/s41598-018-22852-2

  • CrossRef
  • Google Scholar

• 432

  SimonFFlorosNIbingWSchelzigHKnapsisA. Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system. Neural regeneration Res (2019) 14(8):1309–12. doi: 10.4103/1673-5374.253507

  • CrossRef
  • Google Scholar

• 433

  ZhangZYangJLZhangLLChenZZChenJOCaoYGet al. 2-(2-Benzofuranyl)-2-Imidazoline Treatment within 5 Hours after Cerebral Ischemia/Reperfusion Protects the Brain. Neural regeneration Res (2018) 13(12):2111–8. doi: 10.4103/1673-5374.241461

  • CrossRef
  • Google Scholar

• 434

  SunFLiSGZhangHWHuaFWSunGZHuangZ. Mirna-411 attenuates inflammatory damage and apoptosis following spinal cord injury. Eur Rev Med Pharmacol Sci (2020) 24(2):491–8. doi: 10.26355/eurrev_202001_20022

  • CrossRef
  • Google Scholar

• 435

  YueJLiangCWuKHouZWangLZhangCet al. Upregulated shp-2 expression in the epileptogenic zone of temporal lobe epilepsy and various effects of shp099 treatment on a pilocarpine model. Brain Pathol (2019) 30(2):373–85. doi: 10.1111/bpa.12777

  • CrossRef
  • Google Scholar

• 436

  LiYLiuLTianYZhangJ. Rapamycin improves sevoflurane−Induced cognitive dysfunction in aged rats by mediating autophagy through the tlr4/myd88/nf−κb signaling pathway. Mol Med Rep (2019) 20(4):3085–94. doi: 10.3892/mmr.2019.10541

  • CrossRef
  • Google Scholar

• 437

  SunXLZhangJBGuoYXXiaTSXuLCRahmandKet al. Xanthohumol ameliorates memory impairment and reduces the deposition of β-amyloid in app/ps1 mice via regulating the mtor/lc3ii and bax/bcl-2 signalling pathways. J Pharm Pharmacol (2021) 73(9):1230–9. doi: 10.1093/jpp/rgab052

  • CrossRef
  • Google Scholar

• 438

  WangYGaoSZhengVChenLMaMShenSet al. A novel pde4d inhibitor bpn14770 reverses scopolamine-induced cognitive deficits via camp/sirt1/akt/bcl-2 pathway. Front Cell Dev Biol (2020) 8:599389. doi: 10.3389/fcell.2020.599389

  • CrossRef
  • Google Scholar

• 439

  ZhangSHLiuDHuQZhuJWangSZhouS. Ferulic acid ameliorates pentylenetetrazol-induced seizures by reducing neuron cell death. Epilepsy Res (2019) 156:106183. doi: 10.1016/j.eplepsyres.2019.106183

  • CrossRef
  • Google Scholar

• 440

  MaieseK. Forkhead transcription factors: new considerations for alzheimer’s disease and dementia. J Transl Sci (2016) 2(4):241–7. doi: 10.15761/JTS.1000146

  • CrossRef
  • Google Scholar

• 441

  GuoYZengQBrooksDGeisbrechtER. A conserved stripak complex is required for autophagy in muscle tissue. Mol Biol Cell (2023) 34(9):ar91. doi: 10.1091/mbc.E23-01-0006

  • CrossRef
  • Google Scholar

• 442

  ThomasSDJhaNKOjhaSSadekB. Mtor signaling disruption and its association with the development of autism spectrum disorder. Molecules (2023) 28(4):1889. doi: 10.3390/molecules28041889

  • CrossRef
  • Google Scholar

• 443

  EshraghiMAhmadiMAfsharSLorzadehSAdlimoghaddamARezvani JalalNet al. Enhancing autophagy in alzheimer’s disease through drug repositioning. Pharmacol Ther (2022) 237:108171. doi: 10.1016/j.pharmthera.2022.108171

  • CrossRef
  • Google Scholar

• 444

  MoorsTEHoozemansJJIngrassiaABeccariTParnettiLChartier-HarlinMCet al. Therapeutic potential of autophagy-enhancing agents in parkinson’s disease. Mol neurodegeneration (2017) 12(1):11. doi: 10.1186/s13024-017-0154-3

  • CrossRef
  • Google Scholar

• 445

  ZhouZDSelvaratnamTLeeJCTChaoYXTanEK. Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in parkinson’s disease. Trans neurodegeneration (2019) 8:6. doi: 10.1186/s40035-019-0145-0

  • CrossRef
  • Google Scholar

• 446

  GuYLindnerJKumarAYuanWMagnusonMA. Rictor/mtorc2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes (2011) 60(3):827–37. doi: 10.2337/db10-1194

  • CrossRef
  • Google Scholar

• 447

  LimYMLimHHurKYQuanWLeeHYCheonHet al. Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes. Nat Commun (2014) 5:4934. doi: 10.1038/ncomms5934

  • CrossRef
  • Google Scholar

• 448

  MaLFuRDuanZLuJGaoJTianLet al. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathology Res Pract (2016) 212(4):310–8. doi: 10.1016/j.prp.2016.02.001

  • CrossRef
  • Google Scholar

• 449

  LiuZStanojevicVBrindamourLJHabenerJF. Glp1-derived nonapeptide glp1(28-36)Amide protects pancreatic beta-cells from glucolipotoxicity. J Endocrinol (2012) 213(2):143–54. doi: 10.1530/joe-11-0328

  • CrossRef
  • Google Scholar

• 450

  HeCBassikMCMoresiVSunKWeiYZouZet al. Exercise-induced bcl2-regulated autophagy is required for muscle glucose homeostasis. Nature (2012) 481(7382):511–5. doi: 10.1038/nature10758

  • CrossRef
  • Google Scholar

• 451

  LiuYPalanivelRRaiEParkMGaborTVScheidMPet al. Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high fat diet feeding in mice. Diabetes (2014) 64(1):36–48. doi: 10.2337/db14-0267

  • CrossRef
  • Google Scholar

• 452

  HuaKLiTHeYGuanAChenLGaoYet al. Resistin secreted by porcine alveolar macrophages leads to endothelial cell dysfunction during haemophilus parasuis infection. Virulence (2023) 14(1):2171636. doi: 10.1080/21505594.2023.2171636

  • CrossRef
  • Google Scholar

• 453

  TanCAiJZhuY. Mtorc1-dependent protein and parkinson’s disease: A mendelian randomization study. Brain Sci (2023) 13(4):536. doi: 10.3390/brainsci13040536

  • CrossRef
  • Google Scholar

• 454

  ChongZZShangYCMaieseK. Cardiovascular disease and mtor signaling. Trends Cardiovasc Med (2011) 21(5):151–5. doi: 10.1016/j.tcm.2012.04.005

  • CrossRef
  • Google Scholar

• 455

  MaieseKChongZZShangYCWangS. Mtor: on target for novel therapeutic strategies in the nervous system. Trends Mol Med (2013) 19(1):51–60. doi: 10.1016/j.molmed.2012.11.001

  • CrossRef
  • Google Scholar

• 456

  RadulovicJGabbayV. Pfc mtor signaling as a biological signature for cognitive deficits in bipolar disorder without psychosis. Cell Rep Med (2021) 2(5):100282. doi: 10.1016/j.xcrm.2021.100282

  • CrossRef
  • Google Scholar

• 457

  CappoliNMezzogoriDTabolacciEColettaINavarraPPaniGet al. The mtor kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells. Excli J (2019) 18:779–98. doi: 10.17179/excli2019-1715

  • CrossRef
  • Google Scholar

• 458

  JungCHJunCBRoSHKimYMOttoNMCaoJet al. Ulk-atg13-fip200 complexes mediate mtor signaling to the autophagy machinery. Mol Biol Cell (2009) 20(7):1992–2003. doi: 10.1091/mbc.e08-12-1249

  • CrossRef
  • Google Scholar

• 459

  JavdanNAyatollahiSAChoudharyMIAl-HasaniSKobarfardFAtharAet al. Capsaicin Protects against Testicular Torsion Injury through Mtor-Dependent Mechanism. Theriogenology (2018) 113:247–52. doi: 10.1016/j.theriogenology.2018.03.012

  • CrossRef
  • Google Scholar

• 460

  ParkAKohHC. Nf-kappab/mtor-mediated autophagy can regulate diquat-induced apoptosis. Arch Toxicol (2019) 93(5):1239–53. doi: 10.1007/s00204-019-02424-7

  • CrossRef
  • Google Scholar

• 461

  ZhaoYWangQWangYLiJLuGLiuZ. Glutamine Protects against Oxidative Stress Injury through Inhibiting the Activation of Pi3k/Akt Signaling Pathway in Parkinsonian Cell Model. Environ Health Prev Med (2019) 24(1):4. doi: 10.1186/s12199-018-0757-5

  • CrossRef
  • Google Scholar

• 462

  DaiCCiccotostoGDCappaiRWangYTangSHoyerDet al. Rapamycin Confers Neuroprotection against Colistin-Induced Oxidative Stress, Mitochondria Dysfunction and Apoptosis through the Activation of Autophagy and Mtor/Akt/Creb Signaling Pathways. ACS Chem Neurosci (2017) 9(4):824–37. doi: 10.1021/acschemneuro.7b00323

  • CrossRef
  • Google Scholar

• 463

  ZhangZHWuQYZhengRChenCChenYLiuQet al. Selenomethionine mitigates cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an alzheimer’s disease mouse model. J Neurosci (2017) 37(9):2449–62. doi: 10.1523/jneurosci.3229-16.2017

  • CrossRef
  • Google Scholar

• 464

  HanKJiaNZhongYShangX. S14g-humanin alleviates insulin resistance and increases autophagy in neurons of app/ps1 transgenic mouse. J Cell Biochem (2017) 19(4):3111–7. doi: 10.1002/jcb.26452

  • CrossRef
  • Google Scholar

• 465

  Damstra-OddyJLWarrenECPerryCJDesfougèresYFitzpatrickJKSchafJet al. Phytocannabinoid-dependent mtorc1 regulation is dependent upon inositol polyphosphate multikinase activity. Br J Pharmacol (2021) 178(5):1149–63. doi: 10.1111/bph.15351

  • CrossRef
  • Google Scholar

• 466

  Dello RussoCLisiLFeinsteinDLNavarraP. Mtor kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia (2013) 61(3):301–11. doi: 10.1002/glia.22433

  • CrossRef
  • Google Scholar

• 467

  LeeYHongYLeeSRChangKT. Autophagy contributes to retardation of cardiac growth in diabetic rats. Lab Anim Res (2012) 28(2):99–107. doi: 10.5625/lar.2012.28.2.99

  • CrossRef
  • Google Scholar

• 468

  HuPLaiDLuPGaoJHeH. Erk and akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int J Mol Med (2012) 29(4):613–8. doi: 10.3892/ijmm.2012.891

  • CrossRef
  • Google Scholar

• 469

  MartinoLMasiniMNovelliMBeffyPBuglianiMMarselliLet al. Palmitate activates autophagy in ins-1e beta-cells and in isolated rat and human pancreatic islets. PloS One (2012) 7(5):e36188. doi: 10.1371/journal.pone.0036188

  • CrossRef
  • Google Scholar

• 470

  SaleemSBiswasSC. Tribbles pseudokinase 3 induces both apoptosis and autophagy in amyloid-beta-induced neuronal death. J Biol Chem (2017) 292(7):2571–85. doi: 10.1074/jbc.M116.744730

  • CrossRef
  • Google Scholar

• 471

  LiQHanYDuJJinHZhangJNiuMet al. Recombinant human erythropoietin protects against hippocampal damage in developing rats with seizures by modulating autophagy via the S6 protein in a time-dependent manner. Neurochem Res (2017) 43(2):465–76. doi: 10.1007/s11064-017-2443-1

  • CrossRef
  • Google Scholar

• 472

  DingCZhangJLiBDingZChengWGaoFet al. Cornin Protects Shsy5y Cells against Oxygen and Glucose Deprivationinduced Autophagy through the Pi3k/Akt/Mtor Pathway. Mol Med Rep (2017) 17(1):87–92. doi: 10.3892/mmr.2017.7864

  • CrossRef
  • Google Scholar

• 473

  KaMSmithALKimWY. Mtor controls genesis and autophagy of gabaergic interneurons during brain development. Autophagy (2017) 13(8):1348–63. doi: 10.1080/15548627.2017.1327927

  • CrossRef
  • Google Scholar

• 474

  FieldsCRBengoa-VergnioryNWade-MartinsR. Targeting alpha-synuclein as a therapy for parkinson’s disease. Front Mol Neurosci (2019) 12:299. doi: 10.3389/fnmol.2019.00299

  • CrossRef
  • Google Scholar

• 475

  JobstMKissEGernerCMarkoDDel FaveroG. Activation of autophagy triggers mitochondrial loss and changes acetylation profile relevant for mechanotransduction in bladder cancer cells. Arch Toxicol (2022) 97(1):217–33. doi: 10.1007/s00204-022-03375-2

  • CrossRef
  • Google Scholar

• 476

  WangNLuoZJinMShengWWangHTLongXet al. Exploration of age-related mitochondrial dysfunction and the anti-aging effects of resveratrol in zebrafish retina. Aging (Albany NY) (2019) 11(10):3117–37. doi: 10.18632/aging.101966

  • CrossRef
  • Google Scholar

• 477

  XuGShenHNibonaEWuKKeXAl HafizMAet al. Fundc1 is necessary for proper body axis formation during embryogenesis in zebrafish. Sci Rep (2019) 9(1):18910. doi: 10.1038/s41598-019-55415-0

  • CrossRef
  • Google Scholar

• 478

  ZengZLiangJWuLZhangHLvJChenN. Exercise-induced autophagy suppresses sarcopenia through akt/mtor and akt/foxo3a signal pathways and ampk-mediated mitochondrial quality control. Front Physiol (2020) 11:583478. doi: 10.3389/fphys.2020.583478

  • CrossRef
  • Google Scholar

• 479

  DechandtCRPFerrariGDDos SantosJRde OliveiraJACda Silva-JrRMPCunhaAOSet al. Energy metabolism and redox state in brains of wistar audiogenic rats, a genetic model of epilepsy. Front Neurol (2019) 10:1007. doi: 10.3389/fneur.2019.01007

  • CrossRef
  • Google Scholar

• 480

  KimKAShinYJAkramMKimESChoiKWSuhHet al. High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. Biol Pharm Bull (2014) 37(7):1248–52. doi: 10.1248/bpb.b14-00172

  • CrossRef
  • Google Scholar

• 481

  FesselJ. Supplementary pharmacotherapy for the behavioral abnormalities caused by stressors in humans, focused on post-traumatic stress disorder (Ptsd). J Clin Med (2023) 12(4):1680. doi: 10.3390/jcm12041680

  • CrossRef
  • Google Scholar

• 482

  YangKZhangLChenWChengJZhaoXZhangYet al. Expression of epo and related factors in the liver and kidney of plain and tibetan sheep. Histol Histopathol (2023), 18592. doi: 10.14670/hh-18-592

  • CrossRef
  • Google Scholar

• 483

  ChongZZKangJQMaieseK. Erythropoietin is a novel vascular protectant through activation of akt1 and mitochondrial modulation of cysteine proteases. Circulation (2002) 106(23):2973–9. doi: 10.1161/01.cir.0000039103.58920.1f

  • CrossRef
  • Google Scholar

• 484

  García-LlanoMPedroso-IbáñezIMorales-ChacónLRodríguez-ObayaTPérez-RuizLSosa-TestéIet al. Short-term tolerance of nasally-administered neuroepo in patients with parkinson disease. MEDICC Rev (2021) 23(1):49–54. doi: 10.37757/mr2021.V23.N1.10

  • CrossRef
  • Google Scholar

• 485

  ChongZZMaieseK. Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and foxo3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol (2007) 150(7):839–50. doi: 10.1038/sj.bjp.0707161

  • CrossRef
  • Google Scholar

• 486

  MaieseKHouJChongZZShangYC. Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal (2009) 9:1072–104. doi: 10.1100/tsw.2009.121

  • CrossRef
  • Google Scholar

• 487

  ChamorroMEWenkerSDVotaDMVittoriDCNesseAB. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative. Biochim Biophys Acta (2013) 1833(8):1960–8. doi: 10.1016/j.bbamcr.2013.04.006

  • CrossRef
  • Google Scholar

• 488

  ChongZZShangYCWangSMaieseK. Pras40 is an integral regulatory component of erythropoietin mtor signaling and cytoprotection. PloS One (2012) 7(9):e45456. doi: 10.1371/journal.pone.0045456

  • CrossRef
  • Google Scholar

• 489

  WangGBNiYLZhouXPZhangWF. The akt/mtor pathway mediates neuronal protective effects of erythropoietin in sepsis. Mol Cell Biochem (2014) 385(1-2):125–32. doi: 10.1007/s11010-013-1821-5

  • CrossRef
  • Google Scholar

• 490

  BinMowynaMNAlFarisNA. Kaempferol suppresses acetaminophen-induced liver damage by upregulation/activation of sirt1. Pharm Biol (2021) 59(1):146–56. doi: 10.1080/13880209.2021.1877734

  • CrossRef
  • Google Scholar

• 491

  DaiCXiaoXZhangYXiangBHoyerDShenJet al. Curcumin attenuates colistin-induced peripheral neurotoxicity in mice. ACS Infect Dis (2020) 6(4):715–24. doi: 10.1021/acsinfecdis.9b00341

  • CrossRef
  • Google Scholar

• 492

  De GiorgiFLartigueLBauerMKSchubertAGrimmSHansonGTet al. The permeability transition pore signals apoptosis by directing bax translocation and multimerization. FASEB J (2002) 16(6):607–9. doi: 10.1096/fj.01-0269fje

  • CrossRef
  • Google Scholar

• 493

  DengDYanJWuYWuKLiW. Morroniside suppresses hydrogen peroxide-stimulated autophagy and apoptosis in rat ovarian granulosa cells through the pi3k/akt/mtor pathway. Hum Exp Toxicol (2020) 40(4):577–86. doi: 10.1177/0960327120960768

  • CrossRef
  • Google Scholar

• 494

  HaciogluCKarFKanbakG. Reproductive effects of nicotinamide on testicular function and structure in old male rats: oxidative, apoptotic, hormonal, and morphological analyses. Reprod Sci (2021) 28(12):3352–60. doi: 10.1007/s43032-021-00647-7

  • CrossRef
  • Google Scholar

• 495

  HajializadehZKhaksariM. The protective effects of 17-β Estradiol and sirt1 against cardiac hypertrophy: A review. Heart failure Rev (2021) 27(2):725–38. doi: 10.1007/s10741-021-10171-0

  • CrossRef
  • Google Scholar

• 496

  AllozaISalegiAMenaJNavarroRTMartinCAspichuetaPet al. Birc6 is associated with vulnerability of carotid atherosclerotic plaque. Int J Mol Sci (2020) 21(24):9387. doi: 10.3390/ijms21249387

  • CrossRef
  • Google Scholar

• 497

  ChenSLiB. Mir-128-3p post-transcriptionally inhibits wisp1 to suppress apoptosis and inflammation in human articular chondrocytes via the pi3k/akt/nf-κb signaling pathway. Cell Transplant (2020) 29:963689720939131. doi: 10.1177/0963689720939131

  • CrossRef
  • Google Scholar

• 498

  GallyasFJr.SumegiBSzaboC. Role of akt activation in parp inhibitor resistance in cancer. Cancers (2020) 12(3):532. doi: 10.3390/cancers12030532

  • CrossRef
  • Google Scholar

• 499

  GovindappaPKElfarJC. Erythropoietin promotes M2 macrophage phagocytosis of schwann cells in peripheral nerve injury. Cell Death Dis (2022) 13(3):245. doi: 10.1038/s41419-022-04671-6

  • CrossRef
  • Google Scholar

• 500

  YeMZhaoYWangYXieRTongYSauerJDet al. Nad(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis. Nat Nanotechnol (2022) 17(8):880–90. doi: 10.1038/s41565-022-01137-w

  • CrossRef
  • Google Scholar

• 501

  YangLChengCFLiZFHuangXJCaiSQYeSYet al. Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR-18a-3p/Gsdmd pathway. Int J Mol Med (2023) 51(6):49. doi: 10.1002/biof.1607

  • CrossRef
  • Google Scholar

• 502

  HouJChongZZShangYCMaieseK. Early apoptotic vascular signaling is determined by sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res (2010) 7(2):95–112. doi: 10.2174/156720210791184899

  • CrossRef
  • Google Scholar

• 503

  ShangYCChongZZHouJMaieseK. Wnt1, foxo3a, and nf-kappab oversee microglial integrity and activation during oxidant stress. Cell Signal (2010) 22(9):1317–29. doi: 10.1016/j.cellsig.2010.04.009

  • CrossRef
  • Google Scholar

• 504

  TaveiraGBMelloEOSouzaSBMonteiroRMRamosACCarvalhoAOet al. Programmed cell death in yeast by thionin-like peptide from capsicum annuum fruits involving activation of capases and extracelullar H(+) flux. Bioscience Rep (2018) 38(2):BSR20180119. doi: 10.1042/bsr20180119

  • CrossRef
  • Google Scholar

• 505

  AlmasiehMCatrinescuMMBinanLCostantinoSLevinLA. Axonal degeneration in retinal ganglion cells is associated with a membrane polarity-sensitive redox process. J Neurosci (2017) 37(14):3824–39. doi: 10.1523/jneurosci.3882-16.2017

  • CrossRef
  • Google Scholar

• 506

  ViolaGBortolozziRHamelEMoroSBrunPCastagliuoloIet al. Mg-2477, a new tubulin inhibitor, induces autophagy through inhibition of the akt/mtor pathway and delayed apoptosis in A549 cells. Biochem Pharmacol (2012) 83(1):16–26. doi: 10.1016/j.bcp.2011.09.017

  • CrossRef
  • Google Scholar

• 507

  BaileyTJFossumSLFimbelSMMontgomeryJEHydeDR. The inhibitor of phagocytosis, O-phospho-L-serine, suppresses muller glia proliferation and cone cell regeneration in the light-damaged zebrafish retina. Exp Eye Res (2010) 91(5):601–12. doi: 10.1016/j.exer.2010.07.017

  • CrossRef
  • Google Scholar

• 508

  ShangYCChongZZHouJMaieseK. Foxo3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis. Curr Neurovasc Res (2009) 6(4):223–38. doi: 10.2174/156720209789630302

  • CrossRef
  • Google Scholar

• 509

  WeiLSunCLeiMLiGYiLLuoFet al. Activation of wnt/beta-catenin pathway by exogenous wnt1 protects sh-sy5y cells against 6-hydroxydopamine toxicity. J Mol Neurosci (2013) 49(1):105–15. doi: 10.1007/s12031-012-9900-8

  • CrossRef
  • Google Scholar

• 510

  HouJWangSShangYCChongZZMaieseK. Erythropoietin employs cell longevity pathways of sirt1 to foster endothelial vascular integrity during oxidant stress. Curr Neurovasc Res (2011) 8(3):220–35. doi: 10.2174/156720211796558069

  • CrossRef
  • Google Scholar

• 511

  KimSKangIHNamJBChoYChungDYKimSHet al. Ameliorating the effect of astragaloside iv on learning and memory deficit after chronic cerebral hypoperfusion in rats. Molecules (2015) 20(2):1904–21. doi: 10.3390/molecules20021904

  • CrossRef
  • Google Scholar

• 512

  XinYJYuanBYuBWangYQWuJJZhouWHet al. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress. Sci Rep (2015) 5:7645. doi: 10.1038/srep07645

  • CrossRef
  • Google Scholar

• 513

  YuTLiLChenTLiuZLiuHLiZ. Erythropoietin attenuates advanced glycation endproducts-induced toxicity of schwann cells in vitro. Neurochem Res (2015) 40(4):698–712. doi: 10.1007/s11064-015-1516-2

  • CrossRef
  • Google Scholar

• 514

  YousafzaiNAJinHUllahMWangX. Recent advances of sirt1 and implications in chemotherapeutics resistance in cancer. Am J Cancer Res (2021) 11(11):5233–48.

  • Google Scholar

• 515

  MaieseK. Pyroptosis, apoptosis, and autophagy: critical players of inflammation and cell demise in the nervous system. Curr Neurovasc Res (2022) 19:241–4. doi: 10.2174/1567202619666220729093449

  • CrossRef
  • Google Scholar

• 516

  PangYQinMHuPJiKXiaoRSunNet al. Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing opa1 expression. Int J Mol Med (2020) 46(5):1707–20. doi: 10.3892/ijmm.2020.4711

  • CrossRef
  • Google Scholar

• 517

  CuiLWeiyaoJChenghongSLimeiLXinghuaZBoYet al. Rheumatoid arthritis and mitochondrial homeostasis: the crossroads of metabolism and immunity. Front Med (Lausanne) (2022) 9:1017650. doi: 10.3389/fmed.2022.1017650

  • CrossRef
  • Google Scholar

• 518

  MaieseKVincentAM. Critical temporal modulation of neuronal programmed cell injury. Cell Mol Neurobiol (2000) 20(3):383–400. doi: 10.1023/A:1007070311203

  • CrossRef
  • Google Scholar

• 519

  RazzaghiAChoobinehSGaeiniASooriR. Interaction of exercise training with taurine attenuates infarct size and cardiac dysfunction via akt-foxo3a-caspase-8 signaling pathway. Amino Acids (2023) 55(7):869–80. doi: 10.1007/s00726-023-03275-4

  • CrossRef
  • Google Scholar

• 520

  ShangYCChongZZWangSMaieseK. Wnt1 inducible signaling pathway protein 1 (Wisp1) targets pras40 to govern beta-amyloid apoptotic injury of microglia. Curr Neurovasc Res (2012) 9(4):239–49. doi: 10.2174/156720212803530618

  • CrossRef
  • Google Scholar

• 521

  ShangYCChongZZWangSMaieseK. Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on wnt1, the pi 3-K/mtor pathway, bad, and bcl-xl. Aging (Albany NY) (2012) 4(3):187–201. doi: 10.18632/aging.100440

  • CrossRef
  • Google Scholar

• 522

  ShangYCChongZZWangSMaieseK. Tuberous sclerosis protein 2 (Tsc2) modulates ccn4 cytoprotection during apoptotic amyloid toxicity in microglia. Curr Neurovasc Res (2013) 10(1):29–38. doi: 10.2174/156720213804806007

  • CrossRef
  • Google Scholar

• 523

  BhowmickSD’MelloVCarusoDAbdul-MuneerPM. Traumatic brain injury-induced downregulation of nrf2 activates inflammatory response and apoptotic cell death. J Mol Med (Berlin Germany) (2019) 97(12):1627–41. doi: 10.1007/s00109-019-01851-4

  • CrossRef
  • Google Scholar

• 524

  ChongZZLiFMaieseK. Stress in the brain: novel cellular mechanisms of injury linked to alzheimer’s disease. Brain Res Brain Res Rev (2005) 49(1):1–21. doi: 10.1016/j.brainresrev.2004.11.005

  • CrossRef
  • Google Scholar

• 525

  NajjarRSTurnerCGWongBJFeresinRG. Berry-derived polyphenols in cardiovascular pathologies: mechanisms of disease and the role of diet and sex. Nutrients (2021) 13(2):387. doi: 10.3390/nu13020387

  • CrossRef
  • Google Scholar

• 526

  LiangHLiuQ. The role of non-coding rna in lupus nephritis. Hum Cell (2023) 36(3):923–36. doi: 10.1007/s13577-023-00883-w

  • CrossRef
  • Google Scholar

• 527

  ScrimieriRLocatelliLCazzanigaACazzolaRMalucelliESorrentinoAet al. Ultrastructural features mirror metabolic derangement in human endothelial cells exposed to high glucose. Sci Rep (2023) 13(1):15133. doi: 10.1038/s41598-023-42333-5

  • CrossRef
  • Google Scholar

• 528

  WangJChenSZhaoXGuoQYangRZhangCet al. Effect of pparγ on oxidative stress in diabetes-related dry eye. Exp Eye Res (2023) 231:109498. doi: 10.1016/j.exer.2023.109498

  • CrossRef
  • Google Scholar

• 529

  YegerH. Ccn proteins: opportunities for clinical studies-a personal perspective. J Cell Commun Signal (2023) 17(2):333–52. doi: 10.1007/s12079-023-00761-y

  • CrossRef
  • Google Scholar

• 530

  Sierra-PaganJEDsouzaNDasSLarsonTASorensenJRMaXet al. Foxk1 regulates wnt signaling to promote cardiogenesis. Cardiovasc Res (2023) 119(8):1728–39. doi: 10.1093/cvr/cvad054

  • CrossRef
  • Google Scholar

• 531

  ZhangYZhouHDingC. The ameliorative effect of cangfu daotan decoction on polycystic ovary syndrome of rodent model is associated with M6a methylation and wnt/β-catenin pathway. Gynecol Endocrinol (2023) 39(1):2181637. doi: 10.1080/09513590.2023.2181637

  • CrossRef
  • Google Scholar

• 532

  FaridHASayedRHEl-ShamarkaMEAbdel-SalamOMEEl SayedNS. Pi3k/akt signaling activation by roflumilast ameliorates rotenone-induced parkinson’s disease in rats. Inflammopharmacology (2023). doi: 10.1007/s10787-023-01305-x

  • CrossRef
  • Google Scholar

• 533

  HuGWangTMaC. Epo activates pi3k-ikkα-cdk1 signaling pathway to promote the proliferation of glial cells under hypoxia environment. Genet Mol Biol (2022) 45(1):e20210249. doi: 10.1590/1678-4685-gmb-2021-0249

  • CrossRef
  • Google Scholar

• 534

  LiuHWangCSunXZhanCLiZQiuLet al. Silk fibroin/collagen/hydroxyapatite scaffolds obtained by 3d printing technology and loaded with recombinant human erythropoietin in the reconstruction of alveolar bone defects. ACS Biomater Sci Eng (2022) 8(12):5245–56. doi: 10.1021/acsbiomaterials.2c00690

  • CrossRef
  • Google Scholar

• 535

  SergioCMRolandoCA. Erythropoietin regulates signaling pathways associated with neuroprotective events. Exp Brain Res (2022) 240(5):1303–15. doi: 10.1007/s00221-022-06331-9

  • CrossRef
  • Google Scholar

• 536

  MaieseK. Regeneration in the nervous system with erythropoietin. Front bioscience (Landmark edition) (2016) 21:561–96. doi: 10.2741/4408

  • CrossRef
  • Google Scholar

• 537

  SunNVictorMBParkYPXiongXScannailANLearyNet al. Human microglial state dynamics in alzheimer’s disease progression. Cell (2023) 186(20):4386–403.e29. doi: 10.1016/j.cell.2023.08.037

  • CrossRef
  • Google Scholar

• 538

  Duarte-SilvaEMeuthSGPeixotoCA. The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis. Front Immunol (2023) 14:1137635. doi: 10.3389/fimmu.2023.1137635

  • CrossRef
  • Google Scholar

• 539

  MaieseK. Ferroptosis, iron metabolism, and forkhead transcription factors (Foxos). Curr Neurovasc Res (2023) 20(3):291–5. doi: 10.2174/1567202620666230706160056

  • CrossRef
  • Google Scholar

• 540

  HeLYangYChenJZouPLiJ. Transcriptional activation of enpp2 by foxo4 protects cardiomyocytes from doxorubicin−Induced toxicity. Mol Med Rep (2021) 24(3):668. doi: 10.3892/mmr.2021.12307

  • CrossRef
  • Google Scholar

• 541

  MalhotraSHurtado-NavarroLPappollaAVillarLMMRíoJMontalbanXet al. Increased nlrp3 inflammasome activation and pyroptosis in patients with multiple sclerosis with fingolimod treatment failure. Neurol Neuroimmunol Neuroinflamm (2023) 10(3):e200100. doi: 10.1212/nxi.0000000000200100

  • CrossRef
  • Google Scholar

• 542

  ContiPRonconiGCaraffaAGallengaCERossRFrydasIet al. Induction of pro-inflammatory cytokines (Il-1 and il-6) and lung inflammation by coronavirus-19 (Covi-19 or sars-cov-2): anti-inflammatory strategies. J Biol Regul Homeost Agents (2020) 34(2):327–31. doi: 10.23812/conti-e

  • CrossRef
  • Google Scholar

• 543

  CrespoIFernández-PalancaPSan-MiguelBÁlvarezMGonzález-GallegoJTuñónMJ. Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral-induced fulminant hepatic failure. J Cell Mol Med (2020) 24(13):7625–36. doi: 10.1111/jcmm.15398

  • CrossRef
  • Google Scholar

• 544

  ParkMHGutierrez-GarciaAKChoudhuryM. Mono-(2-ethylhexyl) phthalate aggravates inflammatory response via sirtuin regulation and inflammasome activation in raw 264.7 cells. Chem Res Toxicol (2019) 32(5):935–42. doi: 10.1021/acs.chemrestox.9b00101

  • CrossRef
  • Google Scholar

• 545

  Vaamonde-GarciaCLopez-ArmadaMJ. Role of mitochondrial dysfunction on rheumatic diseases. Biochem Pharmacol (2019) 165:181–95. doi: 10.1016/j.bcp.2019.03.008

  • CrossRef
  • Google Scholar

• 546

  QianDDaiSSunYYuanYWangL. Mir-128-3p attenuates the neurotoxicity in rats induced by isoflurane anesthesia. Neurotox Res (2022) 40(3):714–20. doi: 10.1007/s12640-022-00512-8

  • CrossRef
  • Google Scholar

• 547

  TonioloSScarioniMDi LorenzoFHortJGeorgesJTomicSet al. Dementia and covid-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. J Alzheimers Dis (2021) 82(3):883–98. doi: 10.3233/jad-210335

  • CrossRef
  • Google Scholar

• 548

  HassaneinEHMSalehFMAliFEMRashwanEKAtwaAMAbd El-GhafarOAM. Neuroprotective effect of canagliflozin against cisplatin-induced cerebral cortex injury is mediated by regulation of ho-1/ppar-Γ, sirt1/foxo-3, jnk/ap-1, tlr4/inos, and ang ii/ang 1-7 signals. Immunopharmacol Immunotoxicol (2023) 45(3):304–16. doi: 10.1080/08923973.2022.2143371

  • CrossRef
  • Google Scholar

• 549

  MaieseK. Sirtuins in metabolic disease: Innovative Therapeutic Strategies with Sirt1, Ampk, Mtor, and Nicotinamide. In: MaieseK, editor. Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery. Academic Press, Elsevier (2021), Cambridge, MA, USA; Elsevier, Amsterdam, The Netherlands: ISBN.

  • Google Scholar

• 550

  FangmaYWanHShaoCJinLHeY. Research progress on the role of sirtuin 1 in cerebral ischemia. Cell Mol Neurobiol (2022) 43(5):1769–83. doi: 10.1007/s10571-022-01288-3

  • CrossRef
  • Google Scholar

• 551

  KangXLiCXieXZhanKBYangSQTangYYet al. Hydrogen sulfide inhibits homocysteine-induced neuronal senescence by up-regulation of sirt1. Int J Med Sci (2020) 17(3):310–9. doi: 10.7150/ijms.38602

  • CrossRef
  • Google Scholar

• 552

  LiHPengDZhangSJZhangYWangQGuanL. Buyang huanwu decoction promotes neurogenesis via sirtuin 1/autophagy pathway in a cerebral ischemia model. Mol Med Rep (2021) 24(5):791. doi: 10.3892/mmr.2021.12431

  • CrossRef
  • Google Scholar

• 553

  MaieseK. Novel treatment strategies for the nervous system: circadian clock genes, non-coding rnas, and forkhead transcription factors. Curr Neurovasc Res (2018) 15(1):81–91. doi: 10.2174/1567202615666180319151244

  • CrossRef
  • Google Scholar

• 554

  YinQWangJFXuXHXieH. Effect of lycopene on pain facilitation and the sirt1/mtor pathway in the dorsal horn of burn injury rats. Eur J Pharmacol (2020) 889:173365. doi: 10.1016/j.ejphar.2020.173365

  • CrossRef
  • Google Scholar

• 555

  LeeYImE. Regulation of mirnas by natural antioxidants in cardiovascular diseases: focus on sirt1 and enos. Antioxidants (Basel Switzerland) (2021) 10(3):377. doi: 10.3390/antiox10030377

  • CrossRef
  • Google Scholar

• 556

  MoriMCazzanigaGMeneghettiFVillaSGelainA. Insights on the modulation of sirt5 activity: A challenging balance. Molecules (2022) 27(14):4449. doi: 10.3390/molecules27144449

  • CrossRef
  • Google Scholar

• 557

  RongYRenJSongWXiangRGeYLuWet al. Resveratrol suppresses severe acute pancreatitis-induced microcirculation disturbance through targeting sirt1-foxo1 axis. Oxid Med Cell Longev (2021) 2021:8891544. doi: 10.1155/2021/8891544

  • CrossRef
  • Google Scholar

• 558

  GuimeraAMClarkPWordsworthJAnugulaSRasmussenLJShanleyDP. Systems modelling predicts chronic inflammation and genomic instability prevent effective mitochondrial regulation during biological ageing. Exp Gerontol (2022) 166:111889. doi: 10.1016/j.exger.2022.111889

  • CrossRef
  • Google Scholar

• 559

  SadriaMSeoDLaytonAT. The mixed blessing of ampk signaling in cancer treatments. BMC Cancer (2022) 22(1):105. doi: 10.1186/s12885-022-09211-1

  • CrossRef
  • Google Scholar

• 560

  BittermanKJAndersonRMCohenHYLatorre-EstevesMSinclairDA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human sirt1. J Biol Chem (2002) 277(47):45099–107. doi: 10.1074/jbc.M205670200

  • CrossRef
  • Google Scholar

• 561

  GuerraJDevesaJ. Usefulness of melatonin and other compounds as antioxidants and epidrugs in the treatment of head and neck cancer. Antioxidants (Basel Switzerland) (2021) 11(1):35. doi: 10.3390/antiox11010035

  • CrossRef
  • Google Scholar

• 562

  MaieseKChongZZShangYCWangS. Translating cell survival and cell longevity into treatment strategies with sirt1. Rom J Morphol Embryol (2011) 52(4):1173–85.

  • Google Scholar

• 563

  PenteadoABHassanieHGomesRASilva EmeryFDGoulart TrossiniGH. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Med Chem (2023) 15(3):291–311. doi: 10.4155/fmc-2022-0253

  • CrossRef
  • Google Scholar

• 564

  GiacaloneSSpigarioloCBBortoluzziPNazzaroG. Oral nicotinamide: the role in skin cancer chemoprevention. Dermatol Ther (2021) 34(3):e14892. doi: 10.1111/dth.14892

  • CrossRef
  • Google Scholar

• 565

  ChongMCSilvaAJamesPFWuSSXHowittJ. Exercise increases the release of nampt in extracellular vesicles and alters nad(+) activity in recipient cells. Aging Cell (2022) 21(7):e13647. doi: 10.1111/acel.13647

  • CrossRef
  • Google Scholar

• 566

  PotthastABNeblJWasserfurthPHaufeSEigendorfJHahnAet al. Impact of nutrition on short-term exercise-induced sirtuin regulation: vegans differ from omnivores and lacto-ovo vegetarians. Nutrients (2020) 12(4):1004. doi: 10.3390/nu12041004

  • CrossRef
  • Google Scholar

• 567

  AlSalehAShahidMFaridEBindaynaK. The effect of ascorbic acid and nicotinamide on panton-valentine leukocidin cytotoxicity: an ex vivo study. Toxins (Basel) (2023) 15(1):38. doi: 10.3390/toxins15010038

  • CrossRef
  • Google Scholar

• 568

  KumarAOuY. From bench to behaviour: the role of lifestyle factors on intraocular pressure, neuroprotection, and disease progression in glaucoma. Clin Exp Ophthalmol (2023) 51(4):380–94. doi: 10.1111/ceo.14218

  • CrossRef
  • Google Scholar

• 569

  LiMZhangLPanLZhouPYuRZhangZet al. Nicotinamide efficiently suppresses porcine epidemic diarrhea virus and porcine deltacoronavirus replication. Viruses (2023) 15(7):1591. doi: 10.3390/v15071591

  • CrossRef
  • Google Scholar

• 570

  TaiS-HChaoL-CHuangS-YLinH-WLeeA-HChenY-Yet al. Nicotinamide deteriorates post-stroke immunodepression following cerebral ischemia–reperfusion injury in mice. Biomedicines (2023) 11(8):2145. doi: 10.3390/biomedicines11082145

  • CrossRef
  • Google Scholar

• 571

  JacksonMDSchmidtMTOppenheimerNJDenuJM. Mechanism of nicotinamide inhibition and transglycosidation by sir2 histone/protein deacetylases. J Biol Chem (2003) 278(51):50985–98. doi: 10.1074/jbc.M306552200

  • CrossRef
  • Google Scholar

• 572

  AvalosJLBeverKMWolbergerC. Mechanism of sirtuin inhibition by nicotinamide: altering the nad(+) cosubstrate specificity of a sir2 enzyme. Mol Cell (2005) 17(6):855–68. doi: 10.1016/j.molcel.2005.02.022

  • CrossRef
  • Google Scholar

• 573

  ZhangXMJingYPJiaMYZhangL. Negative transcriptional regulation of inflammatory genes by group B3 vitamin nicotinamide. Mol Biol Rep (2012) 39(12):10367–71. doi: 10.1007/s11033-012-1915-2

  • CrossRef
  • Google Scholar

• 574

  FulcoMCenYZhaoPHoffmanEPMcBurneyMWSauveAAet al. Glucose restriction inhibits skeletal myoblast differentiation by activating sirt1 through ampk-mediated regulation of nampt. Dev Cell (2008) 14(5):661–73. doi: 10.1016/j.devcel.2008.02.004

  • CrossRef
  • Google Scholar

• 575

  PalPBSonowalHShuklaKSrivastavaSKRamanaKV. Aldose reductase regulates hyperglycemia-induced huvec death via sirt1/ampk-alpha1/mtor pathway. J Mol Endocrinol (2019) 63(1):11–25. doi: 10.1530/jme-19-0080

  • CrossRef
  • Google Scholar

• 576

  GengCXuHZhangYGaoYLiMLiuXet al. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. Sci China Life Sci (2017) 60(11):1234–41. doi: 10.1007/s11427-016-9027-6

  • CrossRef
  • Google Scholar

• 577

  GhiasiRNaderiRSheervalilouRAlipourMR. Swimming training by affecting the pancreatic sirtuin1 (Sirt1) and oxidative stress, improves insulin sensitivity in diabetic male rats. Hormone Mol Biol Clin Invest (2019) 40(3). doi: 10.1515/hmbci-2019-0011

  • CrossRef
  • Google Scholar

• 578

  XuePZhaoJZhengALiLChenHTuWet al. Chrysophanol alleviates myocardial injury in diabetic db/db mice by regulating the sirt1/hmgb1/nf-kappab signaling pathway. Exp Ther Med (2019) 18(6):4406–12. doi: 10.3892/etm.2019.8083

  • CrossRef
  • Google Scholar

• 579

  ChenYRFangSRFuYCZhouXHXuMYXuWC. Calorie restriction on insulin resistance and expression of sirt1 and sirt4 in rats. Biochem Cell Biol (2010) 88(4):715–22. doi: 10.1139/O10-010

  • CrossRef
  • Google Scholar

• 580

  CaronAZHeXMottaweaWSeifertELJardineKDewar-DarchDet al. The sirt1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J (2014) 28(3):1306–16. doi: 10.1096/fj.13-243568

  • CrossRef
  • Google Scholar

• 581

  FrojdoSDurandCMolinLCareyALEl-OstaAKingwellBAet al. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by sirt1. Mol Cell Endocrinol (2011) 335(2):166–76. doi: 10.1016/j.mce.2011.01.008

  • CrossRef
  • Google Scholar

• 582

  GuoWQianLZhangJZhangWMorrisonAHayesPet al. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mtor signaling. J Neurosci Res (2011) 89(11):1723–36. doi: 10.1002/jnr.22725

  • CrossRef
  • Google Scholar

• 583

  PanYRSongJYFanBWangYCheLZhangSMet al. Mtor may interact with parp-1 to regulate visible light-induced parthanatos in photoreceptors. Cell Commun Signal (2020) 18(1):27. doi: 10.1186/s12964-019-0498-0

  • CrossRef
  • Google Scholar

• 584

  ZhangHYangXPangXZhaoZYuHZhouH. Genistein Protects against Ox-Ldl-Induced Senescence through Enhancing Sirt1/Lkb1/Ampk-Mediated Autophagy Flux in Huvecs. Mol Cell Biochem (2019) 455((1-2):127–34. doi: 10.1007/s11010-018-3476-8

  • CrossRef
  • Google Scholar

• 585

  OuXLeeMRHuangXMessina-GrahamSBroxmeyerHE. Sirt1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells (2014) 32(5):1183–94. doi: 10.1002/stem.1641

  • CrossRef
  • Google Scholar

• 586

  LiMZZhengLJShenJLiXYZhangQBaiXet al. Sirt1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes. Neural regeneration Res (2018) 13(11):2005–13. doi: 10.4103/1673-5374.239449

  • CrossRef
  • Google Scholar

• 587

  BalanVMillerGSKaplunLBalanKChongZZLiFet al. Life span extension and neuronal cell protection by drosophila nicotinamidase. J Biol Chem (2008) 283(41):27810–9. doi: 10.1074/jbc.M804681200

  • CrossRef
  • Google Scholar

• 588

  WangSChongZZShangYCMaieseK. Wisp1 neuroprotection requires foxo3a post-translational modulation with autoregulatory control of sirt1. Curr Neurovasc Res (2013) 10(1):54–60. doi: 10.2174/156720213804805945

  • CrossRef
  • Google Scholar

• 589

  MaieseKShangYCChongZZHouJ. Diabetes mellitus: channeling care through cellular discovery. Curr Neurovasc Res (2010) 7(1):59–64. doi: 10.2174/156720210790820217

  • CrossRef
  • Google Scholar

• 590

  WuHWangHZhangWWeiXZhaoJYanPet al. Rhepo affects apoptosis in hippocampus of aging rats by upregulating sirt1. Int J Clin Exp Pathol (2015) 8(6):6870–80.

  • Google Scholar

• 591

  ChongZZKangJQMaieseK. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, akt1, bad, and caspase-mediated pathways. Br J Pharmacol (2003) 138(6):1107–18. doi: 10.1038/sj.bjp.0705161

  • CrossRef
  • Google Scholar

• 592

  CuiLGuoJZhangQYinJLiJZhouWet al. Erythropoietin activates sirt1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity. Toxicol Lett (2017) 275:28–38. doi: 10.1016/j.toxlet.2017.04.018

  • CrossRef
  • Google Scholar

• 593

  ReyFOttolenghiSGiallongoTBalsariAMartinelliCReyRet al. Mitochondrial metabolism as target of the neuroprotective role of erythropoietin in parkinson’s disease. Antioxidants (Basel Switzerland) (2021) 10(1):121. doi: 10.3390/antiox10010121

  • CrossRef
  • Google Scholar

• 594

  ShangYCChongZZWangSMaieseK. Erythropoietin and wnt1 govern pathways of mtor, apaf-1, and xiap in inflammatory microglia. Curr Neurovasc Res (2011) 8(4):270–85. doi: 10.2174/156720211798120990

  • CrossRef
  • Google Scholar

• 595

  EntezariMFlavarjaniZKRamezaniANikkhahHKarimiSMoghadamHFet al. Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: A randomized double-blind clinical trial. Graefes Arch Clin Exp Ophthalmol (2019) 257(11):2375–80. doi: 10.1007/s00417-019-04383-2

  • CrossRef
  • Google Scholar

• 596

  MontesanoABonfigliARDe LucaMCroccoPGaragnaniPMarascoEet al. Erythropoietin (Epo) haplotype associated with all-cause mortality in a cohort of italian patients with type-2 diabetes. Sci Rep (2019) 9(1):10395. doi: 10.1038/s41598-019-46894-2

  • CrossRef
  • Google Scholar

• 597

  KimSHYuHSHuhSKangUGKimYS. Electroconvulsive seizure inhibits the mtor signaling pathway via ampk in the rat frontal cortex. Psychopharmacology (2022) 239(2):443–54. doi: 10.1007/s00213-021-06015-2

  • CrossRef
  • Google Scholar

• 598

  LiXLiKChuFHuangJYangZ. Graphene oxide enhances β-amyloid clearance by inducing autophagy of microglia and neurons. Chem Biol Interact (2020) 325:109126. doi: 10.1016/j.cbi.2020.109126

  • CrossRef
  • Google Scholar

• 599

  NejabatiHRSamadiNShahnaziVMihanfarAFattahiALatifiZet al. Nicotinamide and its metabolite N1-methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of polycystic ovary syndrome. Chem Biol Interact (2020) 324:109093. doi: 10.1016/j.cbi.2020.109093

  • CrossRef
  • Google Scholar

• 600

  ChongZZMaieseK. The src homology 2 domain tyrosine phosphatases shp-1 and shp-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol (2007) 22(11):1251–67. doi: 10.14670/HH-22.1251

  • CrossRef
  • Google Scholar

• 601

  ChiuSCChaoCYChiangEISyuJNRodriguezRLTangFY. N-3 polyunsaturated fatty acids alleviate high glucose-mediated dysfunction of endothelial progenitor cells and prevent ischemic injuries both in vitro and in vivo. J Nutr Biochem (2017) 42:172–81. doi: 10.1016/j.jnutbio.2017.01.009

  • CrossRef
  • Google Scholar

• 602

  LiuPYangXHeiCMeliYNiuJSunTet al. Rapamycin reduced ischemic brain damage in diabetic animals is associated with suppressions of mtor and erk1/2 signaling. Int J Biol Sci (2016) 12(8):1032–40. doi: 10.7150/ijbs.15624

  • CrossRef
  • Google Scholar

• 603

  PeixotoCAde OliveiraWHda Rocha AraujoSMNunesAKS. Ampk activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol (2017) 298(PtA):31–41. doi: 10.1016/j.expneurol.2017.08.013

  • CrossRef
  • Google Scholar

• 604

  ZhaoHWangZCWangKFChenXY. Abeta peptide secretion is reduced by radix polygalaeinduced autophagy via activation of the ampk/mtor pathway. Mol Med Rep (2015) 12(2):2771–6. doi: 10.3892/mmr.2015.3781

  • CrossRef
  • Google Scholar

• 605

  LinCLHuangWNLiHHHuangCNHsiehSLaiCet al. Hydrogen-rich water attenuates amyloid beta-induced cytotoxicity through upregulation of sirt1-foxo3a by stimulation of amp-activated protein kinase in sk-N-mc cells. Chem Biol Interact (2015) 240:12–21. doi: 10.1016/j.cbi.2015.07.013

  • CrossRef
  • Google Scholar

• 606

  AnTZhangXLiHDouLHuangXManYet al. Gpr120 facilitates cholesterol efflux in macrophages through activation of ampk signaling pathway. FEBS J (2020) 287(23):5080–95. doi: 10.1111/febs.15310

  • CrossRef
  • Google Scholar

• 607

  HungCMLombardoPSMalikNBrunSNHellbergKVan NostrandJLet al. Ampk/ulk1-mediated phosphorylation of parkin act domain mediates an early step in mitophagy. Sci Adv (2021) 7(15):eabg4544. doi: 10.1126/sciadv.abg4544

  • CrossRef
  • Google Scholar

• 608

  DuLLChaiDMZhaoLNLiXHZhangFCZhangHBet al. Ampk activation ameliorates alzheimer’s disease-like pathology and spatial memory impairment in a streptozotocin-induced alzheimer’s disease model in rats. J Alzheimers Dis (2015) 43(3):775–84. doi: 10.3233/jad-140564

  • CrossRef
  • Google Scholar

• 609

  HeCZhuHLiHZouMHXieZ. Dissociation of bcl-2-beclin1 complex by activated ampk enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes (2013) 62(4):1270–81. doi: 10.2337/db12-0533

  • CrossRef
  • Google Scholar

• 610

  MorozNCarmonaJJAndersonEHartACSinclairDABlackwellTK. Dietary restriction involves nad -dependent mechanisms and a shift toward oxidative metabolism. Aging Cell (2014) 13(6):1075–85. doi: 10.1111/acel.12273

  • CrossRef
  • Google Scholar

• 611

  GaoJYaoMChangDLiuJ. Mtor (Mammalian target of rapamycin): hitting the bull’s eye for enhancing neurogenesis after cerebral ischemia? Stroke (2022) 54(1):279–85. doi: 10.1161/strokeaha.122.040376

  • CrossRef
  • Google Scholar

• 612

  LanFCacicedoJMRudermanNIdoY. Sirt1 modulation of the acetylation status, cytosolic localization, and activity of lkb1. Possible role in amp-activated protein kinase activation. J Biol Chem (2008) 283(41):27628–35. doi: 10.1074/jbc.M805711200

  • CrossRef
  • Google Scholar

• 613

  CantoCAuwerxJ. Caloric restriction, sirt1 and longevity. Trends Endocrinol Metab (2009) 20(7):325–31. doi: 10.1016/j.tem.2009.03.008

  • CrossRef
  • Google Scholar

• 614

  HerranzDSerranoM. Sirt1: recent lessons from mouse models. Nat Rev Cancer (2010) 10(12):819–23. doi: 10.1038/nrc2962

  • CrossRef
  • Google Scholar

• 615

  BarchettaICiminiFACapocciaDDe GioannisRPorziaAMainieroFet al. Wisp1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes. J Endocr Soc (2017) 1(6):660–70. doi: 10.1210/js.2017-00108

  • CrossRef
  • Google Scholar

• 616

  LiuLHuJYangLWangNLiuYWeiXet al. Association of wisp1/ccn4 with risk of overweight and gestational diabetes mellitus in chinese pregnant women. Dis Markers (2020) 2020:4934206. doi: 10.1155/2020/4934206

  • CrossRef
  • Google Scholar

• 617

  MurahovschiVPivovarovaOIlkavetsIDmitrievaRMDockeSKeyhani-NejadFet al. Wisp1 is a novel adipokine linked to inflammation in obesity. Diabetes (2015) 64(3):856–66. doi: 10.2337/db14-0444

  • CrossRef
  • Google Scholar

• 618

  MaieseK. Wnt1 inducible Signaling Pathway Protein 1 (Wisp1). In: Encyclopedia of Signaling Molecules (2017) (Cham, Switzerland). doi: 10.1007/978-1-4614-6438-9_101926-1

  • CrossRef
  • Google Scholar

• 619

  GaoJXuHRongZChenL. Wnt family member 1 (Wnt1) overexpression-induced M2 polarization of microglia alleviates inflammation-sensitized neonatal brain injuries. Bioengineered (2022) 13(5):12409–20. doi: 10.1080/21655979.2022.2074767

  • CrossRef
  • Google Scholar

• 620

  LiPWuCGuoXWenYLiuLLiangXet al. Integrative analysis of genome-wide association studies and DNA methylation profile identified genetic control genes of DNA methylation for kashin-beck disease. Cartilage (2021) 13(1_suppl):780s–8s. doi: 10.1177/1947603519858748

  • CrossRef
  • Google Scholar

• 621

  FuYChangHPengXBaiQYiLZhouYet al. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing wnt/beta-catenin signaling pathway. PloS One (2014) 9(7):e102535. doi: 10.1371/journal.pone.0102535

  • CrossRef
  • Google Scholar

• 622

  GengYJuYRenFQiuYTomitaYTomoedaMet al. Insulin receptor substrate 1/2 (Irs1/2) regulates wnt/beta-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem (2014) 289(16):11230–41. doi: 10.1074/jbc.M113.544999

  • CrossRef
  • Google Scholar

• 623

  Ortiz-MasiaDCosin-RogerJCalatayudSHernandezCAlosRHinojosaJet al. Hypoxic macrophages impair autophagy in epithelial cells through wnt1: relevance in ibd. Mucosal Immunol (2014) 7(4):929–38. doi: 10.1038/mi.2013.108

  • CrossRef
  • Google Scholar

• 624

  WangSChongZZShangYCMaieseK. Wisp1 (Ccn4) autoregulates its expression and nuclear trafficking of beta-catenin during oxidant stress with limited effects upon neuronal autophagy. Curr Neurovasc Res (2012) 9(2):91–101. doi: 10.2174/156720212800410858

  • CrossRef
  • Google Scholar

• 625

  L’EpiscopoFTiroloCTestaNCanigliaSMoraleMCDeleidiMet al. Plasticity of subventricular zone neuroprogenitors in mptp (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of parkinson’s disease involves cross talk between inflammatory and wnt/beta-catenin signaling pathways: functional consequences for neuroprotection and repair. J Neurosci (2012) 32(6):2062–85. doi: 10.1523/jneurosci.5259-11.2012

  • CrossRef
  • Google Scholar

• 626

  SunTJTaoRHanYQXuGLiuJHanYF. Therapeutic potential of umbilical cord mesenchymal stem cells with wnt/beta-catenin signaling pathway pre-activated for the treatment of diabetic wounds. Eur Rev Med Pharmacol Sci (2014) 18(17):2460–4.

  • Google Scholar

• 627

  AlyHRohatgiNMarshallCAGrossenheiderTCMiyoshiHStappenbeckTSet al. A novel strategy to increase the proliferative potential of adult human beta-cells while maintaining their differentiated phenotype. PloS One (2013) 8(6):e66131. doi: 10.1371/journal.pone.0066131

  • CrossRef
  • Google Scholar

• 628

  CaiDHongSYangJSanP. The effects of microrna-515-5p on the toll-like receptor 4 (Tlr4)/jnk signaling pathway and wnt1-inducible-signaling pathway protein 1 (Wisp-1) expression in rheumatoid arthritis fibroblast-like synovial (Rafls) cells following treatment with receptor activator of nuclear factor-kappa-B ligand (Rankl). Med Sci Monit (2020) 26:e920611. doi: 10.12659/msm.920611

  • CrossRef
  • Google Scholar

• 629

  BayodSFelicePAndresPRosaPCaminsAPallasMet al. Downregulation of canonical wnt signaling in hippocampus of samp8 mice. Neurobiol Aging (2015) 36(2):720–39. doi: 10.1016/j.neurobiolaging.2014.09.017

  • CrossRef
  • Google Scholar

• 630

  KrupskaIBrufordEAChaqourB. Eyeing the cyr61/ctgf/nov (Ccn) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics (2015) 9(1):24. doi: 10.1186/s40246-015-0046-y

  • CrossRef
  • Google Scholar

• 631

  WangARYanXQZhangCDuCQLongWJZhanDet al. Characterization of wnt1-inducible signaling pathway protein-1 in obese children and adolescents. Curr Med Sci (2018) 38(5):868–74. doi: 10.1007/s11596-018-1955-5

  • CrossRef
  • Google Scholar

• 632

  Sahin ErsoyGAltun EnsariTSubasSGirayBSimsekEECevikO. Wisp1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus. J Matern Fetal Neonatal Med (2016) 30(8):942–6. doi: 10.1080/14767058.2016.1192118

  • CrossRef
  • Google Scholar

• 633

  LimHWLeeJEShinSJLeeYEOhSHParkJYet al. Identification of differentially expressed mrna during pancreas regeneration of rat by mrna differential display. Biochem Biophys Res Commun (2002) 299(5):806–12. doi: 10.1016/s0006-291x(02)02741-9

  • CrossRef
  • Google Scholar

• 634

  DuJKleinJDHassounahFZhangJZhangCWangXH. Aging increases ccn1 expression leading to muscle senescence. Am J Physiol Cell Physiol (2014) 306(1):C28–36. doi: 10.1152/ajpcell.00066.2013

  • CrossRef
  • Google Scholar

• 635

  HeWLuQSherchanPHuangLHuXZhangJHet al. Activation of Frizzled-7 Attenuates Blood-Brain Barrier Disruption through Dvl/β-Catenin/Wisp1 Signaling Pathway after Intracerebral Hemorrhage in Mice. Fluids Barriers CNS (2021) 18(1):44. doi: 10.1186/s12987-021-00278-9

  • CrossRef
  • Google Scholar

• 636

  GaudreauPOClairefondSClassCABoulayPLChrobakPAllardBet al. Wisp1 is associated to advanced disease, emt and an inflamed tumor microenvironment in multiple solid tumors. Oncoimmunology (2019) 8(5):e1581545. doi: 10.1080/2162402x.2019.1581545

  • CrossRef
  • Google Scholar

• 637

  LiYWangFLiuTLvNYuanXLiP. Wisp1 induces ovarian cancer via the igf1/αvβ3/wnt axis. J Ovarian Res (2022) 15(1):94. doi: 10.1186/s13048-022-01016-x

  • CrossRef
  • Google Scholar

• 638

  LiYZhuZHouXSunY. Lncrna afap1-as1 promotes the progression of colorectal cancer through mir-195-5p and wisp1. J Oncol (2021) 2021:6242798. doi: 10.1155/2021/6242798

  • CrossRef
  • Google Scholar

• 639

  LiuYQinWZhangFWangJLiXLiSet al. Association between wnt-1-inducible signaling pathway protein-1 (Wisp1) genetic polymorphisms and the risk of gastric cancer in guangxi chinese. Cancer Cell Int (2021) 21(1):405. doi: 10.1186/s12935-021-02116-2

  • CrossRef
  • Google Scholar

• 640

  WangQYFengYJJiR. High expression of wisp1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci (2020) 24(20):10445–51. doi: 10.26355/eurrev_202010_23396

  • CrossRef
  • Google Scholar

• 641

  WangYYangSHHsuPWChienSYWangCQSuCMet al. Impact of wnt1-inducible signaling pathway protein-1 (Wisp-1) genetic polymorphisms and clinical aspects of breast cancer. Medicine (2019) 98(44):e17854. doi: 10.1097/md.0000000000017854

  • CrossRef
  • Google Scholar

• 642

  ZhuYLiWYangYLiYZhaoY. Wisp1 indicates poor prognosis and regulates cell proliferation and apoptosis in gastric cancer via targeting akt/mtor signaling pathway. Am J Transl Res (2020) 12(11):7297–311.

  • Google Scholar

• 643

  ChongZZShangYCZhangLWangSMaieseK. Mammalian target of rapamycin: hitting the bull’s-eye for neurological disorders. Oxid Med Cell Longev (2010) 3(6):374–91. doi: 10.4161/oxim.3.6.14787

  • CrossRef
  • Google Scholar

• 644

  KoppCHosseiniASinghSPRegenhardPKhalilvandi-BehroozyarHSauerweinHet al. Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling. Int J Mol Sci (2014) 15(11):21401–18. doi: 10.3390/ijms151121401

  • CrossRef
  • Google Scholar

• 645

  Martinez de MorentinPBMartinez-SanchezNRoaJFernoJNogueirasRTena-SempereMet al. Hypothalamic mtor: the rookie energy sensor. Curr Mol Med (2014) 14(1):3–21. doi: 10.2174/1566524013666131118103706

  • CrossRef
  • Google Scholar

• 646

  LaiCSTsaiMLBadmaevVJimenezMHoCTPanMH. Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of ppargamma and C/ebps and modulation of sirt-1, ampk, and foxo pathways. J Agric Food Chem (2012) 60(4):1094–101. doi: 10.1021/jf204862d

  • CrossRef
  • Google Scholar

• 647

  DongYChenHGaoJLiuYLiJWangJ. Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol (2019) 136:27–41. doi: 10.1016/j.yjmcc.2019.09.001

  • CrossRef
  • Google Scholar

• 648

  Shokri AfraHZangooeiMMeshkaniRGhahremaniMHIlbeigiDKhedriAet al. Hesperetin is a potent bioactivator that activates sirt1-ampk signaling pathway in hepg2 cells. J Physiol Biochem (2019) 75(2):125–33. doi: 10.1007/s13105-019-00678-4

  • CrossRef
  • Google Scholar

• 649

  TsaiCFKuoYHYehWLWuCYLinHYLaiSWet al. Regulatory effects of caffeic acid phenethyl ester on neuroinflammation in microglial cells. Int J Mol Sci (2015) 16(3):5572–89. doi: 10.3390/ijms16035572

  • CrossRef
  • Google Scholar

• 650

  ChenGHLiXLDengYQZhouFMZouWQJiangWXet al. The Molecular Mechanism of Epo Regulates the Angiogenesis after Cerebral Ischemia through Ampk-Klf2 Signaling Pathway. Crit Rev Eukaryot Gene Expr (2019) 29(2):105–12. doi: 10.1615/CritRevEukaryotGeneExpr.2019029018

  • CrossRef
  • Google Scholar

• 651

  WangDSongYZhangJPangWWangXZhuYet al. Ampk-klf2 signaling pathway mediates the proangiogenic effect of erythropoietin in endothelial colony-forming cells. Am J Physiol Cell Physiol (2017) 313(6):C674–c85. doi: 10.1152/ajpcell.00257.2016

  • CrossRef
  • Google Scholar

• 652

  SuKHYuYBHouHHZhaoJFKouYRChengLCet al. Amp-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase. J Cell Physiol (2012) 227(8):3053–62. doi: 10.1002/jcp.23052

  • CrossRef
  • Google Scholar

• 653

  JangWKimHJLiHJoKDLeeMKYangHO. The neuroprotective effect of erythropoietin on rotenone-induced neurotoxicity in sh-sy5y cells through the induction of autophagy. Mol Neurobiol (2015) 53(6):3812–21. doi: 10.1007/s12035-015-9316-x

  • CrossRef
  • Google Scholar

• 654

  MaieseK. Charting a course for erythropoietin in traumatic brain injury. J Transl Sci (2016) 2(2):140–4. doi: 10.15761/JTS.1000131

  • CrossRef
  • Google Scholar

• 655

  WangLDiLNoguchiCT. Ampk is involved in mediation of erythropoietin influence on metabolic activity and reactive oxygen species production in white adipocytes. Int J Biochem Cell Biol (2014) 54:1–9. doi: 10.1016/j.biocel.2014.06.008

  • CrossRef
  • Google Scholar

• 656

  AndreucciMFuianoGPrestaPLucisanoGLeoneFFuianoLet al. Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. Cell Prolif (2009) 42(4):554–61. doi: 10.1111/j.1365-2184.2009.00617.x

  • CrossRef
  • Google Scholar

• 657

  Kubat OktemEAydinBYazarMArgaKY. Integrative analysis of motor neuron and microglial transcriptomes from sod1(G93a) mice models uncover potential drug treatments for als. J Mol Neurosci (2022) 72(11):2360–76. doi: 10.1007/s12031-022-02071-1

  • CrossRef
  • Google Scholar

• 658

  WangYLinYWangLZhanHLuoXZengYet al. Trem2 ameliorates neuroinflammatory response and cognitive impairment via pi3k/akt/foxo3a signaling pathway in alzheimer’s disease mice. Aging (Albany NY) (2020) 12:20862–79. doi: 10.18632/aging.104104

  • CrossRef
  • Google Scholar

• 659

  OaksZPatelAHuangNChoudharyGWinansTFaludiTet al. Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis. Nat Metab (2023) 5(1):41–60. doi: 10.1038/s42255-022-00711-9

  • CrossRef
  • Google Scholar

• 660

  MontiCColugnatILopianoLChiòAAlberioT. Network analysis identifies disease-specific pathways for parkinson’s disease. Mol Neurobiol (2018) 55(1):370–81. doi: 10.1007/s12035-016-0326-0

  • CrossRef
  • Google Scholar

• 661

  OaksZWinansTCazaTFernandezDLiuYLandasSKet al. Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice. Arthritis Rheumatol (Hoboken NJ) (2016) 68(11):2728–39. doi: 10.1002/art.39791

  • CrossRef
  • Google Scholar